Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,39093,-0.117543334352034,0.00393913161140117,-0.12526403231038,-0.109822636393688,3.36309810028694e-190
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,38727,-0.258250318463981,0.0111471025555419,-0.280098639472843,-0.236401997455119,1.11831668904568e-116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39253,0.24884255982846,0.0112640932567532,0.226764937045223,0.270920182611696,1.706253588907e-106
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,39023,-0.178087676446896,0.00811147374677576,-0.193986164990576,-0.162189187903215,3.35344149441265e-105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,36791,-0.0772901123329075,0.00365539903421141,-0.0844546944399619,-0.0701255302258531,1.39007026660574e-97
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,36796,0.101429425009738,0.00486623271461841,0.0918916088890856,0.11096724113039,6.2892651689397e-95
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,39095,-0.149017979331623,0.00733816098155492,-0.16340077485547,-0.134635183807775,1.7429688916124e-90
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,39291,-0.0929266424641984,0.00481497923517044,-0.102364001765132,-0.0834892831632643,5.01445175581457e-82
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,39255,-0.115655496003581,0.00600438558701205,-0.127424091754125,-0.103886900253038,1.02593977945142e-81
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36420,-0.0749953313266201,0.00398905778995551,-0.0828138845949329,-0.0671767780583073,8.74962495865089e-78
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,36391,-0.15769789853757,0.00846295837377403,-0.174285296950168,-0.141110500124973,1.83525450235684e-76
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,36792,-0.140987282331136,0.00757784444677395,-0.155839857446813,-0.126134707215459,2.8770296052017e-76
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,39086,0.306066000521926,0.0165688190461916,0.27359111519139,0.338540885852462,2.29046955179884e-75
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,39189,-0.057073811272099,0.00316575335346423,-0.0632786878448889,-0.0508689346993091,6.43138858362373e-72
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39119,-0.0861828571015945,0.00480300932310757,-0.0955967553748854,-0.0767689588283037,2.9093841625069e-71
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,36796,0.0824962184067252,0.00472013209678721,0.0732447594970222,0.0917476773164281,1.26916492201731e-67
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,39147,-0.0528733166149212,0.00310750033799711,-0.0589640172773955,-0.0467826159524468,2.49516610543226e-64
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,36796,0.0735932064671928,0.00436717756414527,0.065033538441468,0.0821528744929175,4.80930344191231e-63
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39162,0.0434940998975455,0.00259390279150599,0.0384100504261938,0.0485781493688972,1.51674513480936e-62
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,38994,-0.112976175230256,0.00690385739548882,-0.126507735725414,-0.0994446147350976,1.12051626859176e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39165,0.0575820665019018,0.00353475149935252,0.0506539535631709,0.0645101794406328,3.63900014808598e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,38886,0.0806115969822205,0.00496495096232725,0.0708802930960591,0.0903429008683819,8.85749831394226e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,38714,-0.087700049421445,0.00543559123951558,-0.0983538082508956,-0.0770462905919945,4.55337711054942e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39246,0.09118351448632,0.00572309053503252,0.0799662570376562,0.102400771934984,1.06951186818297e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39255,-0.0542970644891637,0.00342444581467823,-0.061008978285933,-0.0475851506923943,3.57134926853919e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,39182,0.0401190242775475,0.00255483020199437,0.0351115570816385,0.0451264914734565,3.86813991259802e-55
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,39106,0.0677914206010829,0.00434691494728195,0.0592714673044103,0.0763113738977556,2.06230929852338e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,36420,-0.086233609743631,0.00553616743626922,-0.0970844979187186,-0.0753827215685433,3.38070903175595e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,39106,-0.088264042698842,0.00571486082222699,-0.0994651699104069,-0.0770629154872771,2.07988385688715e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,39106,-0.0873342159803897,0.00573360666340353,-0.0985720850406606,-0.0760963469201188,5.23647947313328e-52
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,39064,-0.137657375379747,0.00921366298361378,-0.15571615482763,-0.119598595931864,4.06857523907673e-50
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,39237,-0.164476738929402,0.0110251614741496,-0.186086055418735,-0.142867422440069,5.6027439204228e-50
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,36421,-0.109216530386354,0.0073318045781795,-0.123586867359586,-0.0948461934131225,9.26118005231549e-50
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,36796,0.0345104386457942,0.00235458685415076,0.0298954484116588,0.0391254288799297,2.97391146992136e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,39093,-0.0551142921279919,0.00379336542950463,-0.062549288369821,-0.0476792958861628,1.64640897148393e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,36743,-0.09592778706294,0.00660227196830554,-0.108868240120819,-0.0829873340050611,1.86841108594321e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39147,-0.0335320630888941,0.00231039792811552,-0.0380604430280005,-0.0290036831497877,2.05504988186356e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,36500,-0.0379839147551083,0.00263281498173288,-0.0431442321193047,-0.0328235973909118,8.22186692111949e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39023,-0.0574010655314038,0.00398522597006885,-0.0652121084327387,-0.0495900226300688,1.00096609141193e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,39039,-0.0530006276429699,0.00370197694438139,-0.0602565024539574,-0.0457447528319824,3.43268104153551e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,38007,-0.0518550847156747,0.00362869795209716,-0.0589673327017852,-0.0447428367295643,5.25844516450233e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,39099,-0.0523716501195587,0.00367505389340979,-0.0595747557506419,-0.0451685444884755,8.75098553791171e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,38832,-0.107767454742013,0.00780383271364904,-0.123062966860765,-0.0924719426232607,4.10169432134789e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39099,-0.0669770756605083,0.00485214639097087,-0.0764872825868112,-0.0574668687342054,4.40386060557629e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,38672,-0.0695505723031092,0.00505409910501707,-0.0794566065489427,-0.0596445380572758,7.9981325446308e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39093,-0.0660487149600138,0.00486889899523404,-0.0755917569906725,-0.0565056729293551,1.12093333143305e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),36552,0.219713052693343,0.0161909550740934,0.18797878074812,0.251447324638566,1.17557628897115e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,38951,-0.0894237065378935,0.00662716819920227,-0.10241295620833,-0.076434456867457,2.96259138598818e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,36792,-0.0414469329921464,0.00308115642553463,-0.0474859995861943,-0.0354078663980985,5.66874841988885e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,38727,-0.0950667818607623,0.00707395442498755,-0.108931732533738,-0.0812018311877867,6.19359609881454e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,38727,-0.0731076502380395,0.00548756389839834,-0.0838632754789003,-0.0623520249971788,2.91708809490098e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,38824,-0.176224000325408,0.0132713029394197,-0.20223575408667,-0.150212246564145,5.19020770521129e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,38832,-0.0662914063282972,0.00502993790042502,-0.0761500846131303,-0.0564327280434642,1.91263865330976e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39023,-0.0432057338712043,0.0032835142368387,-0.0496414217754082,-0.0367700459670005,2.50169792301305e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,36791,0.0702751654210478,0.0053421808075349,0.0598044910382794,0.0807458398038162,2.8548207337809e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,38987,-0.0434551327384885,0.00330616747742262,-0.0499352209942369,-0.0369750444827402,3.03644427907386e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,39241,-0.0290422993032446,0.00221829402410005,-0.0333901555904807,-0.0246944430160085,5.89582116848364e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36500,0.036068424676559,0.00276025765278606,0.0306583196770983,0.0414785296760197,9.05620219136144e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,39153,-0.0708411847232811,0.0054333579147812,-0.0814905662362522,-0.06019180321031,1.1923577271938e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,39118,0.0233962477587438,0.00179749993655446,0.0198731478830971,0.0269193476343906,1.59158106493568e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39079,-0.10242625555812,0.0078749780052487,-0.117861212448408,-0.086991298667833,1.80079113523152e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,36792,-0.0337386556162615,0.00259696467614734,-0.0388287063815102,-0.0286486048510127,2.37321975935274e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,39283,-0.0595852574483196,0.00459354585544785,-0.0685886073249974,-0.0505819075716418,2.81431936668976e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,39103,-0.0370100268655185,0.00286153619359542,-0.0426186378049656,-0.0314014159260715,4.61116091424252e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,36792,-0.109277634369532,0.00850585568135133,-0.125949111504981,-0.0926061572340836,1.51013165117409e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39086,-0.134763951496635,0.0105349448999029,-0.155412443500445,-0.114115459492825,2.82387008868883e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,39093,0.0314330675492759,0.00246231916789334,0.026606921980205,0.0362592131183469,3.95268966039184e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,36614,-0.0299569327988553,0.00235727288154838,-0.0345771876466902,-0.0253366779510205,8.88449873049341e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,39042,-0.0355419125132813,0.00281694566416606,-0.0410631260150468,-0.0300206990115159,2.58317398951072e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39183,-0.0361692170350433,0.00287323520730072,-0.0418007580413527,-0.0305376760287339,3.6964010316691e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,36728,-0.097558855527572,0.00781170614087576,-0.112869799563688,-0.0822479114914555,1.38166465383774e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,39023,-0.0908100158976299,0.00727536023833142,-0.105069721964759,-0.0765503098305003,1.40251690470833e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,38832,-0.073908721096169,0.00592314508115855,-0.0855180854552397,-0.0622993567370982,1.47982132916912e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36500,-0.0563656083234843,0.00451871578257262,-0.0652222912573266,-0.0475089253896419,1.6783105018194e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,36747,-0.0879112490020064,0.00706043294964533,-0.101749697583311,-0.0740728004207015,2.19937288557427e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39255,-0.0319829177658512,0.002583826625723,-0.0370472179522683,-0.0269186175794341,5.03818511422087e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39165,-0.0485924255289996,0.00392667041639622,-0.0562886995451362,-0.040896151512863,5.24960874761605e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,38832,-0.0573035598265324,0.00464501307721984,-0.0664077854578833,-0.0481993341951815,8.49338902652853e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,36806,-0.0215336483668005,0.00174848505502043,-0.0249606790746405,-0.0181066176589604,1.16686415572745e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39023,-0.0900875878032978,0.00732920609808828,-0.104452831755551,-0.0757223438510448,1.46800135185195e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36490,-0.0539393214205949,0.0043917895423504,-0.0625472289236016,-0.0453314139175881,1.7828878980957e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39099,-0.0457941313188855,0.00373148899143097,-0.0531078497420902,-0.0384804128956808,1.85438956821041e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36420,-0.0648980359018268,0.00528746492303766,-0.0752614671509806,-0.0545346046526729,1.96869517542763e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39023,-0.0972526698578862,0.00798321932211987,-0.112899779729241,-0.0816055599865313,5.57836218349699e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,38905,-0.0422081980061043,0.00347473204506168,-0.0490186728144251,-0.0353977231977834,8.54750619143998e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,39099,-0.051372972275318,0.00423326009251372,-0.0596701620566449,-0.0430757824939911,9.79364350006335e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,36731,-0.0420291532061604,0.00347189451521423,-0.0488340664559803,-0.0352242399563405,1.5019067596978e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,36500,-0.0301889057255752,0.00249390259609598,-0.0350769548139233,-0.025300856637227,1.52165294739386e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,36500,-0.0584642439973271,0.0048484223056165,-0.0679671517163355,-0.0489613362783188,2.66740488271889e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36500,-0.0843569101623995,0.00700144663197936,-0.098079745561079,-0.0706340747637199,3.00411882986153e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,38750,-0.0546737732089105,0.004542118965882,-0.0635763263820393,-0.0457712200357818,3.23595569922133e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,36792,-0.0713882675891899,0.00593795333958216,-0.0830266561347709,-0.0597498790436088,4.07015878568187e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,39255,-0.0504722476082854,0.00422767815093614,-0.0587584967841202,-0.0421859984324505,1.03926342640214e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,38960,-0.0565815245413138,0.00475435246164359,-0.0659000553661352,-0.0472629937164923,1.6343421385629e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,39023,-0.0614687545251642,0.00518993830925403,-0.0716410336113021,-0.0512964754390263,3.2122784984667e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39099,-0.0302018040863175,0.0025525690718728,-0.0352048394671882,-0.0251987687054469,3.69142609367853e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,38841,-0.0593090985988804,0.00504247345047725,-0.0691923465618158,-0.049425850635945,8.46344746727739e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,38727,-0.0898738357254855,0.00766391810603074,-0.104895115213306,-0.0748525562376652,1.27907201030758e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,36806,-0.0776943679481715,0.00662772352426984,-0.0906847060557403,-0.0647040298406026,1.40915956350078e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36391,-0.0658649580663158,0.00564187102206684,-0.0769230252695668,-0.0548068908630647,2.50497748914774e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,39178,-0.033479191662445,0.00287586370933134,-0.0391158845327344,-0.0278424987921555,3.43275922633358e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39062,-0.0536972574449886,0.00461936436878606,-0.0627512116078093,-0.0446433032821679,4.19443114210231e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,36806,0.0703037553172578,0.00608656635241205,0.0583740852665302,0.0822334253679854,1.03612425832319e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,39106,-0.0677175050083194,0.00586689741133014,-0.0792166239345265,-0.0562183860821123,1.08295061907273e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39255,-0.0345272365708203,0.00299338635437651,-0.0403942738253982,-0.0286601993162423,1.18139688094805e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,38922,-0.049538699211884,0.00430434307177821,-0.0579752116325693,-0.0411021867911987,1.59443104404851e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,36791,-0.0337268340710967,0.00292975557133926,-0.0394691549909217,-0.0279845131512718,1.61968386190731e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,36767,-0.0465974516143933,0.00406180708923483,-0.0545585935092936,-0.0386363097194931,2.55524180697362e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,38741,-0.0534761960208715,0.00468364643056336,-0.0626561430247757,-0.0442962490169673,4.55395992523548e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,36792,-0.0310646303085759,0.00272443740423739,-0.0364045276208812,-0.0257247329962706,5.66713678912309e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,38987,-0.0776650265093637,0.00684898296464785,-0.0910890331200735,-0.0642410198986539,1.10012546808191e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39099,0.0356232140000561,0.00320703917459278,0.0293374172178543,0.041909010782258,1.47932360902034e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39234,-0.0507676573984585,0.00458098529522104,-0.0597463885770918,-0.0417889262198253,1.9601034981854e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,36731,-0.0531882988708061,0.00481424493581429,-0.0626242189450021,-0.0437523787966101,2.99883919289199e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,39147,-0.0551228860142362,0.00499539282436417,-0.0649138559499899,-0.0453319160784824,3.31958537608906e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,38977,-0.0374447178228602,0.00340720948640304,-0.0441228484162102,-0.0307665872295103,5.45774228235698e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,38951,-0.0237117898203331,0.00216784788791719,-0.0279607716806508,-0.0194628079600154,9.64754685265189e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,39133,-0.0301870507327126,0.00276598563602318,-0.0356083825793181,-0.0247657188861072,1.2542904746705e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39023,-0.0824248712007503,0.00755633906360215,-0.0972352957654106,-0.0676144466360901,1.33598835497303e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39072,-0.0289471833040185,0.00266302877736069,-0.0341667197076455,-0.0237276469003916,2.02005468772823e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36500,-0.0225026542144416,0.0020749425798967,-0.0265695416710391,-0.018435766757844,2.77873738582555e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39147,-0.0216536603461779,0.00199933071311379,-0.025572348543881,-0.0177349721484749,3.10059623621007e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,39106,0.0372157080629025,0.00344197248104592,0.0304694420000525,0.0439619741257525,3.7756909962657e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39023,-0.0662970629571399,0.00613210474054291,-0.078315988248604,-0.0542781376656758,3.81530885969185e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39241,-0.0520730262654951,0.00483042019851818,-0.0615406498545907,-0.0426054026763995,5.33017248435593e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,36792,-0.0563340392901646,0.00523935607313861,-0.0666031771935163,-0.0460649013868129,7.52301780196754e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,39291,-0.0375710219257536,0.0035100448896487,-0.0444507099094651,-0.0306913339420422,1.21081183876705e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,39023,-0.067610237669987,0.00634706090373658,-0.0800504770413107,-0.0551699982986633,2.11099471585127e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,39291,-0.0271895677593252,0.00256439181474704,-0.0322157757162294,-0.022163359802421,3.56077105191903e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,36806,0.0248113873508184,0.00235119814202959,0.0202030389924404,0.0294197357091964,6.29240199761105e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,36731,-0.0538369749583219,0.00510376093560771,-0.063840346392113,-0.0438336035245308,6.58444846068145e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,39166,-0.0627688607311957,0.00595258859686159,-0.0744359343810444,-0.0511017870813469,6.58736001072878e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39099,-0.048308355091532,0.00458714341188642,-0.0572991561788294,-0.0393175540042347,7.60696999163295e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,39260,-0.0668336677392254,0.00635244726503753,-0.079284464378699,-0.0543828710997518,8.46318485388989e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,38987,-0.0408264038514419,0.00389842108448449,-0.0484673091770314,-0.0331854985258523,1.41263355024078e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,36792,-0.0251850750201676,0.00240704300590772,-0.0299028793117467,-0.0204672707285884,1.61390108476869e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",38741,-0.0490703437996202,0.00469199161323294,-0.0582666473615568,-0.0398740402376837,1.64530856331502e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39237,-0.0413222984511106,0.00395441180416413,-0.0490729455872723,-0.0335716513149489,1.78956497275069e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,38727,-0.0605328746906965,0.00580472800832315,-0.0719101415870099,-0.0491556077943831,2.2550232027407e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36430,-0.115791986011154,0.01112027349058,-0.13758772205269,-0.093996249969617,2.74960510773384e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,39086,-0.0358666915523192,0.00345579842002859,-0.0426400564555753,-0.0290933266490632,3.76006437013397e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,36743,-0.105383082602292,0.0102062937906744,-0.125387418432014,-0.0853787467725703,6.7705230450586e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,39023,-0.0693691968459108,0.00673551851614138,-0.0825708131375479,-0.0561675805542737,8.59206207801156e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,36791,-0.105169476166119,0.0102847786146156,-0.125327642250766,-0.0850113100814729,1.88397157857585e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36500,-0.0203641168447562,0.00199495262594176,-0.0242742239916021,-0.0164540096979104,2.27410651625199e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,36420,-0.0607481842363612,0.00596037052499996,-0.0724305104653611,-0.0490658580073613,2.67609850456884e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,39106,-0.0239732428596032,0.00235628468361651,-0.0285915608394915,-0.0193549248797148,3.0906002840499e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,36792,-0.0344371044688291,0.00338675421472612,-0.0410751427296923,-0.0277990662079659,3.39121208456555e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,36792,-0.0275011341203661,0.00270837770022362,-0.0328095544128044,-0.0221927138279278,3.91345474506422e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,36747,-0.108719081716403,0.010759555787799,-0.129807811060489,-0.087630352372317,6.48272409059175e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,39190,-0.0641377295809706,0.00635198405082536,-0.0765876183205883,-0.0516878408413529,6.74630254020774e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39029,0.0592079098591495,0.00587497873901594,0.0476929515306783,0.0707228681876208,8.21559988383433e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39106,-0.0306810406052651,0.00304826770325303,-0.0366556453036411,-0.0247064359068892,9.35137603963251e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,38864,-0.0272106731613789,0.00270484513602278,-0.0325121696279836,-0.0219091766947743,9.87229343901202e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,36466,-0.0348413294071833,0.00349591389511338,-0.0416933206416055,-0.0279893381727611,2.61064452045389e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,36607,-0.0214137868281328,0.00216002053061801,-0.0256474270681441,-0.0171801465881214,4.39923950843108e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,36767,-0.0530128988234157,0.00536026139593749,-0.0635190111594531,-0.0425067864873782,5.55341560004533e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,39241,-0.0380483576563173,0.00387466892204277,-0.0456427087435211,-0.0304540065691134,1.07922344544409e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,38841,-0.0716905705322798,0.00734238780558034,-0.0860816506312173,-0.0572994904333424,1.87604458471996e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,36420,-0.0465783687971732,0.00476987509083168,-0.0559273239752033,-0.0372294136191431,1.91012540022247e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39093,-0.0275282194238943,0.00282522935667305,-0.0330656689629735,-0.0219907698848151,2.28106435590181e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,39291,-0.0369414470634377,0.00381069930512495,-0.0444104177014826,-0.0294724764253928,3.69341033407501e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39162,0.017915920508555,0.00186441697015576,0.0142616632470497,0.0215701777700603,8.40888124273663e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39224,-0.0267610254043852,0.00279317438076001,-0.0322356471906748,-0.0212864036180955,1.10645140719705e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,36791,-0.0473748781743842,0.00495011479787476,-0.0570771031782188,-0.0376726531705497,1.2551656982284e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,39283,-0.0492007273876938,0.00517634632555113,-0.0593463661857741,-0.0390550885896136,2.29080759509135e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,38625,-0.0877716856675406,0.00923838091120729,-0.105878912253507,-0.0696644590815744,2.39766852729343e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,36792,-0.0801788831879308,0.00843759160164087,-0.0967165627271469,-0.0636412036487147,2.40368865050596e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,36792,-0.060141889798324,0.00633323681729772,-0.0725550339602276,-0.0477287456364205,2.55365611740218e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,36646,-0.0278826182223279,0.00293795962639557,-0.0336410190900633,-0.0221242173545926,2.70271138521631e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,39210,0.0315867452082266,0.0033300914198075,0.0250597660254039,0.0381137243910493,2.76542098609644e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39140,0.0393846349129483,0.0041600966706828,0.03123084543841,0.0475384243874866,3.28481082058909e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39136,-0.0290797150270206,0.00307457274399684,-0.0351058776052544,-0.0230535524487868,3.5821631611983e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39291,-0.0671705941014172,0.00710267701832984,-0.0810918410573437,-0.0532493471454907,3.6132974073579e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36391,-0.0596544039975014,0.00631063979938499,-0.072023258004296,-0.0472855499907068,3.87235966359123e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,36731,-0.060598554056817,0.00642790450939034,-0.0731972468952221,-0.0479998612184119,4.91330237275155e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,39131,-0.0390007606132906,0.00413945503115976,-0.0471140924743637,-0.0308874287522174,5.06095283168898e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,39093,-0.0283546810516154,0.00301774382149579,-0.0342694589417472,-0.0224399031614836,6.45725551824914e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,39147,-0.035072853562173,0.00373502688179199,-0.0423935062504853,-0.0277522008738607,6.81327611424107e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,39023,-0.0309084353837162,0.00329164272407188,-0.0373600551228971,-0.0244568156445354,6.83864462436237e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,36806,-0.0305161966098447,0.00325347757375547,-0.0368930126544054,-0.0241393805652839,7.71342930562972e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,36500,-0.0551104000027258,0.00588534530354628,-0.0666456767976765,-0.0435751232077751,8.96244732326298e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39023,-0.0912432236991548,0.0098431413348164,-0.110535780715395,-0.0719506666829147,2.1128091918178e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,39211,-0.0423338977536239,0.0045670833975696,-0.0512853812128603,-0.0333824142943874,2.1170076398688e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,36420,-0.0517097142496678,0.00559291152899154,-0.0626718208464912,-0.0407476076528443,2.71330575581045e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39053,-0.045655418545255,0.00494514960228716,-0.0553479117657378,-0.0359629253247722,2.99040251978963e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,36747,-0.039222009780056,0.00424839919659212,-0.0475488722053766,-0.0308951473547354,3.06109768479495e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,38741,-0.0518564635775124,0.00562439073215246,-0.0628802694125312,-0.0408326577424936,3.36479188905738e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,36747,-0.0521998725983766,0.00566217878876084,-0.0632977430243479,-0.0411020021724054,3.45770558722312e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,38741,-0.0296225432133551,0.00321454996475072,-0.0359230611442666,-0.0233220252824437,3.51727650112496e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,38727,-0.0547883060061763,0.0059455024629179,-0.0664414908334954,-0.0431351211788572,3.51965747785506e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39255,-0.0288149219994506,0.00313431775815861,-0.0349581848054415,-0.0226716591934597,4.28561029180486e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39099,0.0329930640742347,0.00359450808328046,0.025947828231005,0.0400382999174644,4.91152818535804e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39106,-0.0538894965691198,0.00588820978871288,-0.0654303877549971,-0.0423486053832426,6.2788664509861e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,39117,-0.0250475914541018,0.00274730261393421,-0.0304323045774129,-0.0196628783307908,8.65631632504505e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,39291,-0.0383799430418386,0.00421016162827612,-0.0466318598332598,-0.0301280262504174,8.73532002060581e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,39099,-0.04523535900042,0.00496223029464437,-0.054961330377923,-0.0355093876229171,8.75531511760615e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,36500,0.0186502314293692,0.00205304815652899,0.0146262570425724,0.0226742058161661,1.19880102210664e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,36571,-0.023048854489329,0.0025382858845648,-0.028023894823076,-0.018073814155582,1.23889240858574e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39117,-0.0223105578884345,0.00246040483492217,-0.027132951364882,-0.017488164411987,1.35931161160244e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36420,-0.0709873287182159,0.00783135262949891,-0.0863367798720337,-0.055637877564398,1.43556260323819e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,36743,-0.0500839187415929,0.00552740656742321,-0.0609176356137424,-0.0392502018694434,1.47686631546932e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,36747,-0.039640194787762,0.0043775368341119,-0.0482201669826213,-0.0310602225929027,1.55480139001269e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,38987,-0.0591745442939131,0.00653743612249389,-0.0719879190940011,-0.0463611694938251,1.57715930386785e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36391,-0.0560540728744837,0.00622285233920415,-0.0682508634593238,-0.0438572822896436,2.40423393701481e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39131,-0.0291262294266634,0.0032411873937396,-0.0354789567183931,-0.0227735021349338,2.85182916745149e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39241,-0.0538732559614151,0.00600606595262218,-0.0656451452285546,-0.0421013666942757,3.30725473271275e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,39023,-0.0424282052458331,0.00473949619076706,-0.0517176177797366,-0.0331387927119297,3.88791048787517e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36500,-0.0320275164766476,0.0035773803639554,-0.0390391819900002,-0.0250158509632951,3.94617533207211e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39165,0.0476550780067364,0.0053415255768981,0.0371856878760162,0.0581244681374567,5.10736767471399e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39093,-0.0228287889861238,0.00256485623136875,-0.0278559071996066,-0.0178016707726411,6.17023712099467e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39165,-0.0227716333649322,0.00256353810904608,-0.0277961680586625,-0.0177470986712019,7.22771471074257e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,39255,-0.0534531838062444,0.00602169820912833,-0.0652557122961359,-0.0416506553163529,7.63043656192036e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39099,-0.0520993544814651,0.00587991815249031,-0.0636239940603461,-0.0405747149025841,8.82814476803186e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,36796,0.0504847559780397,0.0057001946151293,0.0393123745323863,0.0616571374236932,9.30827631101035e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,39162,-0.0625915760648071,0.00710127340982018,-0.0765100719480546,-0.0486730801815595,1.33404340079286e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,39106,-0.0284870299947319,0.00323471876154315,-0.0348270787673564,-0.0221469812221073,1.42622090326518e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,38727,-0.0480124829633619,0.00546238256025852,-0.0587187527814686,-0.0373062131452552,1.66222629094263e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39241,-0.112739948523427,0.0128318300582012,-0.137890335437501,-0.0875895616093524,1.71171459770755e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,36791,-0.0226682325840556,0.00258545298961944,-0.0277357204437097,-0.0176007447244015,2.05104462737492e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,38832,-0.0419178839768574,0.00480063965924628,-0.0513271377089801,-0.0325086302447346,2.76981884757391e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,38987,-0.0431216421510273,0.00493958941046248,-0.0528032373955338,-0.0334400469065208,2.81429824277798e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36500,-0.033249669940538,0.00381301260276888,-0.040723174641965,-0.025776165239111,3.12550637564821e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39206,-0.0463418315180856,0.00533510134025286,-0.0567986301449812,-0.03588503289119,4.12011391153423e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,38642,-0.0155199908186411,0.00178758434677837,-0.0190236561383267,-0.0120163254989555,4.28649467250354e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,38741,-0.0405019322687335,0.00467411668729274,-0.0496632009758273,-0.0313406635616397,4.96789420483795e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39241,0.0357746772831784,0.00413047946870072,0.027678937524525,0.0438704170418318,5.12874051774052e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,36747,-0.0505460410383933,0.00584918037862236,-0.0620104345804931,-0.0390816474962935,6.19379960118241e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,38795,-0.0600229757077661,0.00696214628248618,-0.073668782421439,-0.0463771689940931,7.27486816965998e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,39091,0.0466978290535441,0.00542783001261218,0.0360592822288242,0.057336375878264,8.48452297486667e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,38727,-0.0490352541415122,0.00570356711685568,-0.0602142456905493,-0.0378562625924751,8.96630586777339e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39182,-0.0375951162147509,0.00437421359854859,-0.0461685748679061,-0.0290216575615956,9.14371173206018e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39099,-0.0451614599480501,0.00526142466999477,-0.0554738523012399,-0.0348490675948604,1.00809669824075e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,38741,-0.0411927290845683,0.00480655501023845,-0.0506135769046357,-0.0317718812645009,1.13432105553768e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,38994,-0.0205397052556793,0.00240442371143875,-0.0252523757300992,-0.0158270347812593,1.43772828057481e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,39291,-0.0235988900239581,0.00276445151715649,-0.0290172149975848,-0.0181805650503314,1.51020456553462e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,36806,-0.0182742901322251,0.00214713989341462,-0.0224826843233177,-0.0140658959411324,1.91299566823009e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,36747,-0.0518749692114855,0.00611855718525259,-0.0638673412945806,-0.0398825971283904,2.53203144799012e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,38741,-0.0214483123715709,0.0025383923874279,-0.0264235614509296,-0.0164730632922122,3.19202293280324e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39093,0.0285519929065741,0.0033793923974571,0.0219283838075582,0.03517560200559,3.20495416859614e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,38727,-0.0526930199520662,0.00624221930255374,-0.0649277697850715,-0.0404582701190608,3.42250744495404e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,38727,-0.0556501252831426,0.00659800426780675,-0.0685822136480438,-0.0427180369182414,3.632780715726e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,38736,-0.0327327755686514,0.00389422340113678,-0.0403654534348795,-0.0251000977024233,4.64414655580124e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39023,-0.0463251023016443,0.00552527715039462,-0.0571546455164177,-0.0354955590868708,5.55142195985494e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,39255,0.0272491567269372,0.00325069108990261,0.0208778021907281,0.0336205112631463,5.62192588799549e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39106,-0.0253997340026446,0.00303122423848888,-0.0313409335100828,-0.0194585344952064,5.78121125660401e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",38832,-0.0706955729853797,0.00845089658586681,-0.0872593302936787,-0.0541318156770808,6.51217404786551e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39237,-0.0206691392172071,0.00248486037396336,-0.0255394655501752,-0.0157988128842389,9.68709816556829e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,36791,-0.0307633977629945,0.00370506545999633,-0.0380253260645873,-0.0235014694614017,1.11482344680691e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36224,-0.0244891631887921,0.00295130638904874,-0.0302737237113276,-0.0187046026662566,1.17069788823384e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,39162,-0.0315188123984532,0.00380290050594673,-0.0389724973901088,-0.0240651274067976,1.24544097126104e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,36747,-0.0291005456571553,0.00351153697778296,-0.0359831581336099,-0.0222179331807007,1.27429656985353e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,38741,-0.0395010653687171,0.00478396717813465,-0.048877641037861,-0.0301244896995731,1.61883487302489e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39283,0.0259402404714715,0.00314698890679836,0.0197721422141467,0.0321083387287963,1.81538878033829e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39063,-0.0149779971776893,0.00181731829674331,-0.0185399410393062,-0.0114160533160724,1.83356093258341e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,36747,-0.0315818158459397,0.00383357243988973,-0.0390956178281236,-0.0240680138637559,1.91567529448911e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,36747,-0.0238288893096822,0.00290095302732088,-0.0295147572432311,-0.0181430213761333,2.33918312795634e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36531,-0.0331698761970607,0.00404246147616918,-0.0410931006903523,-0.0252466517037692,2.5198068443675e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,39106,-0.0514150514075451,0.00627012947815348,-0.063704505184726,-0.0391255976303643,2.59399682962132e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39099,-0.0538758141581776,0.00657470217121911,-0.0667622304137671,-0.0409893979025882,2.71689878151313e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39023,-0.0740239481889151,0.00904604417263944,-0.0917541947672884,-0.0562937016105418,2.98648740148663e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39023,-0.0227254777629932,0.00277828889044349,-0.0281709239882624,-0.0172800315377239,3.0703618948857e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,38841,-0.0391535719423742,0.00479945822666394,-0.0485605100666355,-0.0297466338181128,3.67733935956049e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",38741,-0.0381523106824789,0.00468776488802358,-0.0473403298630052,-0.0289642915019527,4.30964561864983e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,36500,-0.0873672493969091,0.0107382408255093,-0.108414201414907,-0.066320297378911,4.46245732451452e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39274,-0.0395170670367293,0.00485850912074858,-0.0490397449133965,-0.0299943891600621,4.48321438250542e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,39057,-0.0509790037110382,0.00628008458273406,-0.063287969493197,-0.0386700379288794,5.11835037730725e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,39086,-0.0287143088911316,0.00353781137478025,-0.0356484191857009,-0.0217801985965623,5.16662811512492e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,36500,-0.0245732346077806,0.00303116055264982,-0.0305143092909742,-0.018632159924587,5.67002638202862e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,39291,-0.0370360669116753,0.00457193042645612,-0.0459970505475293,-0.0280750832758213,5.86800387295189e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,36747,-0.0284017503474433,0.00350694763034691,-0.0352753677029232,-0.0215281329919633,6.05149882655697e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,39206,-0.0445967757194164,0.00551081158237789,-0.0553979664208771,-0.0337955850179558,6.27529740353117e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,39079,0.0337918859053515,0.00418735506675754,0.0255846699745068,0.0419991018361963,7.5525753954183e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39023,0.0147548348797534,0.00182981730527018,0.0111683929614239,0.018341276798083,7.9609406522543e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,36767,-0.0448936778591001,0.00557474447368297,-0.0558201770275188,-0.0339671786906815,8.78065856870657e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,39093,-0.0422412046587457,0.00524642049839093,-0.052524188835592,-0.0319582204818995,8.78407652010272e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,39255,-0.0246502961868527,0.00306693330103651,-0.0306614854568843,-0.0186391069168212,9.83518120417939e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,38950,-0.0540477658427313,0.00672753361363764,-0.0672337317254611,-0.0408617999600015,1.01433127548043e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39147,-0.0256914384377889,0.00322041994022263,-0.0320034615206252,-0.0193794153549526,1.59637173199512e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39106,-0.0308696098631133,0.00386952158765088,-0.038453872174909,-0.0232853475513175,1.59714763257328e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39106,-0.0207218412087964,0.00260003934094101,-0.0258179183170408,-0.015625764100552,1.70095906759991e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,38741,-0.0482503867825956,0.00605645674158047,-0.0601210419960933,-0.0363797315690979,1.74617503661646e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,36731,-0.0588473680697375,0.00739610453567256,-0.0733437329596557,-0.0443510031798193,1.91663740615604e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,36796,-0.0160374684061157,0.00201939626843372,-0.0199954850922458,-0.0120794517199857,2.1580693707396e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,39023,-0.0239340651178905,0.00301906473584572,-0.0298514320001481,-0.0180166982356329,2.38821667878808e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39106,-0.0221254917474266,0.00279504084763821,-0.0276037718087975,-0.0166472116860558,2.62111755681326e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,39093,-0.0329301862962976,0.00416067820634126,-0.0410851155807265,-0.0247752570118687,2.64999421617441e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,36747,-0.0644001505009517,0.00816292358339059,-0.0803994807243973,-0.0484008202775062,3.28181925327985e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,36616,-0.0384123017709972,0.00487170652676169,-0.0479608465634501,-0.0288637569785443,3.40641414481324e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,36731,-0.0156588558269099,0.00198709778299494,-0.01955356748158,-0.0117641441722398,3.52855998788258e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,36743,-0.0215492511062221,0.00273803934433169,-0.0269158082211122,-0.016182693991332,3.81889577864128e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39023,-0.0147876245480887,0.00187966766103992,-0.0184717731637269,-0.0111034759324504,3.87185536882552e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,38788,-0.0431572091177549,0.00548857889916984,-0.0539148237601278,-0.032399594475382,4.00287735911857e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,36657,-0.0198959620033103,0.00253223698291964,-0.0248591464898328,-0.0149327775167878,4.24530166150107e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39283,-0.0291733007880236,0.00371677625227561,-0.0364581822424838,-0.0218884193335634,4.46479289920517e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,39147,-0.04126079220149,0.00525820827777157,-0.0515668804259223,-0.0309547039770578,4.54447396562578e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,36500,-0.0500212588438607,0.00637460042726303,-0.0625154756812962,-0.0375270420064252,4.60419735313833e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39147,-0.0603416697791076,0.00769984132896042,-0.07543335878387,-0.0452499807743452,4.92704473175682e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39023,-0.0248545418130164,0.00317453090202569,-0.0310766223809868,-0.0186324612450461,5.22662870922592e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,39283,0.0169382066519521,0.00216733882166886,0.0126902225614811,0.0211861907424231,5.839734268045e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,39241,-0.0419318122258843,0.00537238815739654,-0.0524616930143816,-0.0314019314373871,6.32850543747662e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,36767,-0.0401371193222101,0.00514724366351635,-0.0502257169027022,-0.0300485217417181,6.78214542781459e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,36806,0.0196283245954146,0.00251967056030923,0.0146897702972085,0.0245668788936206,7.20787431151474e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,36726,-0.0589501705342473,0.00756995538897262,-0.0737872830966337,-0.044113057971861,7.36319488051769e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,36806,-0.0175807898999484,0.00225809157670193,-0.0220066493902842,-0.0131549304096126,7.45914008161094e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,36731,-0.0348331263451165,0.00448718890552509,-0.0436280165999457,-0.0260382360902873,8.93367946452485e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,38727,-0.0487779950928665,0.00628575669011221,-0.0610980782054865,-0.0364579119802466,9.03765919334459e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36430,-0.0618163573047103,0.00796528496245765,-0.0774283158311273,-0.0462043987782933,9.0960091735032e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39079,-0.0701859832937018,0.00904843241092688,-0.0879209108191185,-0.0524510557682851,9.26746955240073e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,36500,-0.0330570215968796,0.00426121638474829,-0.0414090057109862,-0.0247050374827729,9.31413057567668e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,38741,-0.0407185163504649,0.0052500767160649,-0.0510086667139521,-0.0304283659869777,9.34659584891456e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,38727,-0.044940500999357,0.0057980543333932,-0.0563046874928077,-0.0335763145059063,9.70835913670973e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,38741,-0.0254621600505594,0.00328694309145275,-0.0319045685098068,-0.019019751591312,1.00569923192857e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39291,-0.0308356765207525,0.0039816399103991,-0.0386396907451348,-0.0230316622963703,1.01924870136671e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,36538,-0.0385241474721211,0.00497979117092204,-0.0482845381671283,-0.0287637567771139,1.10250562033089e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,38741,-0.0315287302847877,0.00408216832595368,-0.0395297802036569,-0.0235276803659185,1.20346232048369e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39099,-0.0658951576631451,0.00853764900095989,-0.0826289497050265,-0.0491613656212637,1.25294222456023e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39099,-0.043606226808299,0.00565779558442524,-0.0546955061537725,-0.0325169474628255,1.36427835824744e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39099,-0.0530202177459696,0.00688063354602563,-0.0665062594961798,-0.0395341759957593,1.38103498405776e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39291,-0.0231987436188219,0.00301353617812842,-0.0291052745279536,-0.0172922127096902,1.46355576052825e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36420,-0.0427075810586307,0.00554975279588742,-0.05358509653857,-0.0318300655786913,1.51567374200457e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,39093,0.0203037944566821,0.00264333332646197,0.0151228611368167,0.0254847277765476,1.67254660602825e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,36796,-0.0513577067861427,0.00670617764173839,-0.06450181496395,-0.0382135986083355,2.0182283731629e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,38727,-0.0402112300206278,0.00525304492690284,-0.0505071980773574,-0.0299152619638983,2.05423423581947e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,38727,-0.0206916445999428,0.00270399255797275,-0.0259914700135694,-0.0153918191863162,2.09581238710221e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36261,-0.0378514749206619,0.00494749500448099,-0.0475485651294447,-0.0281543847118792,2.14746167918829e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,36391,-0.0278039090765431,0.00364004102248351,-0.0349383894806108,-0.0206694286724754,2.35977561009448e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,36806,-0.0140102450426417,0.00183631072897065,-0.0176094140714242,-0.0104110760138592,2.51994014295876e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,36747,-0.077202146741862,0.0101333204344635,-0.0970634547934104,-0.0573408386903136,2.74229133295343e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36500,-0.037477388004203,0.00491967436033493,-0.0471199497504594,-0.0278348262579465,2.7625232748675e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,39162,-0.0229998586140385,0.00302298166896946,-0.0289249026852186,-0.0170748145428584,2.93781807212711e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,38727,-0.0777432175027126,0.0102385406353746,-0.0978107571480469,-0.0576756778573782,3.30647710117621e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,38741,-0.0433859205082943,0.00571617765767858,-0.0545896287173443,-0.0321822122992443,3.38788322569927e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,36792,-0.0308393563257245,0.00407162135748421,-0.0388197341863935,-0.0228589784650554,3.85799715503054e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,36670,-0.0175028077217847,0.00231748578831292,-0.022045079866878,-0.0129605355766914,4.55896944479362e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36430,-0.0312426147235512,0.00413738613630021,-0.0393518915506996,-0.0231333378964028,4.60692168980426e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,38741,-0.0471402931454158,0.00624691773442685,-0.0593842519048925,-0.0348963343859392,4.74179284061358e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,39255,-0.0298873579230229,0.00396616307508678,-0.0376610375501929,-0.0221136782958528,5.13156948237605e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,39071,-0.064059059386331,0.00850799819186449,-0.0807347358423854,-0.0473833829302766,5.38825236955811e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39023,-0.0867277455161904,0.0115244094672527,-0.109315588072006,-0.0641399029603752,5.54367239410106e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,36420,-0.0210875008706984,0.0028042806422702,-0.026583890929548,-0.0155911108118489,5.86050336172798e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39229,-0.0229124533415026,0.00304808831398367,-0.0288867064369106,-0.0169382002460946,5.9139233309128e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,39013,-0.039021327278875,0.00519582224103364,-0.049205138871301,-0.0288375156864491,6.23559656523643e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39023,-0.0474604750637159,0.0063433871107844,-0.0598935138008533,-0.0350274363265785,7.72817500119115e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,36731,-0.0395695179340075,0.00528991633947839,-0.0499377539593851,-0.0292012819086299,7.90313058586758e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,38727,-0.0342979966552479,0.00459493600883623,-0.0433040712325669,-0.0252919220779288,8.83812342073679e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',36747,-0.0279119899568481,0.0037563970433497,-0.0352745281618135,-0.0205494517518826,1.14984289552588e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39241,-0.0459879742703391,0.00619050149057536,-0.0581213571918668,-0.0338545913488114,1.15343084785969e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,36731,-0.0685854606891465,0.00923671522333898,-0.0866894225268909,-0.0504814988514022,1.19594220156952e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,38684,-0.0596081295176285,0.00807976418731288,-0.0754444673247617,-0.0437717917104952,1.698916487536e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,38841,-0.0407537756978512,0.00553810477069951,-0.0516084610484223,-0.0298990903472802,1.95211654954421e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,38987,-0.0607636025714114,0.00825780210468141,-0.0769488946965869,-0.0445783104462358,1.95799701848528e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,36747,-0.0375838753857217,0.00510696451660667,-0.0475935258382707,-0.0275742249331726,1.96023740018949e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39099,-0.0670199530899237,0.00910894671493826,-0.0848734886512027,-0.0491664175286447,1.96796928274841e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,36747,-0.0476871757435874,0.00652257882009676,-0.060471430230977,-0.0349029212561977,2.80613606802607e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39023,0.0274588914856798,0.00376088349174504,0.0200875598418595,0.0348302231295,2.99423054904145e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,36538,-0.0363237036354886,0.00498312522537618,-0.0460906290772259,-0.0265567781937513,3.29937484618374e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,39145,-0.0122869567736839,0.00168622027065314,-0.0155919485041641,-0.00898196504320377,3.33201252932935e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39101,-0.0387312598817868,0.00532547297351623,-0.0491691869098786,-0.028293332853695,3.6915982258446e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36500,-0.0248876805979266,0.00342920871610204,-0.0316089296814866,-0.0181664315143666,4.17169465025572e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39099,-0.0368789763704579,0.005087510337284,-0.0468504966315345,-0.0269074561093812,4.40267346879714e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39095,0.0228126199336209,0.00314710812557994,0.0166442880074842,0.0289809518597576,4.40816545714988e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39023,-0.0365362426509452,0.00505085160813152,-0.046435911802883,-0.0266365734990074,4.92576711261381e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39255,-0.0863891481620172,0.0119623846398628,-0.109835422056148,-0.062942874267886,5.37318811917129e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,38727,-0.0370157570825311,0.00512668969402081,-0.0470640688828119,-0.0269674452822503,5.44246304441461e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,36743,-0.0172402255455256,0.00238759797741964,-0.0219199175812681,-0.0125605335097831,5.46075848333067e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,36743,-0.0710441090935958,0.00983983350517273,-0.0903301827637343,-0.0517580354234572,5.48836990853686e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,36743,-0.0268882414642138,0.00372908213720515,-0.0341972424531359,-0.0195792404752917,5.88934426807785e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,36767,-0.0286459559434831,0.00397802634178285,-0.0364428875733775,-0.0208490243135887,6.30628248980599e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,36747,-0.0463742334251337,0.00643993815269839,-0.0589965122044225,-0.0337519546458449,6.30728099922305e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39204,-0.0689208712819656,0.00957309942614275,-0.0876841461572054,-0.0501575964067258,6.32691224057503e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,38727,-0.0365147452315757,0.0050727355040669,-0.0464573068195469,-0.0265721836436046,6.39170512628175e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36420,-0.0482262006940337,0.00671214614193114,-0.0613820071322187,-0.0350703942558486,7.10464452764942e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,36747,-0.0417071996167928,0.00580667641164546,-0.0530882853836179,-0.0303261138499677,7.21401429685638e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39099,-0.0500758532670809,0.00697317592196843,-0.063743278074139,-0.0364084284600228,7.22914290509778e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,36792,-0.0499723854544041,0.0069594437871583,-0.0636128952772343,-0.0363318756315738,7.32465511512343e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,38907,-0.0239524221926486,0.00333638164658503,-0.0304917302199553,-0.017413114165342,7.3422314360843e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,38841,-0.0471897441476267,0.00658703502899689,-0.0601003328044606,-0.0342791554907928,8.19878281829565e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,38727,-0.043135400904149,0.00602220511316634,-0.054938922925955,-0.0313318788823429,8.28008826537628e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,38939,-0.0197062049475457,0.00275302614707646,-0.0251021361958156,-0.0143102736992758,8.56298577521118e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,39283,-0.0379779448245734,0.00531450109747298,-0.0483943669756204,-0.0275615226735264,9.32783774113908e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36155,-0.0327692341869268,0.00458518847466655,-0.0417562035972732,-0.0237822647765803,9.38704576820687e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,36718,-0.0209468271591641,0.00293218319446751,-0.0266939062203204,-0.0151997480980078,9.57004781397015e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,36500,-0.0364116715124093,0.00510156819315079,-0.0464107451709849,-0.0264125978538338,1.00345434484215e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39023,-0.0752711242110894,0.0105487058834008,-0.095946587742555,-0.0545956606796238,1.00747248210871e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39106,-0.0414141762975748,0.00580751952662151,-0.0527969145697529,-0.0300314380253966,1.0402223587982e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,38987,-0.0191810930119451,0.00269067761128423,-0.0244548211300622,-0.013907364893828,1.05888235366639e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36391,-0.0282773738075555,0.00397246323921461,-0.0360634017564161,-0.0204913458586948,1.15183941124365e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39114,-0.0421230940926405,0.00591963005683886,-0.0537255690040447,-0.0305206191812363,1.16193464420543e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39023,-0.0290460005672149,0.00409167254987045,-0.0370656787649609,-0.0210263223694688,1.31421278477605e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36420,-0.0458419391139556,0.00645853669857378,-0.0585006710431603,-0.033183207184751,1.33493311928119e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39136,-0.0333459713074281,0.00469935385266024,-0.0425567048586421,-0.024135237756214,1.34198972902095e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,39023,0.0500305540778841,0.00705491362242994,0.0362029233779214,0.0638581847778468,1.38439639060172e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,36430,-0.0554192904023939,0.00782130546194773,-0.0707490491078114,-0.0400895316969763,1.45741994329644e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,38816,-0.0272919028580154,0.00385839113832813,-0.0348543494891385,-0.0197294562268922,1.57901817572729e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,38987,-0.0378730907020307,0.005354658476567,-0.0483682213161021,-0.0273779600879594,1.58353538581263e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,39093,-0.0421989393910958,0.0059708076393114,-0.0539017223641462,-0.0304961564180455,1.64544584412059e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36500,-0.0540192882620077,0.00764315474905379,-0.0689998715701531,-0.0390387049538622,1.65830910817e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39093,-0.0153761968169744,0.00217632905395808,-0.0196418017627322,-0.0111105918712165,1.67337467722966e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,36747,-0.0199687417009052,0.00282675180458726,-0.0255091752378963,-0.0144283081639142,1.69843056055434e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,39032,-0.0284642968447313,0.00403108013247079,-0.036365213904374,-0.0205633797850885,1.72227437747562e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,39093,-0.0236670766961638,0.00335509803903244,-0.0302430688526674,-0.0170910845396602,1.81249638479525e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,38832,-0.0377494533493484,0.00535328497795829,-0.0482418919061466,-0.0272570147925501,1.84557143376322e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,36792,-0.049770591763187,0.00706479827729099,-0.0636175963866774,-0.0359235871396967,1.95033068432773e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,36712,-0.0285984081173784,0.00406986131613277,-0.0365753362969986,-0.0206214799377582,2.21862563403905e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",36806,-0.0105789499985052,0.00150640344700845,-0.0135315007546418,-0.00762639924236865,2.28564946648005e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,38841,-0.031105410034057,0.00443802883496649,-0.0398039465505913,-0.0224068735175227,2.50570449098168e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36420,-0.0481732051422622,0.00688162839890611,-0.0616611968041181,-0.0346852134804062,2.68475892809963e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36430,-0.0517228909708991,0.00739335682769936,-0.0662138703531899,-0.0372319115886084,2.76998678584499e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,39205,-0.0349817979501368,0.00500376913524644,-0.0447891854552199,-0.0251744104450538,2.84008098907372e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,36608,-0.0393391382891837,0.00563148255130861,-0.0503768440897486,-0.0283014324886189,2.97783977895038e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,38832,-0.0241701494536596,0.00346147745974317,-0.0309546452747562,-0.017385653632563,3.01937365900271e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,38741,-0.024755403612814,0.00354714426481431,-0.03170780637185,-0.0178030008537779,3.09922687168936e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",38727,-0.053824090157114,0.0077223619295945,-0.0689599195391193,-0.0386882607751088,3.30511608277672e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36421,-0.0783306120519262,0.0112456145441146,-0.100372016558391,-0.0562892075454617,3.43705274666603e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,36791,-0.0485705592052608,0.0069742113332991,-0.062240013418527,-0.0349011049919946,3.45978739912536e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,38987,-0.0322059745270654,0.00462825082021994,-0.0412773461346965,-0.0231346029194343,3.57880092563351e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,36792,-0.0378385410990853,0.00543979344755362,-0.0485005362562904,-0.0271765459418802,3.67230953795953e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,38741,-0.0513172472912637,0.00738823164578002,-0.0657981813169925,-0.0368363132655348,3.91897628247995e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,38741,0.0472842625031037,0.00680923177985609,0.0339381682145857,0.0606303567916216,3.96542151634975e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,39099,-0.0524684373059562,0.00757156284221839,-0.0673087004767043,-0.0376281741352082,4.38733135342368e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36373,-0.0327251176018898,0.00472334856906828,-0.0419828807972637,-0.023467354406516,4.4656057249942e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,36731,-0.073271575339718,0.0105838878403832,-0.094015995506869,-0.0525271551725669,4.63364008398345e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36500,-0.0497000383841717,0.00720767635918161,-0.0638270840481676,-0.0355729927201757,5.62555142266317e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39283,-0.0431948705717898,0.00626662665106448,-0.0554774588078762,-0.0309122823357034,5.68087904702847e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,36770,-0.0285083399422143,0.00413743808343604,-0.036617718585749,-0.0203989612986797,5.82436076043516e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,36796,0.0163014581363219,0.0023669596312644,0.0116622172590437,0.0209406990136001,5.95784275358792e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39106,0.0494729716865672,0.00720195755056628,0.0353571348874573,0.0635888084856771,6.69776882815356e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39147,-0.0580090016461072,0.00846274055832825,-0.0745959731404306,-0.0414220301517838,7.42303006752583e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39064,-0.0411789852681982,0.00601060784702911,-0.0529597766483753,-0.0293981938880212,7.61238323921275e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,39147,-0.0350422341107775,0.00511857984160055,-0.0450746506003146,-0.0250098176212405,7.8788034801528e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,39255,-0.0157629967839694,0.00230268995013245,-0.020276269086229,-0.0112497244817098,7.91052672246946e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,36500,-0.0340620634981564,0.00497672068520267,-0.0438164360411537,-0.0243076909551592,8.04101672471477e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39076,-0.0526041713400023,0.0076885112722724,-0.0676736534336562,-0.0375346892463484,8.11212533697911e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",36721,-0.069223401655838,0.0101183250534673,-0.0890553187606339,-0.049391484551042,8.19796376110944e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,38987,-0.0411279081222718,0.00602122839790403,-0.0529295157821637,-0.0293263004623799,8.78555702796624e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,39069,-0.0572005252571176,0.00837610415864034,-0.0736176894080527,-0.0407833611061826,8.87407000528775e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],38739,-0.0305799131903924,0.00447862620528899,-0.0393580205527589,-0.021801805828026,8.9461450667533e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,36421,-0.0286911938034944,0.00420168781949577,-0.0369265019297061,-0.0204558856772826,8.97614228071359e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39283,-0.0305611955782092,0.00449220915281564,-0.0393659255177279,-0.0217564656386906,1.06118779291681e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,36806,-0.0167356431361599,0.00245976517239313,-0.0215567828740504,-0.0119145033982693,1.06409602547923e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39106,-0.0219680440390144,0.00323064879779572,-0.028300115682694,-0.0156359723953348,1.08592738757624e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,39106,0.0192811452611884,0.00283889967223387,0.01371690190361,0.0248453886187668,1.14865073148769e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,38727,-0.0281589511710413,0.00414658528757205,-0.0362862583346826,-0.0200316440074001,1.15680570910359e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39211,-0.0373126495314121,0.00550173747308111,-0.048096054978651,-0.0265292440841731,1.22872364359158e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,36747,-0.0409755139618391,0.00604388670406815,-0.0528215319018127,-0.0291294960218655,1.25705418756974e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,38987,-0.038899381796762,0.00574399940398793,-0.0501576206285784,-0.0276411429649457,1.31533870214356e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",38994,-0.0468118118878473,0.00692485719154591,-0.0603845319832773,-0.0332390917924173,1.43070234310666e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,39291,-0.0212184826693326,0.00314263233843963,-0.0273780420526742,-0.0150589232859909,1.51213882099413e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,36806,-0.0127656328169438,0.00189172153368143,-0.0164734070229593,-0.00905785861092816,1.56109943327592e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,36631,-0.0345373287237097,0.00512031088585613,-0.0445731380599877,-0.0245015193874317,1.59442376751342e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,39099,-0.0596885897898401,0.00885256051942446,-0.077039608407912,-0.0423375711717682,1.6125514496201e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39071,-0.0530844141196422,0.00787382377090544,-0.0685171087106168,-0.0376517195286675,1.61973028159931e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39023,-0.0243332172184543,0.0036123246934834,-0.0314133736176818,-0.0172530608192268,1.68474094975741e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36420,-0.0256654136189871,0.00381290058108512,-0.0331386987579139,-0.0181921284800602,1.755780044768e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,36743,-0.0315639448244042,0.00469365532098997,-0.0407635092535446,-0.0223643803952639,1.83239364996983e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,36420,-0.0291541949700459,0.00433531989244036,-0.037651421959229,-0.0206569679808628,1.83437188719669e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",36750,-0.0251146634680827,0.00373564529947613,-0.0324365282550559,-0.0177927986811095,1.85547164499173e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36500,-0.0431004452662784,0.00641223650945232,-0.055668428824805,-0.0305324617077518,1.87466556571088e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,38951,-0.0400507501451642,0.00595968735378024,-0.0517317373585735,-0.028369762931755,1.87877877923065e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39099,-0.0662256904987778,0.00985975616546887,-0.0855508125830968,-0.0469005684144589,1.923775221634e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,39244,0.0328316000382433,0.00489266036411831,0.0232419857245714,0.0424212143519152,2.00901627434839e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,36743,-0.0646686390059583,0.00965336609090903,-0.08358923654414,-0.0457480414677766,2.18456276856404e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,36731,-0.0224340593201933,0.00335090871236876,-0.029001840396436,-0.0158662782439505,2.24745918269365e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,38973,-0.0207394500650023,0.00310083486001449,-0.0268170863906307,-0.0146618137393739,2.33633350928313e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36421,-0.0305950480782365,0.00458157134068657,-0.0395749279059822,-0.0216151682504908,2.52681061585868e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,39283,-0.0364468590652931,0.00546581236809511,-0.0471598513067595,-0.0257338668238266,2.67848608947596e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39099,-0.0268014402851204,0.00402059001444419,-0.034681796713431,-0.0189210838568098,2.71812419017263e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,39086,-0.0178794298191589,0.00268329182756773,-0.0231386818011916,-0.0126201778371261,2.77040254244101e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,36792,-0.0393774589616847,0.00592073310186335,-0.0509820958413369,-0.0277728220820326,3.03280513491552e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39093,-0.0185481674287523,0.0027921557025228,-0.024020792605697,-0.0130755422518076,3.17873928058971e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,36796,-0.0163234114807221,0.00245853527422643,-0.0211421406182059,-0.0115046823432383,3.27347822812569e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,36779,-0.0172842716820087,0.0026039232336974,-0.0223879612200556,-0.0121805821439618,3.31160907762106e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36420,-0.0191459984403938,0.00289179847374343,-0.0248139234489309,-0.0134780734318567,3.71814724369262e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,36430,-0.0280034948480209,0.00423097673823748,-0.0362962092549663,-0.0197107804410754,3.77127939136041e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,36767,-0.0293369476057119,0.00443545598322132,-0.0380304413328257,-0.0206434538785981,3.88318833070366e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39283,-0.0167405442391891,0.00253195387561084,-0.0217031738353864,-0.0117779146429919,3.92385035548447e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36430,-0.0200561299672516,0.00303397221699818,-0.026002715512568,-0.0141095444219352,3.9844990641611e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39023,-0.0328820085081217,0.00497768471320444,-0.0426382705460024,-0.023125746470241,4.08311056330678e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,39255,0.0275428871143854,0.00417298394755107,0.0193638385771853,0.0357219356515855,4.23777333129134e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36538,-0.069319886593197,0.0105231700663328,-0.0899452999232093,-0.0486944732631848,4.65406616556532e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,39106,-0.0342568530131233,0.00520573369544085,-0.0444600910561874,-0.0240536149700593,4.83835199509478e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39147,-0.016158834782703,0.00245730833530482,-0.0209751591199004,-0.0113425104455055,4.99527453551848e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,36747,-0.0468019256708507,0.00711959061967734,-0.0607563232854183,-0.0328475280562831,5.09770747735761e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,38987,-0.0317717666607038,0.00483380052407565,-0.0412460156878921,-0.0222975176335155,5.09820483621147e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,39165,-0.0311864441689104,0.0047481406426752,-0.0404927998285537,-0.021880088509267,5.25910925004107e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,39255,-0.0188052937202693,0.002865080530584,-0.024420851560214,-0.0131897358803247,5.41965280772526e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,36791,-0.0162837850264454,0.00248232249095978,-0.0211491371087266,-0.0114184329441643,5.58942523498941e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39241,-0.028709469693278,0.0043801265106595,-0.0372945176541706,-0.0201244217323854,5.76112167777956e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39023,0.0259840330685946,0.00396545345603362,0.0182117442947687,0.0337563218424205,5.83669400963082e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,36767,-0.0399316111667875,0.00609962202096392,-0.0518868703278767,-0.0279763520056982,6.11006400589219e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,39099,-0.0557586946171912,0.00852729799078517,-0.0724721986791302,-0.0390451905552523,6.39675494155495e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36420,-0.0224520665009527,0.00343412620016626,-0.0291829538532786,-0.0157211791486268,6.47911529756217e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36403,-0.0347912673270619,0.00532291953780608,-0.0452241896211618,-0.024358345032962,6.55769071528942e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39093,-0.0282836660734821,0.00432916875564816,-0.0367688368345525,-0.0197984953124117,6.63864536771824e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36391,-0.0454530656135409,0.00695957006199742,-0.0590938229350559,-0.031812308292026,6.78480519349968e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,36363,-0.0239752668398815,0.00367179471807417,-0.0311719844873069,-0.0167785491924561,6.85067312240745e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,36733,-0.0357411812493561,0.00549346037425624,-0.0465083635828983,-0.0249739989158139,7.99644717611167e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,38958,-0.0270904513438316,0.00416707346627053,-0.0352579153377218,-0.0189229873499413,8.22520075333598e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,36792,-0.0144390277087737,0.00222517593251194,-0.0188003725364971,-0.0100776828810503,8.95953482563946e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,36747,-0.0181223930755359,0.00279294609433597,-0.0235965674204344,-0.0126482187306374,8.9789173844787e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,36141,-0.0141127962765062,0.00217499954004545,-0.0183757953749953,-0.00984979717801711,8.99400433032178e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,36743,-0.0649824314734759,0.0100219751736727,-0.0846255028138744,-0.0453393601330775,9.25848311812476e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39241,-0.0350199386588848,0.00540193222953616,-0.0456077258287756,-0.0244321514889939,9.27452350165866e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39274,-0.0230620319735081,0.00355795943701386,-0.0300356324700552,-0.0160884314769609,9.33791625394789e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,36806,0.0104174353677976,0.00160804671381506,0.00726566380872006,0.0135692069268751,9.61076153031009e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,36725,-0.0249769758946213,0.00386694194148551,-0.0325561820999329,-0.0173977696893097,1.09115670404364e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39291,0.0151061882616431,0.00233952462730537,0.0105207199921246,0.0196916565311617,1.10028467041438e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39099,-0.0620565736514892,0.0096275907137581,-0.080926651450455,-0.0431864958525233,1.18525707947495e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36430,-0.0190447477244658,0.0029639824860615,-0.0248541533971463,-0.0132353420517853,1.36276869427171e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,39099,-0.0502456602140667,0.00782760480547206,-0.0655877656327919,-0.0349035547953414,1.41196835409115e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,36731,-0.0432315370493743,0.00674249231867865,-0.0564468219939844,-0.0300162521047641,1.48831619396916e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39241,-0.0173260808117124,0.00270277397794347,-0.0226235178084816,-0.0120286438149432,1.49287971522294e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39147,0.016005655825653,0.00250322546564549,0.0110993339129879,0.0209119777383182,1.66277231623299e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,38841,-0.0417644804028805,0.00654084571495001,-0.0545845380041825,-0.0289444228015784,1.76238751680948e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36500,-0.0442213668230903,0.00693010952776364,-0.057804381497507,-0.0306383521486736,1.82018933838455e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,39099,-0.0192523834602356,0.00302076527043209,-0.0251730833902825,-0.0133316835301888,1.90263343905676e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,36792,-0.041857872362598,0.00657386322228776,-0.054742644278282,-0.028973100446914,1.9886843664479e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36430,-0.0281924817434724,0.00443135371757457,-0.0368779350299185,-0.0195070284570262,2.05988803021468e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,38960,-0.0526394854249954,0.00827962700074503,-0.0688675543464556,-0.0364114165035351,2.10663965802647e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,38727,-0.0503407724587238,0.00792076021501871,-0.0658654624801605,-0.0348160824372872,2.1373798135775e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39023,-0.0497054995981018,0.00782834163612506,-0.0650490492049069,-0.0343619499912967,2.2226650625361e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,39283,-0.0306128524108567,0.00482700141903519,-0.0400737751921657,-0.0211519296295477,2.33113998317638e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39099,0.0290936251955613,0.00460970045326669,0.0200586123071586,0.038128638083964,2.84184189495577e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39162,-0.0222335572430888,0.00352385444993178,-0.0291403119649551,-0.0153268025212225,2.87744423856426e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39079,-0.0359396184561245,0.00569997365833404,-0.0471115668264592,-0.0247676700857898,2.9571234796865e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,36792,-0.0326047628436177,0.00517294697414331,-0.0427437389129386,-0.0224657867742968,3.01542726247829e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39099,-0.04542440461614,0.0072205285857996,-0.0595766406443072,-0.0312721685879728,3.2402160763406e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,36792,-0.0195671598988244,0.00311144730550294,-0.0256655966176102,-0.0134687231800386,3.3030405590993e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,38987,-0.0314004803113617,0.00499661204074924,-0.0411938399112302,-0.0216071207114932,3.38236603044687e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,36792,-0.0151570072149887,0.00241765003405767,-0.0198956012817417,-0.0104184131482356,3.74174395926452e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39110,-0.0228401610589717,0.00364444984790885,-0.029983282760873,-0.0156970393570703,3.77699304396744e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,36767,-0.0450652515326909,0.00720781610808995,-0.0591925711045472,-0.0309379319608346,4.17266015570868e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39149,0.0174365663891683,0.00279109073924106,0.0119660285402558,0.0229071042380808,4.28873508122279e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,38743,-0.0217860752340708,0.00349063424014869,-0.0286277183447622,-0.0149444321233794,4.457247388892e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,36792,-0.0152535783067461,0.00244494895271114,-0.02004567825406,-0.0104614783594323,4.5465757027886e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,36743,-0.0497094184213945,0.00796957732811612,-0.0653297899845021,-0.0340890468582869,4.58830299911775e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,39106,-0.022418557327955,0.00359817608536137,-0.0294709824552633,-0.0153661322006467,4.77058453342111e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,36743,-0.0456006475313839,0.00732416600362905,-0.0599560128984969,-0.031245282164271,4.93188280662804e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,39099,0.0247469011024685,0.00397750548220088,0.0169509903573548,0.0325428118475822,5.04603334195471e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36470,-0.016384416555841,0.00263738700646141,-0.0215536950885054,-0.0112151380231766,5.38345458530368e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,39237,0.0177237370642326,0.00285411157123312,0.0121296783846157,0.0233177957438495,5.43821824595298e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,39241,-0.0214022277793454,0.00345106820483262,-0.0281663214608174,-0.0146381340978735,5.73117367661702e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,36420,-0.0426368259729717,0.00689366758072918,-0.0561484144312009,-0.0291252375147425,6.4060278143026e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36507,-0.0373684794037848,0.00604369065977438,-0.0492141130969426,-0.025522845710627,6.48081569966511e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,36731,-0.0186277235260716,0.0030138814659553,-0.024534931199344,-0.0127205158527992,6.57693524035342e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,39106,-0.0305409543329959,0.00495346595129285,-0.0402497475975299,-0.020832161068462,7.19983152490467e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39093,-0.0244191118930798,0.00396143101049066,-0.0321835166736415,-0.0166547071125181,7.26187614275406e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,38832,-0.0209090839588856,0.00339390625794444,-0.0275611402244567,-0.0142570276933144,7.42433368133722e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,36737,-0.014482207083385,0.00235280755809931,-0.0190937098972597,-0.0098707042695104,7.71671331544288e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,36792,-0.04120958556469,0.00670075925876358,-0.0543430737118666,-0.0280760974175134,7.97727624020558e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",36767,-0.0235268913258345,0.00382842242732154,-0.0310305992833847,-0.0160231833682842,8.21504886437197e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39106,-0.0444287804018032,0.00723740296491627,-0.0586140902130391,-0.0302434705905673,8.52208264896125e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,36743,-0.0581848420973611,0.00949583632781791,-0.0767966812998842,-0.039573002894838,9.19279355844227e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39023,-0.0254774816613915,0.00415844799799789,-0.0336280397374673,-0.0173269235853156,9.19492153235009e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,36743,-0.0797696469684961,0.0130230907245681,-0.10529490478865,-0.0542443891483426,9.31793957164277e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,39291,-0.0222992306562531,0.00364373689352942,-0.0294409549675708,-0.0151575063449354,9.59100863927901e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,38608,-0.0435685538307069,0.00712039513908823,-0.0575245283033198,-0.0296125793580939,9.66432160463521e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,36767,-0.0433390049820734,0.00709109719996194,-0.0572375554939988,-0.029440454470148,1.01384274259001e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39089,-0.0320798557649574,0.00526386340853499,-0.042397028045686,-0.0217626834842288,1.12527086804639e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,38841,-0.0482311464620734,0.0079173888488558,-0.0637492286058308,-0.0327130643183161,1.1437946354016e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,36420,-0.0157624237868696,0.00258735607706942,-0.0208336416979257,-0.0106912058758136,1.1469991191646e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,36791,-0.0485042805055451,0.00796377251308789,-0.0641132746311974,-0.0328952863798928,1.15667424588399e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,36549,-0.0140486297223059,0.00231285856417127,-0.0185818325080816,-0.00951542693653019,1.28218599668034e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39283,-0.0219563578266503,0.0036198365169216,-0.0290512373998166,-0.014861478253484,1.34560278004868e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39023,-0.0306364595501515,0.00505778482413732,-0.0405497178054607,-0.0207232012948424,1.41706754808041e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,39234,-0.0324499972764352,0.00537237802360051,-0.0429798582026922,-0.0219201363501783,1.5751394122255e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,38832,-0.041078209583746,0.00680268524879368,-0.0544114726713816,-0.0277449464961104,1.59203002826737e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,39093,-0.0138899428859768,0.0023005414602349,-0.0183990041480372,-0.00938088162391636,1.59972108667115e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39099,-0.0482920345800112,0.00800887386205278,-0.0639894273496347,-0.0325946418103878,1.67937294041177e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",36767,-0.0351275016716302,0.00582628017021108,-0.0465470108052439,-0.0237079925380164,1.69327135472813e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,36767,-0.0546223111948112,0.00906219533314975,-0.0723842140477847,-0.0368604083418377,1.71064913850619e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,36747,-0.0423359898947157,0.00702642988168419,-0.0561077924628167,-0.0285641873266147,1.73454899264117e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36420,-0.0200712351964737,0.00333400620667811,-0.0266058873615628,-0.0135365830313846,1.79111513498423e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,39077,0.0266387292502591,0.00442858748931048,0.0179586977712105,0.0353187607293076,1.83808490399138e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,36767,-0.0346311033589443,0.00577096930657181,-0.0459422031998251,-0.0233200035180636,2.01465851967266e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36420,-0.0301621112258286,0.00504808381308904,-0.0400563554994831,-0.020267866952174,2.36376274769783e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,36784,-0.0208813727728931,0.0034962922981651,-0.0277341056772967,-0.0140286398684895,2.39880595309152e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39211,0.0188097492513029,0.00315018498253697,0.0126353866855304,0.0249841118170753,2.41006947428803e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",38999,-0.0577434784718857,0.00967513787660776,-0.0767067487100369,-0.0387802082337345,2.45191196849794e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36430,-0.0389696770116745,0.00653466265588201,-0.0517776158172032,-0.0261617382061457,2.53471128524297e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36420,-0.0240121490337179,0.00402830838633066,-0.031907633470926,-0.0161166645965098,2.57659457185534e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36421,-0.0241510218482888,0.00405666785817305,-0.032102090850308,-0.0161999528462696,2.6961753694556e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,36500,-0.0318209348994209,0.00534610772401289,-0.0422993060384862,-0.0213425637603556,2.71626689450661e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,38832,-0.0224065869528181,0.0037745922745186,-0.0298047878108746,-0.0150083860947617,2.98222915120786e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39283,-0.0161734400258064,0.00272612274656584,-0.0215166406090754,-0.0108302394425373,3.04254449643905e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,38945,-0.0152090123753858,0.002564284232226,-0.0202350094705487,-0.0101830152802228,3.07500931064993e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39073,-0.0400730897896556,0.00677322536946858,-0.053348611513814,-0.0267975680654972,3.36134759597644e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,39023,-0.0302997433919316,0.00512232067406027,-0.0403394919130897,-0.0202599948707734,3.38529377839783e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,38741,-0.046813654380477,0.00792356034991625,-0.0623438326663129,-0.0312834760946412,3.53504413150059e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,39114,-0.0342508252219464,0.00579734841436852,-0.0456136281141087,-0.0228880223297841,3.53624844344549e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,39291,-0.0185232496038027,0.00313557215929516,-0.0246689710360212,-0.0123775281715842,3.54742967417777e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,38727,-0.0428853703061254,0.00726405607618861,-0.0571229202154551,-0.0286478203967957,3.63011967587151e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,36796,-0.033324620394726,0.00564437026528369,-0.044387586114682,-0.0222616546747699,3.63589134446476e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36421,-0.0375882374401164,0.00638386096061261,-0.0501006049229171,-0.0250758699573157,4.00864429022122e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39243,-0.0447824137470455,0.0076169631220604,-0.0597116614662839,-0.0298531660278071,4.20536641578159e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,39229,-0.0105279266287356,0.00179097130741508,-0.0140382303912692,-0.00701762286620209,4.23002046979021e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,36779,-0.0202156269153688,0.0034402885853066,-0.0269585925425697,-0.0134726612881679,4.30286968461743e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,39023,-0.0321424828689869,0.00547844659452184,-0.0428802381942497,-0.0214047275437241,4.52781445204194e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,38727,-0.0535542765232625,0.00913902281054311,-0.0714667612319269,-0.035641791814598,4.72784632804238e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,36792,-0.0583886058973767,0.00996428853410164,-0.0779186114242159,-0.0388586003705375,4.74749463758604e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,36792,-0.0247129095480596,0.00421883399837361,-0.0329818241848718,-0.0164439949112473,4.80567647090382e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36420,-0.0289567293564903,0.00495079301135689,-0.0386602836587498,-0.0192531750542308,5.07134059996021e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,38706,-0.0213239191890397,0.00365134000458007,-0.0284805455980166,-0.0141672927800627,5.32840049435925e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,38841,-0.0260759022233362,0.00446765261587756,-0.0348325013504562,-0.0173193030962161,5.43779290428564e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36420,-0.028219801139589,0.00483734780265142,-0.0377010028327858,-0.0187385994463922,5.5536366377359e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,39049,-0.021821560119693,0.00374113843982556,-0.0291541914617511,-0.0144889287776349,5.5591044500939e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,39106,-0.0583373138398529,0.0100210484661082,-0.0779785688334251,-0.0386960588462808,5.95019626374863e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,38841,-0.0160134593518938,0.00275417943828876,-0.0214116510509398,-0.0106152676528478,6.21502407125665e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,38996,-0.0277819213924935,0.00478344167821992,-0.0371574670818046,-0.0184063757031825,6.45168464603637e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,39093,-0.0286108562097394,0.0049286933737205,-0.0382710952222315,-0.0189506171972472,6.56631947120503e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,38987,-0.025314902127197,0.00436136235492153,-0.0338631723428432,-0.0167666319115508,6.59077268990551e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36430,-0.0297119261557686,0.00512110652941316,-0.0397492949534183,-0.0196745573581188,6.71653701645999e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,39291,-0.0508755441539319,0.00877632401403393,-0.0680771392214383,-0.0336739490864254,6.88679804266201e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,39255,-0.0140653996267077,0.00242922408276536,-0.0188266788289278,-0.0093041204244876,7.17242550355302e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36430,-0.0268304608788039,0.00463453023047474,-0.0359141401305344,-0.0177467816270734,7.23903519041692e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,36747,-0.0466045903478289,0.00806023632906439,-0.0624026535527951,-0.0308065271428627,7.55125966947382e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39241,-0.0515668604173921,0.00892400267133287,-0.0690579056532045,-0.0340758151815797,7.68530856333512e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,39191,-0.017860845664964,0.00309457818579036,-0.0239262189091131,-0.0117954724208149,8.00124948855886e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,39165,-0.0307581627796807,0.00532968300034794,-0.0412043414603627,-0.0203119840989988,8.02771637166318e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,38941,0.0256009223641023,0.00443940552799774,0.0168996875292267,0.0343021571989779,8.23995631785492e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,38987,-0.0236705144130919,0.00410477656286603,-0.0317158764763093,-0.0156251523498744,8.24764586763706e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,36747,-0.057667323979923,0.0100054371989647,-0.0772779808898937,-0.0380566670699522,8.42247138150347e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36430,-0.0274884728304533,0.00476943386090014,-0.0368365631978176,-0.018140382463089,8.4338530465362e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36391,-0.029898961250083,0.00518889064470729,-0.0400691869137093,-0.0197287355864567,8.50234919310795e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,39099,-0.0433131693971038,0.00752433052927923,-0.0580608572344911,-0.0285654815597165,8.75723188947437e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,39016,-0.0207994139722497,0.00361476648740288,-0.0278843562875593,-0.01371447165694,8.8832863570317e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36420,-0.0128114521107538,0.00223457658484109,-0.0171912222170423,-0.00843168200446525,1.00774793996387e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,36767,-0.0315110686308803,0.00549751365239317,-0.042286195389571,-0.0207359418721897,1.01547997761303e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,36767,-0.0565675624495444,0.00986940798847365,-0.0759116021069527,-0.037223522792136,1.01709354101347e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36403,-0.0422813354724589,0.00737844634949558,-0.0567430903174702,-0.0278195806274475,1.02508476299241e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39093,-0.0305189885985503,0.00534376515711157,-0.040992768306489,-0.0200452088906117,1.1431662604402e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,36767,-0.0357724515615499,0.00627794303898836,-0.0480772199179671,-0.0234676832051327,1.23786420778103e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,39023,-0.0286043642910573,0.00502361771905798,-0.038450655020411,-0.0187580735617037,1.26413616387158e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39140,-0.0458742996353729,0.00805961981965898,-0.0616711544819045,-0.0300774447888413,1.27963450414266e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,36743,-0.0405187863514298,0.00711932312608279,-0.0544726596785521,-0.0265649130243076,1.28762604963344e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39106,0.0489596075367648,0.00860751922012682,0.0320888698653162,0.0658303452082133,1.3089145847303e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,36743,-0.0442373381436537,0.00778001401944851,-0.0594861656217728,-0.0289885106655346,1.32856302685681e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36421,-0.0422866337844978,0.00744842231041355,-0.0568855415129084,-0.0276877260560872,1.39900339235636e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,36430,-0.0236138790367847,0.00416018519612545,-0.0317678420211905,-0.0154599160523788,1.40797916136564e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39241,-0.0344197024962796,0.00606868290915661,-0.0463143209982266,-0.0225250839943327,1.43937008875629e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36430,-0.0513629605007333,0.00906229667457287,-0.0691250619828962,-0.0336008590185705,1.47853829020767e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,36743,-0.0279615294406105,0.00493959998279548,-0.0376431454068897,-0.0182799134743314,1.53986073779724e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,36747,-0.0568033475669097,0.0100447760018536,-0.0764911085305428,-0.0371155866032765,1.59145595170877e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,39037,-0.0156724711174788,0.00277267853945859,-0.0211069210548177,-0.01023802118014,1.61007451396811e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39291,-0.0519670560908151,0.00921257659589382,-0.070023706218767,-0.0339104059628632,1.72150590882002e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,36743,-0.0311741659278254,0.00552733462495657,-0.0420077417927403,-0.0203405900629105,1.73628088092471e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,36500,-0.0349409005790123,0.00619868069551589,-0.0470903147422235,-0.0227914864158012,1.76917027881643e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36230,-0.0170165078083033,0.00301883220690023,-0.0229334189338278,-0.0110995966827789,1.77043450250366e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,36731,-0.0186376034353545,0.0033148964514934,-0.0251348004802816,-0.0121404063904275,1.92263691246632e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,39241,0.019057609828452,0.00339353505912352,0.0124062811125699,0.0257089385443341,1.98974082777627e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,39099,-0.0462682520562818,0.0082416406173971,-0.0624218676663801,-0.0301146364461834,2.01195700727759e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,39241,-0.0310489639802748,0.0055377007291181,-0.0419028574093463,-0.0201950705512033,2.09605430010784e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,38987,0.0173372405186002,0.00309393830070388,0.0112731214492206,0.0234013595879798,2.1358870370559e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,36735,-0.0329887968213489,0.00590714963803668,-0.0445668101119008,-0.021410783530797,2.39045721869348e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,36791,-0.0255761282058404,0.00458182221750782,-0.0345564997521558,-0.0165957566595251,2.4243373894842e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39023,-0.0308805399103095,0.00553614104991839,-0.0417313763681495,-0.0200297034524694,2.47473139393409e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,39106,0.0266094853564112,0.00477058109656612,0.0172591464071416,0.0359598243056808,2.47679132213046e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39147,-0.0490380735490358,0.00879174364416727,-0.0662698910916036,-0.0318062560064679,2.47792175560423e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,36747,-0.0468007575742601,0.00839244761516315,-0.0632499548999799,-0.0303515602485404,2.50296579127534e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,36791,-0.0184724759454348,0.00331302926745442,-0.0249660133096455,-0.0119789385812242,2.51468725664273e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36538,-0.0223194860795222,0.00400966350577276,-0.0301784265508368,-0.0144605456082076,2.65301395914409e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,36731,-0.0250841823455543,0.0045101305399546,-0.0339240382038654,-0.0162443264872433,2.72419964561831e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,38727,-0.0382338343873327,0.0068800774811495,-0.0517187862503858,-0.0247488825242797,2.78878440157129e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,38925,-0.0259899899563814,0.00467686455243861,-0.0351566444791611,-0.0168233354336018,2.78881459647479e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39023,-0.0395467736936546,0.00711999496602123,-0.0535019638270562,-0.025591583560253,2.83370589437581e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,38832,-0.01909781834927,0.00344198913169429,-0.0258441170473908,-0.0123515196511492,2.93045955478669e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39147,-0.0130737712244414,0.00235630490659119,-0.0176921288413601,-0.00845541360752268,2.93048592865181e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39099,-0.018872577293451,0.00340633133181022,-0.025548986703799,-0.012196167883103,3.06709399683644e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,36731,-0.0272944358359923,0.00493464409643255,-0.0369663382650001,-0.0176225334069845,3.24278236314784e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,36806,0.0277336975022238,0.00501953598464172,0.017895406972326,0.0375719880321216,3.35559502562374e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,36743,-0.0182713522829272,0.00330714409484915,-0.0247533547088316,-0.0117893498570229,3.36237464270793e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39066,-0.0183034817011567,0.00331644535843392,-0.0248037146036872,-0.0118032487986262,3.46497727238843e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,36731,-0.0435416138412182,0.00789085600772618,-0.0590076916163615,-0.0280755360660749,3.49539781456632e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39145,0.0147698927953826,0.00267919524072857,0.00951867012355465,0.0200211154672106,3.58870389708176e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,38700,-0.0144490820313026,0.00262224888659425,-0.0195886898490273,-0.00930947421357786,3.64422345698772e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39099,-0.019026744363448,0.00345761530519374,-0.0258036703616277,-0.0122498183652683,3.79724961860577e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39023,-0.0278885449941988,0.00506880476930268,-0.037823402342032,-0.0179536876463655,3.8159934897532e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,36791,0.0257586281906448,0.00468507368148263,0.0165758837749388,0.0349413726063507,3.91364953118873e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,36261,-0.0355755000086561,0.00647240067585777,-0.0482614053333374,-0.0228895946839749,3.9507713502741e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,36724,-0.0206235085265351,0.00375451728026413,-0.0279823623958528,-0.0132646546572174,4.0270405341105e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39095,-0.0204280766020725,0.00371970028940162,-0.0277186891692997,-0.0131374640348453,4.04088156907427e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,36420,-0.0263162927045387,0.00479400206985592,-0.0357125367614563,-0.0169200486476211,4.11083504217887e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,36792,-0.0404666622192837,0.00737924161275784,-0.0549299757802891,-0.0260033486582784,4.23979106317996e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39229,-0.030472079980605,0.00556011893082269,-0.0413699130850175,-0.0195742468761926,4.30868388504658e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39140,0.0391777731747187,0.00715279889465817,0.0251582873411887,0.0531972590082487,4.38774524353043e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,36792,-0.0155434598159414,0.00284508446426389,-0.0211198253658986,-0.00996709426598415,4.76095997978841e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,36747,-0.032907584562499,0.00602736567712609,-0.0447212212896662,-0.0210939478353319,4.85783448814327e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,38475,-0.0190723266086827,0.0034939361530893,-0.0259204414687378,-0.0122242117486277,4.87470955605885e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,38727,-0.0299960421353665,0.00549603241788966,-0.0407682656744303,-0.0192238185963028,4.89892623588878e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39093,-0.0260488644538785,0.00478051048034515,-0.035418664995355,-0.016679063912402,5.14487363650766e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,36731,-0.0301608742563819,0.00553588197997626,-0.0410112029371354,-0.0193105455756284,5.1803086119767e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,39253,-0.0304243315286347,0.00558543739815349,-0.0413717888290156,-0.0194768742282539,5.19888394515667e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,36538,-0.0282912303978345,0.00519851311897108,-0.0384803161110178,-0.0181021446846512,5.36118111831942e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,38987,-0.0262104922542925,0.00482147363362489,-0.0356605805761973,-0.0167604039323877,5.5272482042726e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,36743,-0.0287972219780157,0.00529932280268278,-0.039183894671274,-0.0184105492847575,5.60652168725694e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,36767,-0.0335605758110691,0.00618202074914654,-0.0456773364793963,-0.0214438151427419,5.77800366160602e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,36391,-0.0237939110099378,0.00438462170552745,-0.0323877695527716,-0.015200052467104,5.84820767997878e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,36506,-0.0105809877569188,0.00195085892943751,-0.0144046712586163,-0.00675730425522132,5.94321841611427e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39283,0.0143489501292152,0.00264836636478537,0.0091581520542359,0.0195397482041946,6.1160387045535e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,38727,-0.0203981367071297,0.00376565494162622,-0.0277788203927171,-0.0130174530215423,6.15879193118923e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,38909,-0.0232868141025156,0.00430183528141154,-0.0317184112540822,-0.014855216950949,6.28470828788674e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,38727,-0.0219091794542854,0.00404830996390729,-0.0298438669835437,-0.0139744919250272,6.33144208399692e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,38969,-0.0476000938862012,0.00880018372120663,-0.0648484539797662,-0.0303517337926362,6.43459373107209e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39237,-0.0288252910283033,0.00534369117204773,-0.0392989257255168,-0.0183516563310897,6.98218272877068e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39162,-0.0140257786914211,0.0026007213167055,-0.0191231924721639,-0.00892836491067832,7.03065048731799e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,38987,-0.0471816591529522,0.00876313407327551,-0.0643574019365722,-0.0300059163693322,7.3891444757526e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,39023,-0.0208941368723223,0.0038826883408231,-0.0285042060203355,-0.013284067724309,7.50244277267899e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39106,0.019480648637043,0.00362350109976877,0.0123785864814962,0.0265827107925898,7.71964611428154e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36421,-0.0333920836313615,0.00621259540674672,-0.0455687706285851,-0.0212153966341379,7.79946800520215e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,38987,-0.0157855518579318,0.00294160209010629,-0.0215510919545402,-0.0100200117613235,8.15473301977456e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,39099,-0.0427082384630558,0.00796024550722424,-0.0583103196572153,-0.0271061572688963,8.20451867782183e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36430,-0.0273011981203705,0.00509162659374264,-0.0372807862441061,-0.017321609996635,8.3771519697195e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",38841,-0.0297815177855451,0.00556627238377354,-0.0406914116577413,-0.018871623913349,8.90741739699831e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,36619,-0.0545137081155597,0.0102090577442248,-0.0745234612942402,-0.0345039549368791,9.46767972185146e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,36629,-0.0147312970607201,0.00276077291876654,-0.0201424119815025,-0.00932018213993769,9.66795122610457e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,36791,-0.0230393548165659,0.00432166186112838,-0.0315098120643775,-0.0145688975687542,9.92431188489655e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",38832,-0.0438337416495877,0.0082260564932805,-0.0599568123764175,-0.0277106709227579,1.00380871829378e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,36731,-0.0409935706858467,0.0076935365562272,-0.056072902336052,-0.0259142390356414,1.00800552578195e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,38728,-0.0346067438336637,0.0064995415513288,-0.0473458452742681,-0.0218676423930593,1.02708813630117e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39023,-0.0677949598888954,0.012737191034733,-0.092759854316972,-0.0428300654608188,1.03751488710919e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,36767,-0.0335348450593406,0.00630069567671549,-0.045884208585703,-0.0211854815329782,1.04119382108039e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39291,-0.016448340745718,0.00309097131574628,-0.0225066445245807,-0.0103900369668552,1.04402339460509e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,36806,-0.0162084811626033,0.00304743375723825,-0.0221814513267902,-0.0102355109984163,1.06232613086343e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,36737,-0.0371508078730417,0.00698654485653833,-0.0508444357918568,-0.0234571799542265,1.06973735312485e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,38960,-0.0253244370612463,0.00476471650039453,-0.0346632814020195,-0.015985592720473,1.08177609328048e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,36452,-0.0322420878167707,0.00607633862965279,-0.0441517115308902,-0.0203324641026513,1.13850928273837e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,36731,-0.0338415965825383,0.00637912850725605,-0.0463446884567601,-0.0213385047083164,1.14509080552744e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",36767,-0.0380577316738036,0.00717804946737018,-0.0521267086298491,-0.023988754717758,1.16455211432739e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,36420,-0.0254476673437418,0.00480244040072562,-0.034860450529164,-0.0160348841583196,1.18470523011796e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,38741,0.0160101217451925,0.00302413157965361,0.0100828238490714,0.0219374196413136,1.21288721149542e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,36767,-0.032804450868513,0.0061968412423489,-0.0449502597035168,-0.0206586420335091,1.21805809268476e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,36767,-0.0515633853028012,0.00975222498682955,-0.0706777462769872,-0.0324490243286153,1.26128631469623e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,38795,-0.0353474248942584,0.00669445158635201,-0.0484685500035084,-0.0222262997850085,1.30917016364008e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36420,-0.0501845388034481,0.009519222773413,-0.0688422154393375,-0.0315268621675586,1.37245382284252e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,38844,-0.0110881984631629,0.00210422540959465,-0.0152124802659684,-0.00696391666035743,1.38697590519954e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39136,-0.0349303784077545,0.00663341679103437,-0.0479318753181818,-0.0219288814973271,1.41456582900435e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,38832,-0.0460189532379751,0.00874996894482411,-0.0631688923698304,-0.0288690141061199,1.46573103809204e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,36767,-0.0353442929334754,0.00672161646934426,-0.0485186612133901,-0.0221699246535606,1.47712802599066e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39106,-0.00855591749459105,0.00162818878061654,-0.0117471675045995,-0.00536466748458263,1.50125874026357e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39086,-0.0333879592423382,0.00636333832033177,-0.0458601023501885,-0.0209158161344879,1.56732608780987e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,39273,-0.0157640892158979,0.0030063238447799,-0.0216564839516665,-0.00987169448012925,1.5951687532376e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39165,0.0209341789333292,0.00399480420119815,0.0131043626989809,0.0287639951676776,1.62398383668282e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,36767,0.0218289165523135,0.00416539105358433,0.0136647500872882,0.0299930830173388,1.62626673757475e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,38960,-0.0191656784629626,0.00366024960525144,-0.0263397676892554,-0.0119915892366698,1.66144728402925e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39162,-0.050522983827958,0.00965623879282742,-0.0694492118618998,-0.0315967557940163,1.69751842854893e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,36743,-0.0231810338338059,0.00443696652949323,-0.0318774882316127,-0.0144845794359992,1.77328667935146e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,36743,-0.0366389527623999,0.0070214204213558,-0.0504009367882573,-0.0228769687365425,1.8350719658496e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,36747,-0.0106604334491255,0.00204400202621138,-0.0146666774204998,-0.00665418947775121,1.86191058653828e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,36767,-0.0452074029724721,0.00868109377109572,-0.0622223467638198,-0.0281924591811245,1.94271692038195e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39145,0.0128909515745365,0.00247953276620594,0.00803106735277291,0.0177508357963002,2.03007177336871e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39162,-0.0608649989195891,0.0117198432354755,-0.0838358916611211,-0.0378941061780571,2.09215091491642e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,39291,-0.0192704803560946,0.00371101941700368,-0.0265440784134218,-0.0119968822987674,2.09817722837754e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39211,-0.0340058416223727,0.00655067648889197,-0.046845167540601,-0.0211665157041445,2.11614026346414e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,36743,-0.0464098165386518,0.00894030358334273,-0.0639328115620035,-0.0288868215153,2.12260991697288e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,39093,-0.043193779925394,0.00832762890691028,-0.0595159325829382,-0.0268716272678499,2.16675183925712e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,38987,0.0158855862411945,0.00306700211179073,0.00987426210208469,0.0218969103803043,2.25317816578684e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,39255,-0.021780632627517,0.00421331751087469,-0.0300387349488314,-0.0135225303062027,2.37692781252758e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,39264,0.0194599061818126,0.00376471589945508,0.0120810630188807,0.0268387493447446,2.38262437058517e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,38727,-0.0245185617339929,0.00474371622351534,-0.0338162455320829,-0.0152208779359028,2.38858299921002e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,36747,-0.0394348694805264,0.00763194252177096,-0.0543934768231975,-0.0244762621378554,2.41329840140449e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36430,-0.0173950869227191,0.00337825679669094,-0.0240164702442334,-0.0107737036012049,2.65650975245256e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39023,-0.00986038428602557,0.00192009692107848,-0.0136237742513394,-0.00609699432071175,2.85095985181522e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39057,0.0224867696935961,0.00438285434503757,0.0138963751773224,0.0310771642098697,2.92342066375295e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39106,-0.0413357833996694,0.00805842080247527,-0.0571302881725209,-0.0255412786268179,2.9405343202885e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,36420,-0.0108374548013103,0.00211487033111724,-0.0149826006503001,-0.00669230895232055,3.02907495120808e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39241,-0.0302925414319075,0.00591298622057139,-0.0418819944242274,-0.0187030884395875,3.04264326364761e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,38832,-0.046170371640085,0.00901756719717967,-0.0638448033465571,-0.0284959399336128,3.09246505562005e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,38727,-0.0271966247129881,0.00531345619492744,-0.0376109988550459,-0.0167822505709303,3.11910132963755e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39283,-0.0151941847013713,0.00297243349560262,-0.0210201543527524,-0.00936821504999014,3.23092988971369e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,39023,-0.0485373120627519,0.00950784674398405,-0.0671726916809606,-0.0299019324445431,3.34844050296008e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",36792,-0.0359077980970764,0.00703373317619575,-0.0496939151224201,-0.0221216810717327,3.35344563694982e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,36748,-0.00934936777700247,0.00183289976745511,-0.0129418513212145,-0.00575688423279044,3.42914844084692e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,39023,-0.0448668479327789,0.00880097561971609,-0.0621167601474224,-0.0276169357181354,3.47502958042501e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,38741,-0.0337069536406586,0.00661343150950758,-0.0466692793992935,-0.0207446278820238,3.49784309008183e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39229,-0.0267529405519821,0.0052656674177155,-0.0370736486907044,-0.0164322324132597,3.80582083071868e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,36157,0.0203826848883218,0.00401227293543448,0.0125186299348702,0.0282467398417734,3.82798262361289e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36538,-0.0499184082615793,0.00983807133473302,-0.069201028077656,-0.0306357884455026,3.95044323568094e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36420,-0.0215255349444545,0.00424857501271066,-0.0298527419693674,-0.0131983279195416,4.10886144151538e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36500,-0.0196837652179381,0.00390194598703219,-0.0273315793525212,-0.012035951083355,4.60772760160049e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,39291,-0.0162974419631382,0.00323263969871577,-0.0226334157726211,-0.00996146815365525,4.67062605950479e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36430,-0.0156793477713116,0.00311198504859257,-0.021778838466553,-0.00957985707607011,4.76021431593546e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,38721,-0.0276147117263748,0.00548316845230889,-0.0383617218929002,-0.0168677015598493,4.8025572123968e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,36743,-0.0332147307529421,0.00660651505000713,-0.0461635002509561,-0.0202659612549282,5.03403173514115e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,39106,0.0325354557966873,0.00647788092891833,0.0198388091760074,0.0452321024173672,5.15671825514824e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39043,-0.00895711760442101,0.00178601449910029,-0.0124577060226576,-0.00545652918618443,5.35920580720666e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,36772,-0.0165132858535572,0.00329522555887477,-0.0229719279489518,-0.0100546437581627,5.47860199316289e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,39291,-0.0231111705771427,0.00461285469972236,-0.0321523657885985,-0.0140699753656869,5.49843237687131e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36500,-0.0321782118902194,0.00642738203936283,-0.0447758806873705,-0.0195805430930682,5.61971471051895e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,39057,-0.0186518305987286,0.00372591017229547,-0.0259546145364277,-0.0113490466610295,5.62007210001661e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36500,-0.0270013082059385,0.00539884942064692,-0.0375830530704065,-0.0164195633414706,5.77069174370804e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,38727,-0.0280089227196351,0.00560099304657606,-0.0389868690909242,-0.017030976348346,5.77715429006986e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,38578,-0.0186915026201718,0.00374592673002529,-0.0260335190110214,-0.0113494862293222,6.11252532150169e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36420,-0.0285684529085027,0.00572722261996942,-0.0397938092436428,-0.0173430965733626,6.17636937496461e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,36767,-0.0253211937094611,0.00508914859007834,-0.0352959249460147,-0.0153464624729076,6.59087128991324e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36430,-0.0270241402547531,0.0054327806173448,-0.0376723902647489,-0.0163758902447573,6.63580776541204e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,39030,-0.0209606069724389,0.00421725938472629,-0.0292264353665024,-0.0126947785783754,6.76145892934418e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39147,-0.0255456698591683,0.00515186843425739,-0.0356433319903128,-0.0154480077280239,7.17920208944575e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,36806,-0.0138205790633369,0.00278802247289456,-0.0192851031102102,-0.00835605501646353,7.24492072170255e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,36731,-0.0252958117240085,0.00510613522861082,-0.0353038367720857,-0.0152877866759313,7.36253734182784e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36407,-0.0127920164275315,0.00258220650788743,-0.0178531411829908,-0.00773089167207214,7.36850111107859e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,36806,0.0119446867330996,0.00241265299819663,0.00721588685663424,0.016673486609565,7.4820260392153e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,36767,-0.0293067858747083,0.00594178438432784,-0.0409526832679909,-0.0176608884814258,8.22702952167891e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,36664,-0.0138535983110429,0.00281025075533555,-0.0193616897915006,-0.0083455068305852,8.34021174280823e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,36778,-0.0211443997348534,0.00429423461546054,-0.0295610995811561,-0.0127276998885508,8.58829816304605e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",36767,-0.036687175336744,0.0074524756920017,-0.0512940276930673,-0.0220803229804207,8.63615767263659e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36430,-0.0206031195105316,0.00418722616747684,-0.0288100827987863,-0.012396156222277,8.74306559698546e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39165,-0.018920844067261,0.00384568094640695,-0.0264583787222186,-0.0113833094123034,8.74327618564063e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,36731,-0.0180526838036001,0.00366920498525018,-0.0252443255746905,-0.0108610420325098,8.75907930003256e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,36792,-0.0121704118454484,0.00247627545297319,-0.0170239117332758,-0.0073169119576209,8.9960165952598e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,36743,-0.0191893084149662,0.00390583709330602,-0.026844749117846,-0.0115338677120864,9.08036438686213e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36430,-0.0414022845745693,0.00844065787427954,-0.0579459740081572,-0.0248585951409814,9.45478569680319e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,38713,-0.0319920910744016,0.0065366960092153,-0.0448040152524636,-0.0191801668963396,9.97273287234378e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",36791,-0.0191131715803161,0.00390905708946721,-0.0267749234756719,-0.0114514196849604,1.02328916730235e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,36747,-0.0314555908484927,0.0064337002033296,-0.0440656432470188,-0.0188455384499667,1.0247171897324e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39117,0.0150452370564223,0.00308337344641626,0.00900182510144643,0.0210886490113982,1.07443805275097e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,36761,-0.0278641039145614,0.00571205115692135,-0.0390597241821272,-0.0166684836469955,1.08377097837695e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",36792,-0.0135778160717476,0.00278558731091409,-0.0190375672011392,-0.00811806494235594,1.10485771198783e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,38841,-0.0253531504851696,0.00520934688403597,-0.0355634703778801,-0.0151428305924591,1.14541019086404e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,38727,-0.0288643419069303,0.0059364511070387,-0.0404997860767261,-0.0172288977371344,1.17262022075353e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36420,-0.0346063606191777,0.00712194035273558,-0.0485653637105394,-0.020647357527816,1.19333070830841e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39224,-0.0208424107627113,0.00429522131685649,-0.02926104454375,-0.0124237769816726,1.23133026976874e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,39145,-0.0115991968194793,0.00239125850136314,-0.0162860634821511,-0.00691233015680758,1.24259570577901e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39162,-0.0184413924154425,0.00380201078218258,-0.0258933335485204,-0.0109894512823647,1.24405204537081e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36391,-0.0164104658489008,0.00338514973604874,-0.0230453593315564,-0.00977557236624529,1.26347861435439e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,36731,-0.0183151400782723,0.00377914453309947,-0.0257222633631472,-0.0109080167933973,1.27206648772851e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,39023,0.0127081025058224,0.00262366797382539,0.00756571327712465,0.0178504917345202,1.28740834937906e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,36762,0.00646946425118186,0.00133580322343916,0.00385128993324109,0.00908763856912262,1.29295431255699e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,36792,-0.0240406815717105,0.00496817586107085,-0.0337783062594093,-0.0143030568840116,1.32043271460412e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,38951,-0.050091947448292,0.0103777163308079,-0.0704322714566754,-0.0297516234399086,1.40049378367442e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,39255,-0.0167349716836361,0.00347015116801278,-0.0235364679729411,-0.00993347539433104,1.43091073618858e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,38828,-0.013386621973062,0.00277595537517886,-0.0188274945084126,-0.00794574943771146,1.43273751810805e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39283,0.0137689364841506,0.00285649606631329,0.00817020419417656,0.0193676687741246,1.44767011255458e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,38727,-0.0198003873187813,0.00410829049096509,-0.0278526366810728,-0.0117481379564897,1.45255129139293e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",36747,-0.0171424355128647,0.00355890305664166,-0.0241178855038824,-0.0101669855218471,1.47557226372467e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,39241,0.0128506076019028,0.00266849632038869,0.00762035481394096,0.0180808603898646,1.48100542274318e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,38926,-0.0162289278713863,0.00337452534501819,-0.0228429975476219,-0.00961485819515065,1.52964280920952e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39291,-0.0160511012813811,0.00334278661897407,-0.0226029630545702,-0.00949923950819189,1.58790176871535e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,36731,-0.0194383300681627,0.00405126338643708,-0.0273788063055794,-0.011497853830746,1.619829623392e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36430,-0.0158378319360183,0.00330483943284153,-0.0223153172243877,-0.00936034664764892,1.66753852815339e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,36478,-0.0251149381040862,0.00524410075331144,-0.0353933755805766,-0.0148365006275957,1.6936864330092e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36420,-0.0173228164912628,0.00361784436843286,-0.0244137914533913,-0.0102318415291344,1.70238436405081e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,36796,-0.0305136948313547,0.00638877490191655,-0.0430356936391111,-0.0179916960235982,1.80650860378538e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,36743,-0.0300941790304956,0.00630429445142273,-0.0424505961552842,-0.0177377619057071,1.82951240315386e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,39099,-0.0380150533234126,0.00797857658735907,-0.0536530634346364,-0.0223770432121888,1.90934668257955e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,36792,-0.0206819793339751,0.00434048798940834,-0.0291893357932154,-0.0121746228747347,1.91004760048427e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39023,-0.0144434387206171,0.0030343269548297,-0.0203907195520833,-0.0084961578891509,1.95366800511838e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36391,-0.0276132683895979,0.00580735537395541,-0.0389956849225505,-0.0162308518566453,2.00776740420942e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,36500,-0.02228517960498,0.00469041687657944,-0.0314783966830757,-0.0130919625268843,2.04422986685606e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,36791,-0.0101694915410467,0.00214366874040418,-0.0143710822722389,-0.00596790080985448,2.11814997949901e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36421,-0.0212784830482961,0.00448749140904912,-0.0300739662100324,-0.0124829998865598,2.14227048663304e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39106,-0.0299474326301827,0.00632607001300558,-0.0423465298556736,-0.0175483354046918,2.22148395461064e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,36763,0.0313444634839565,0.00664183808478188,0.018326460837784,0.044362466130129,2.39207263473524e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,36731,-0.027843477667157,0.00591400574969494,-0.0394349289365591,-0.0162520263977549,2.52697906472159e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,36421,-0.0297478274396138,0.00632522154806195,-0.0421452616738152,-0.0173503932054123,2.59033693025157e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,39241,-0.00960550193879064,0.0020464663874829,-0.0136165760582571,-0.00559442781932417,2.70619090932049e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39099,0.0112058854992717,0.00238875456883518,0.00652392654435476,0.0158878444541887,2.74100543962673e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,38990,0.00993786119317972,0.00211895749991707,0.00578470449334226,0.0140910178930172,2.75624015360633e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39208,-0.0296047001461603,0.00631707591571884,-0.0419861689409692,-0.0172232313513513,2.80363826449906e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,39017,0.0145661226654329,0.00310839315428379,0.00847367208303669,0.0206585732478291,2.80933826219367e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39136,-0.0279328952243057,0.00596219463463813,-0.0396187967081965,-0.016246993740415,2.82370039092509e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,36538,-0.0145719052545063,0.00311122214356952,-0.0206699006559026,-0.00847390985311006,2.84723518179808e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39099,0.022756268448793,0.00486512554958782,0.0132206223716009,0.0322919145259852,2.92991803119431e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36500,-0.0160566698342777,0.00343324194370946,-0.0227858240439482,-0.00932751562460717,2.94368345615417e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36430,-0.0192544537695154,0.00412006166225102,-0.0273297746275274,-0.0111791329115034,2.99415714550928e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,36767,-0.0365894362328872,0.00783308142968527,-0.0519422758350703,-0.021236596630704,3.02552604611961e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,36420,-0.017299988366407,0.00370453363716994,-0.0245608742952601,-0.010039102437554,3.04394252074676e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39004,-0.0201220965047192,0.00431078955551243,-0.0285712440335236,-0.0116729489759149,3.06985175724032e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,36538,-0.0328326199849072,0.00703494508288938,-0.0466211123473704,-0.019044127622444,3.08645818818381e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,39114,-0.0253368599242413,0.00543634136913394,-0.0359920890077438,-0.0146816308407387,3.17886216238503e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,36421,-0.0213247543035026,0.00457672210188014,-0.0302951296231877,-0.0123543789838175,3.2039814214085e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39078,-0.0104784439051067,0.0022521165683893,-0.0148925923791498,-0.00606429543106373,3.30361948292753e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39165,0.0141008361008126,0.00303228223716103,0.00815756291597696,0.0200441092856482,3.34322948383922e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,36747,-0.0308285477217355,0.00665073667987966,-0.0438639916142996,-0.0177931038291714,3.59816224732038e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39153,-0.0142386180342479,0.00307427331388577,-0.020264193729464,-0.00821304233903176,3.6594691527543e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,36421,-0.0181339533298729,0.00392659157156547,-0.0258300728101412,-0.0104378338496046,3.90844713767064e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39106,-0.0311831481289362,0.00675478722714008,-0.0444225310941307,-0.0179437651637416,3.93542520879167e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39106,-0.0281716059406565,0.00611974053076703,-0.0401662973809599,-0.0161769145003531,4.19006439286662e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,36420,-0.0382189009599074,0.00830601305280145,-0.0544986865433982,-0.0219391153764166,4.23863203034604e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,36731,-0.0186843736469147,0.0040612982915603,-0.0266445182983729,-0.0107242289954565,4.25314328149465e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36421,-0.0311956369594822,0.00678143095852161,-0.0444872416381846,-0.0179040322807798,4.26303443744493e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36363,-0.0282284057882294,0.00614530357780463,-0.0402732008007265,-0.0161836107757324,4.40146617356702e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,36538,-0.0548018923450314,0.0119349392344571,-0.0781943732445674,-0.0314094114454954,4.4383755999355e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,39111,-0.020118590753549,0.00438367650251384,-0.0287105966984761,-0.0115265848086219,4.47995833161408e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,39106,-0.0281977255211116,0.00615152655756608,-0.0402547175739412,-0.0161407334682821,4.60098707708159e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39057,0.0120261502107785,0.00263830889244006,0.00685506478159596,0.017197235639961,5.19764276176921e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,38987,-0.0235710847078999,0.00518219211078306,-0.0337281812450347,-0.0134139881707651,5.44551894846694e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,36421,-0.0342850645336728,0.00754549875433334,-0.0490742420921662,-0.0194958869751795,5.57703090501747e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,39255,-0.0168108898732477,0.00370632919331495,-0.024075295092145,-0.00954648465435034,5.78394420917682e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,36747,-0.0112443863685379,0.00248135576303202,-0.0161078436640806,-0.00638092907299513,5.90792559294986e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,38705,-0.0278616422925816,0.0061557140795848,-0.0399268418885678,-0.0157964426965954,6.05365967840458e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39255,0.0245459740975445,0.00543430526628584,0.0138947357756243,0.0351972124194648,6.3231002049642e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,36743,-0.0272793578130218,0.0060418808677433,-0.0391214443137986,-0.0154372713122449,6.38652403194967e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,39092,-0.0164590947595101,0.00365015519556312,-0.0236133989428138,-0.00930479057620637,6.55737879698457e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,38741,-0.0177800523651302,0.00394484076582313,-0.0255119402661435,-0.0100481644641169,6.62002257804323e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39266,-0.00971357688210418,0.00215672981382265,-0.0139407673171966,-0.00548638644701179,6.72250000222305e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39241,-0.0233995748243073,0.00519658584528921,-0.0335848830810741,-0.0132142665675404,6.75331834902644e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,38841,-0.0163470899057978,0.00363144925884137,-0.0234647304531269,-0.00922944935846868,6.79735615766321e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39165,-0.0190179798705315,0.00423185516923781,-0.0273124160022376,-0.0107235437388254,7.04082822248649e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36421,-0.0139882233635756,0.00311652500230755,-0.0200966123680984,-0.00787983435905282,7.23970661506233e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,38727,-0.0410713459705351,0.00915249387322378,-0.0590102339620537,-0.0231324579790165,7.26222028181414e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,38987,-0.0326610728747475,0.00728489259574451,-0.0469394623624068,-0.0183826833870883,7.40037393424667e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,38960,-0.0190120905361765,0.00424212896470657,-0.0273266633070014,-0.0106975177653517,7.45836858757348e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39140,-0.0216800756908548,0.00483801582204651,-0.031162586702066,-0.0121975646796437,7.47665762773812e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36430,-0.0357263013206109,0.00797934201614712,-0.0513658116722593,-0.0200867909689626,7.62410096648184e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,38754,-0.0328469450832195,0.00734148083926577,-0.0472362475281804,-0.0184576426382586,7.72812387796679e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",36792,-0.0364033863478123,0.00813691025864856,-0.0523517304547635,-0.0204550422408612,7.74760020906758e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,36806,0.00764535741377037,0.00171010649960648,0.00429354867454166,0.0109971661529991,7.86300737322192e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,36430,-0.0383990402973672,0.00859004038094451,-0.0552355194440184,-0.021562561150716,7.88371617558074e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39255,-0.0223455803933523,0.00500201015943857,-0.0321495203058519,-0.0125416404808527,7.97698066804932e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,36747,-0.0118711654578285,0.00265743595648293,-0.017079739932535,-0.00666259098312195,7.99433182833064e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,39283,0.0119306818130266,0.00267147347263171,0.00669459380666844,0.0171667698193847,8.02782947688543e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,38741,-0.0308281827698752,0.0069060473114075,-0.0443640355002339,-0.0172923300395165,8.10573423117054e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,38832,-0.0315270963715064,0.00706634614943885,-0.0453771348244065,-0.0176770579186062,8.19491098985557e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,36767,-0.0122846090696895,0.00275547840934555,-0.0176853467520068,-0.00688387138737224,8.33288638674742e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,38997,-0.0249070197666506,0.00559010564879582,-0.0358636268382904,-0.0139504126950108,8.42768427423252e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39070,0.0224908694891428,0.00505008487847615,0.0125927031273295,0.032389035850956,8.50588564903257e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,39209,-0.0105351965170875,0.00236752295290674,-0.0151755415047847,-0.00589485152939032,8.65224382866749e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,36747,-0.0381906399434439,0.00859488980870554,-0.0550366239685067,-0.021344655918381,8.92817502305512e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,36774,0.0139668908075106,0.00314479064594148,0.00780310114146533,0.0201306804735559,9.01689655508992e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36391,-0.0144068347950486,0.00324458929127945,-0.0207662298059563,-0.00804743978414089,9.06170474174516e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,38727,-0.0401959282554881,0.00905445289801332,-0.0579426559355942,-0.022449200575382,9.08788051946605e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,36791,-0.00911895977005335,0.00205592256856033,-0.0131485680044316,-0.00508935153567511,9.26349098705971e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,36743,-0.0278307433811125,0.00628321724816732,-0.0401458491875204,-0.0155156375747045,9.52843173064962e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,36767,-0.0196701026263385,0.00444697432518221,-0.0283861723036956,-0.0109540329489813,9.80204430234788e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39106,-0.0104665718375573,0.00236968562251973,-0.015111155657696,-0.00582198801741864,1.00834304099162e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39055,-0.00815893465056335,0.00185101469007509,-0.0117869234431105,-0.00453094585801617,1.05133437293067e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,38741,-0.0263765421177232,0.00598702443381988,-0.0381111100080101,-0.0146419742274362,1.06219836180232e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36538,-0.0203099714814626,0.00461968499024209,-0.0293645540623371,-0.0112553889005881,1.10958222444807e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,36679,0.0109172035857366,0.0024838329939651,0.00604889091756499,0.0157855162539082,1.11506979076637e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,36608,0.00329810300881438,0.000750463007451169,0.00182719551421009,0.00476901050341867,1.11792880373487e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,36792,-0.0130556087476031,0.00297077522264502,-0.0188783281839873,-0.0072328893112188,1.1181956901171e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,36420,-0.0264053654675114,0.00601085735904473,-0.0381866458912391,-0.0146240850437837,1.12741538790296e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,39132,-0.0107949457422612,0.00245962980606075,-0.0156158201621403,-0.00597407132238215,1.14716321096748e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,39291,-0.0340873645106865,0.00777102444729888,-0.0493185724273923,-0.0188561565939807,1.15968537979352e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,36731,-0.0207166105882271,0.00473162070577541,-0.0299905871715469,-0.0114426340049073,1.20534418498639e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,38727,-0.0237064893212783,0.00541484048943522,-0.0343195766805713,-0.0130934019619853,1.20558748460557e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,38741,-0.0193287862302997,0.0044151656610678,-0.0279825109259926,-0.0106750615346068,1.20691654375856e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39255,0.0144877911876173,0.00330948973092818,0.00800119131499808,0.0209743910602365,1.20755927830606e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,39093,-0.0096489233650779,0.00220425871354233,-0.0139692704436209,-0.00532857628653492,1.20903000586691e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,38832,-0.0214869667131667,0.00491606539440198,-0.0311224548861946,-0.0118514785401388,1.2464611023423e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,36430,-0.0140626043513604,0.00321756377563377,-0.0203690293516026,-0.00775617935111824,1.24914395552539e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39093,-0.0166064178207626,0.00379990337479953,-0.0240542284353697,-0.00915860720615549,1.24942271361643e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39147,-0.0115347475578665,0.00265286132813811,-0.0167343557610172,-0.00633513935471579,1.38247861832404e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,39241,-0.00915967301217098,0.00210808111109394,-0.0132915119899151,-0.00502783403442685,1.40150216121521e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,39093,-0.0211344373083065,0.0048675431042766,-0.0306748217926887,-0.0115940528239244,1.42160835643118e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,36538,-0.0270174632298256,0.00623027065464375,-0.0392287937129274,-0.0148061327467239,1.45898781298014e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,38951,-0.0245215426804685,0.00566035394545504,-0.0356158364135604,-0.0134272489473766,1.48609478400033e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,36363,-0.0221580506975803,0.00511449797049666,-0.0321824667197538,-0.0121336346754069,1.48643693522643e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,36785,-0.0193422466388191,0.00446488023031789,-0.0280934118902422,-0.0105910813873961,1.48817581775049e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,38727,-0.0181678364907974,0.00419986703545866,-0.0263995758802964,-0.00993609710129847,1.52961905181137e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,38727,-0.0371677443921766,0.0085953178652687,-0.0540145674081033,-0.02032092137625,1.54093824974699e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39046,-0.0107247629282144,0.00249088719272682,-0.015606901825959,-0.00584262403046984,1.67578393649341e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,38832,-0.0225722060587208,0.00524541802461104,-0.0328532253869585,-0.0122911867304832,1.6939939419368e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,38972,-0.0231886064381116,0.00539206463361152,-0.0337570531199902,-0.0126201597562331,1.71477597435198e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,36791,0.0147501254025757,0.00343169280036219,0.00802400751386585,0.0214762432912856,1.7344577645613e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,39085,0.020321748409095,0.00472839848671786,0.011054087375128,0.029589409443062,1.73567078073994e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39162,-0.0263369108069525,0.00613120716617639,-0.0383540768526582,-0.0143197447612468,1.75335130448364e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,39241,-0.024412555580446,0.00568362845900869,-0.035552467360103,-0.0132726438007889,1.7557397634453e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,39093,-0.0102237874726047,0.00238563169011042,-0.0148996255852211,-0.00554794935998823,1.83392067340969e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,36430,-0.0126818224011833,0.00297583992317145,-0.0185144686505994,-0.00684917615176726,2.04452991998672e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,36628,0.016262659079939,0.0038231757140852,0.00876923468033202,0.023756083479546,2.11760860144147e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39099,-0.0446012546526375,0.0104963896711121,-0.0651741784080173,-0.0240283308972577,2.15810570147352e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36420,-0.0197841849297666,0.00467365930024716,-0.0289445571582511,-0.0106238127012822,2.32104662558812e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,38832,-0.01349525252605,0.00319151174292976,-0.0197506155421924,-0.00723988950990769,2.36669278909919e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,36767,-0.014860597532023,0.00351635703360442,-0.0217526573178877,-0.00796853774615835,2.3937435150229e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,36792,-0.0156644046487077,0.00370920215658146,-0.0229344408756074,-0.00839436842180806,2.4259245789141e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,36652,-0.0168943062527745,0.00400259623624804,-0.0247393948758206,-0.00904921762972832,2.45077163738995e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36421,0.0124701711960344,0.00296057702627885,0.00666744022452783,0.0182729021675409,2.54800942764705e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,39099,-0.0239685634678581,0.0056923696705312,-0.0351256080220993,-0.012811518913617,2.56101010054222e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39241,0.0502130523546221,0.011927161308894,0.0268358161891898,0.0735902885200543,2.56850197746763e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,39031,-0.0329871679120058,0.00783602794762595,-0.0483457826893526,-0.0176285531346589,2.57206003031947e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39093,-0.010363655848208,0.00246196040852097,-0.0151890982489091,-0.00553821344750691,2.57388925081713e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,39160,0.0105488395386105,0.00250640927832615,0.00563627735309127,0.0154614017241298,2.58257487029868e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39162,-0.0333678979460619,0.00795064571617798,-0.0489511635497707,-0.017784632342353,2.72146015580889e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39023,-0.0147806291119371,0.00352786357265905,-0.0216952417143489,-0.00786601650952538,2.80925695198044e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,39117,-0.012372465882344,0.00295350389078544,-0.0181613335082835,-0.00658359825640453,2.81661401838278e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36420,-0.0182744356741136,0.00436441954202684,-0.0268286979764862,-0.00972017337174101,2.84418038130401e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,38705,-0.0175291150774196,0.00419147535002538,-0.0257444067634694,-0.00931382339136986,2.90503542846394e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39162,-0.0412459812415359,0.00986721537892502,-0.0605857233842289,-0.0219062390988428,2.9299632933495e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39099,-0.0284315564065682,0.0068031892597281,-0.0417658073556352,-0.0150973054575011,2.94231101532745e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39241,-0.0090341945302079,0.00216335455917903,-0.0132743694661988,-0.004794019594217,2.98298859538399e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,36767,-0.018964739740235,0.0045500731640007,-0.0278828831416764,-0.0100465963387936,3.09277335633159e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39147,0.0123462948519179,0.00296943911949551,0.00652619417770665,0.0181663955261291,3.23097791550124e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39064,-0.026234636116029,0.00631495976325274,-0.0386119572520044,-0.0138573149800537,3.27977458641803e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,36703,-0.0172490041694741,0.00415569301166199,-0.0253941624723316,-0.0091038458666166,3.33608838131009e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36391,-0.0257433305858301,0.00620305658194363,-0.0379013214864397,-0.0135853396852206,3.34520023053696e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,36500,-0.0299395762917288,0.00721634145205481,-0.0440836055377562,-0.0157955470457014,3.36324250022199e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,36747,-0.0174740004718728,0.00421386385785225,-0.0257331736332632,-0.00921482731048242,3.3933154112127e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36430,-0.0339686417243197,0.00819831511457457,-0.0500373393488859,-0.0178999440997536,3.44481667810265e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39234,-0.0122775529601821,0.00296349446790918,-0.018086002117284,-0.00646910380308006,3.4472905807428e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,38727,-0.021093179233738,0.00510036739324725,-0.0310898993245026,-0.0110964591429734,3.55943028780908e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,38727,-0.019556372259114,0.00473375803476741,-0.0288345380072581,-0.0102782065109698,3.62758678779363e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,39255,0.0230238069675165,0.0055745110565231,0.0120977652967312,0.0339498486383017,3.6437197751841e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39045,-0.0437265695974003,0.0105920635326423,-0.0644870141213792,-0.0229661250734214,3.67504904614555e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,38727,-0.025190630644968,0.00610225757799135,-0.037151055497831,-0.0132302057921049,3.67794551866783e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,39106,-0.047043265997837,0.0113972491085066,-0.0693818742505099,-0.0247046577451641,3.68521021883734e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39241,-0.0175077850837277,0.00424255905363391,-0.0258232008288502,-0.00919236933860524,3.6993774491465e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,36743,-0.0181272006692853,0.00440048447159236,-0.0267521502336063,-0.00950225110496427,3.82291854729252e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,39291,-0.0210432292163342,0.00510881968560056,-0.0310565158001113,-0.0110299426325571,3.82503183634436e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,36517,0.0117272133729089,0.00284766780553722,0.00614578447405596,0.0173086422717619,3.84299389447741e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",36792,-0.0260704613610571,0.00633369966635422,-0.0384845127071114,-0.0136564100150029,3.87643318183945e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,38987,-0.0149646958657651,0.00363632725795328,-0.0220918972913535,-0.00783749444017666,3.88670381440675e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,38727,-0.0219459622100063,0.00533323798684897,-0.0323991086642303,-0.0114928157557823,3.89365101373434e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,36731,-0.0319642175277342,0.00776852845868394,-0.0471905333067547,-0.0167379017487137,3.90302992261743e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,36767,-0.0183246100986743,0.0044566975506332,-0.0270597372979153,-0.00958948289943321,3.95185701403734e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36500,-0.0106934937783708,0.00260129702690672,-0.015792035951108,-0.00559495160563363,3.96727528547434e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,36743,-0.0317119586183161,0.00771678140859319,-0.0468368501791588,-0.0165870670574735,3.99006007821307e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,36747,-0.00805675960114607,0.00196107343767938,-0.0119004635389976,-0.00421305566329449,4.00974026490352e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39068,0.0144887959978478,0.00352823469917087,0.0075734559874729,0.0214041360082227,4.03749964728287e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39099,-0.021283438631414,0.00518637192872554,-0.031448727611716,-0.0111181496511119,4.08668215159591e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,38630,0.0138770145934928,0.00338841973930684,0.00723571190445144,0.0205183172825342,4.23642277177106e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,36767,0.0139441004195791,0.00340627555561187,0.00726780033057979,0.0206204005085783,4.27220500478178e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39239,-0.0355635041928046,0.00870661559247762,-0.0526284707540608,-0.0184985376315485,4.43663421632523e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39147,-0.0232992480055132,0.00571379378795333,-0.0344982838299017,-0.0121002121811246,4.57098934016024e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,39274,-0.00733685370469841,0.00180425965089002,-0.0108732026204429,-0.00380050478895397,4.79808126440633e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,36767,-0.0129919655906833,0.00319533180050062,-0.0192548159196645,-0.00672911526170211,4.8127098612918e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,39165,0.0177784498742985,0.0043730068173703,0.00920735651225274,0.0263495432363443,4.81697010673982e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39207,0.00862700938748744,0.00212631654531956,0.00445942895866109,0.0127945898163138,4.98984647927475e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,36743,-0.0179763289962784,0.00444307208754676,-0.0266847502878701,-0.00926790770468678,5.24213671021733e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,36702,-0.0360477472277365,0.00891561758836605,-0.053522357700934,-0.0185731367545391,5.30313374232365e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,39099,-0.02867006497426,0.0071012111202073,-0.0425884387698664,-0.0147516911786537,5.43231202570087e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,39030,-0.0403040292712427,0.0099893553725065,-0.0598831658013554,-0.0207248927411299,5.49406066017908e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36391,-0.0251823298187142,0.00624688809443574,-0.0374262304838083,-0.0129384291536202,5.58258686260365e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,36743,-0.0359077519167889,0.0089343029397802,-0.0534189856787581,-0.0183965181548197,5.87561537497986e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36420,-0.022322441590845,0.00555680991756144,-0.0332137890292654,-0.0114310941524245,5.92537470975669e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",36755,-0.0084194722549794,0.00209691677945416,-0.0125294291427096,-0.00430951536724926,5.97399496193006e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39147,0.0128398117327,0.00319863087307827,0.00657049522146655,0.0191091282439334,5.99428132659841e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36466,-0.014332667104231,0.00358022787908687,-0.0213499137472413,-0.00731542046122073,6.28271904452081e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,36731,-0.0241423497882975,0.0060348565185084,-0.035970668564574,-0.012314031012021,6.35666005341934e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,36792,-0.0335141657912262,0.00840186095812773,-0.0499818132691565,-0.0170465183132958,6.67465645545113e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,39031,0.0149882954145954,0.00375823106422858,0.00762216252870738,0.0223544283004834,6.69098930714863e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,38741,-0.0230227549258152,0.00578108302255671,-0.0343536776500263,-0.0116918322016041,6.85387923757349e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,35080,-0.0372501454267987,0.00935455345117431,-0.0555850701911004,-0.0189152206624971,6.87591767730659e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39147,-0.0110037803240535,0.00276393917882393,-0.0164211011145484,-0.0055864595335586,6.88867597825723e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,36796,-0.0175437920755379,0.0044099754606548,-0.0261873439784213,-0.00890024017265452,6.98155509541521e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,38841,-0.0154390467731365,0.00388350988421829,-0.0230507261462043,-0.00782736740006862,7.05494322029149e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,36791,-0.0130255688169702,0.0032763991071197,-0.0194473110669248,-0.00660382656701558,7.05913840131306e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39283,0.00901503065246212,0.00226987774994645,0.00456607026256708,0.0134639910423572,7.17178102486942e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,36430,-0.0212993384775943,0.00536559164084108,-0.0318158980936428,-0.0107827788615458,7.23890391020064e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36420,-0.0282341874106184,0.00711442542431403,-0.0421784612422739,-0.0142899135789629,7.27034431015953e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,36743,-0.030742336129729,0.00775297749032937,-0.0459381720107746,-0.0155465002486835,7.37216515571429e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36391,0.0102154468428294,0.0025766041793469,0.00516530265130944,0.0152655910343493,7.3898385722414e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,36203,-0.0143082043285795,0.00362190105275045,-0.0214071303919704,-0.00720927826518864,7.84324099710165e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,36767,-0.0331544980569719,0.00839393037295579,-0.0496066015879653,-0.0167023945259785,7.86263775727015e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39023,-0.0101939730378841,0.00259310863765038,-0.0152764659676788,-0.00511148010808936,8.49060776590727e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39241,-0.0123091691152069,0.00313435691191835,-0.0184525086625669,-0.00616582956784696,8.63243771148155e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,36500,-0.0269903894197456,0.00687579129531374,-0.0404669403585605,-0.0135138384809307,8.70365430192439e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,39147,0.0102920715636057,0.00263701157836478,0.00512352887001068,0.0154606142572006,9.54427852079896e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,39162,-0.0335705307744372,0.00862419983606945,-0.0504739624531333,-0.016667099095741,9.95976897176613e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,36391,-0.0288181774028681,0.00741215237496489,-0.0433459960577993,-0.0142903587479369,0.000101610291045936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,36792,-0.0232816097685358,0.00599471503644484,-0.0350312512399676,-0.0115319682971039,0.000103395502358854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,36767,-0.0272656228550218,0.0070210756086033,-0.0410269310478843,-0.0135043146621594,0.000103520787155315
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36363,-0.0277048247913252,0.00713440874964889,-0.041688265940637,-0.0137213836420133,0.000103592031970431
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39093,0.00876880856209851,0.00225831706396703,0.00434250711672314,0.0131951100074739,0.000103655747808328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36500,-0.0134376859512622,0.00346884847746346,-0.0202366289670906,-0.00663874293543386,0.000107684057580688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36339,-0.0177134016184139,0.00457352309564305,-0.0266775068858743,-0.00874929635095354,0.000108038407413913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36420,-0.0117100392251158,0.00302730852976403,-0.0176435639434533,-0.00577651450677835,0.000110224369053335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39137,0.0111822707197694,0.00289847481361229,0.00550126008508929,0.0168632813544495,0.000114795550363172
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,36391,-0.0221937087336908,0.00575823428330543,-0.0334798479289695,-0.0109075695384122,0.000116661501522189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,36421,-0.047380849834681,0.0122954544837496,-0.0714799406228302,-0.0232817590465318,0.000117008354043004
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,38951,-0.0285712860960876,0.00741818340342733,-0.0431109255668052,-0.0140316466253701,0.000117871726534311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,39237,-0.0189707849405833,0.00493060340333398,-0.0286347676111179,-0.00930680227004867,0.00011978272331187
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,39023,-0.0262574991731595,0.00682884307343221,-0.0396420315970866,-0.0128729667492323,0.000121001911028578
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39041,-0.0665833917712069,0.0173225403938219,-0.100535570943098,-0.032631212599316,0.000121665897946055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,38727,-0.0157546964327346,0.00410453001191293,-0.0237995752560839,-0.00770981760938526,0.000124367643041456
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,36743,-0.0137268976668772,0.00358184626161572,-0.020747316339644,-0.00670647899411035,0.000127526716514143
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,38832,0.0117545061711468,0.00306850121785148,0.00574024378415792,0.0177687685581357,0.000128300900802711
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,36767,-0.0206809557653323,0.00540070522575913,-0.0312663380078202,-0.0100955735228444,0.000129112458989054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39291,-0.0241094230771777,0.00629786171101138,-0.03645323203076,-0.0117656141235954,0.000129597924976434
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,36420,-0.024472845921929,0.00640918760693547,-0.0370348536315225,-0.0119108382123354,0.000134965347919002
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,38987,-0.0122114466154,0.00320878074371057,-0.0185006568730727,-0.00592223635772731,0.000141998427305824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,38987,-0.034222363753119,0.00899310938294906,-0.0518488581436992,-0.0165958693625389,0.000142133828275911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,36747,-0.0115010374372647,0.0030274953176247,-0.0174349282598091,-0.00556714661472029,0.000146029837705721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,39051,-0.0168115001285106,0.00442589793008631,-0.0254862600714797,-0.00813674018554141,0.00014617790747516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,38733,-0.0100799203840394,0.00265490580362539,-0.0152835357591452,-0.00487630500893367,0.000147208684233788
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,38987,-0.00807740655587139,0.00212934165852341,-0.0122509162065773,-0.00390389690516551,0.000149187653554734
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,38741,-0.0176601313846076,0.00465647492569351,-0.0267868222389669,-0.00853344053024831,0.00014966960553688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36391,-0.0226400998218962,0.00597748358592634,-0.0343559676503118,-0.0109242319934806,0.000152842601046607
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,38658,-0.0298341824898941,0.00787846216034241,-0.0452759683241652,-0.014392396655623,0.000153201358020682
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39117,-0.0165059528378544,0.00435892118907846,-0.0250494383684482,-0.00796246730726065,0.000153242810591012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,38841,-0.028250355877218,0.0074674563823539,-0.0428865703866316,-0.0136141413678044,0.000155471194857711
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",36743,-0.0515357987801883,0.013647115174691,-0.0782841445225827,-0.0247874530377939,0.000159881364702696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,36587,-0.00471387909867824,0.00124865748217655,-0.00716124776374427,-0.00226651043361221,0.000160633042086667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,36421,-0.017463585404504,0.0046283232438836,-0.0265350989625158,-0.00839207184649212,0.000161908172657473
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39241,-0.0240004386331277,0.0063665112928146,-0.0364788007670443,-0.0115220764992111,0.000163992990910042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,38741,-0.018012870891421,0.00477913336619119,-0.0273799722891557,-0.00864576949368628,0.000164492156083973
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36391,-0.0302695344347823,0.0080310599774171,-0.0460104119905198,-0.0145286568790448,0.000164616246934703
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,39093,-0.00901786934724104,0.00239312308544277,-0.0137083905947089,-0.00432734809977321,0.000165020352066106
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,36743,-0.0106957989360469,0.00283873661106981,-0.0162597226937438,-0.00513187517835011,0.000165424829706999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39255,-0.0208726598597983,0.00555010810031724,-0.0317508717364201,-0.00999444798317656,0.000170020710458373
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36466,-0.030070956759438,0.00799559569240536,-0.0457423243165526,-0.0143995892023235,0.000170041621457831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39165,-0.0148072643907441,0.00394157508900815,-0.0225327515652001,-0.00708177721628817,0.000172816102728248
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,39106,-0.0123124379417572,0.0032782063412195,-0.0187377223705475,-0.00588715351296702,0.000173399607741629
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,36430,-0.0148270446807926,0.0039479434525089,-0.0225650138477101,-0.00708907551387518,0.000173680929439833
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36394,-0.0296784466448697,0.00791801476634756,-0.0451977555869109,-0.0141591377028285,0.000178895256246922
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,39106,-0.00828693688761247,0.00221705057384808,-0.0126323560123547,-0.00394151776287024,0.000186300576045428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,36363,-0.0151200789426114,0.00404575966215245,-0.0230497678804302,-0.0071903900047926,0.000186860762930059
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,36767,-0.0412631961063864,0.0110633554823462,-0.0629473728517849,-0.0195790193609878,0.000192514855334275
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,38571,-0.0317958597273753,0.00852820311160041,-0.0485111378261121,-0.0150805816286385,0.000193484343517218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,39083,-0.0116441098879873,0.00312576822141382,-0.0177706156019584,-0.00551760417401616,0.000195865911166567
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,36538,-0.0255613354204788,0.00686527582589783,-0.0390172760392385,-0.012105394801719,0.000197503780005478
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36420,-0.0265463242123514,0.0071355837410825,-0.0405320683448731,-0.0125605800798297,0.000199874256460535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39211,-0.0250081914077593,0.00672942370536743,-0.0381978618702794,-0.0118185209452391,0.000202922854394713
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36500,-0.0233967271858387,0.00629774428941506,-0.0357403059930922,-0.0110531483785852,0.000204001208515768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,36743,-0.0115107378174022,0.00309956666403081,-0.0175858884789026,-0.00543558715590182,0.00020514500725464
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39229,-0.0103785116409716,0.00279659746082853,-0.0158598426641955,-0.00489718061774769,0.000207071295608122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,36693,-0.0118928247050642,0.00320634008974536,-0.0181772512809651,-0.00560839812916325,0.000208825907824177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39147,-0.00877785292220097,0.00236938303169799,-0.013421843664329,-0.00413386218007291,0.000212386913169393
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,39283,0.0104739993473682,0.00283064729757497,0.0049259306441213,0.0160220680506152,0.000216167053270836
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36500,-0.0228689082154049,0.00619001463679432,-0.0350013369035218,-0.0107364795272881,0.000221263466077292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,36779,-0.00771920345543515,0.00208978390846465,-0.0118151799160259,-0.00362322699484444,0.000221855582582778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39099,-0.0210618258692202,0.00570465747619694,-0.0322429545225662,-0.00988069721587415,0.000223238371246965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,39114,-0.0365792171991045,0.00992329832334322,-0.0560288819128572,-0.0171295524853518,0.00022842035086127
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,36430,-0.0143211335286562,0.00389115193597158,-0.0219477913231605,-0.00669447573415191,0.000233809614749777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,38832,-0.0397482093212338,0.0108179079123509,-0.0609513088294416,-0.0185451098130261,0.000239336843112855
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39099,-0.0345016401296277,0.00941075585447538,-0.0529467216043994,-0.0160565586548559,0.000247025551192022
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39083,-0.0106592345774444,0.00291130143420114,-0.0163653853884786,-0.00495308376641013,0.000251758932497225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36500,-0.0244278316839453,0.00668200696448428,-0.0375245653343345,-0.0113310980335561,0.000257458172900992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36430,-0.0265945462830207,0.00730650553139887,-0.0409152971245625,-0.012273795441479,0.000273896610428337
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,36743,-0.03063544854643,0.00842201638839673,-0.0471426006676876,-0.0141282964251724,0.000276325643661192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,36792,-0.0275346203894929,0.00758014465370734,-0.0423917039107593,-0.0126775368682265,0.000281811319679588
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39093,0.00900320933657819,0.00247936874416002,0.00414364659802455,0.0138627720751318,0.000282976177751148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,38652,0.0233468529237362,0.00642970668728927,0.0107446278166493,0.0359490780308232,0.000283178280679413
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,38841,-0.0222700205331428,0.00613944829486624,-0.0343033391910806,-0.010236701875205,0.000287279370920035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,36339,-0.0190475299122381,0.00525403118163615,-0.029345431028245,-0.00874962879623127,0.000289755612861823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36391,0.00677584258833455,0.00186967878874674,0.00311127216239093,0.0104404130142782,0.000291153568066737
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39291,-0.0175797950422232,0.00485495523488383,-0.0270955073025955,-0.00806408278185094,0.00029440615208191
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,38832,0.00720488979777489,0.0019908916766041,0.00330274211163086,0.0111070374839189,0.000296802817759647
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36421,-0.0204326123750765,0.00564874790201479,-0.0315041582630255,-0.00936106648712756,0.000298982761210345
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,38741,-0.0136931218716843,0.00378631367127537,-0.0211142966673841,-0.00627194707598461,0.000299625611894328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,36500,-0.0097444952151106,0.00269436432740509,-0.0150254492968246,-0.00446354113339662,0.000299635861089825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,36391,-0.0225424388274882,0.00623455106482621,-0.0347621589145476,-0.0103227187404289,0.000300680486402353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39099,-0.0154932769428942,0.0042890827694408,-0.0238998791709982,-0.00708667471479025,0.000304517206900357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,38741,-0.022657251548004,0.00630011320090202,-0.035005473421772,-0.0103090296742361,0.000323790196091676
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,38775,-0.0297861591167919,0.00829184229360564,-0.046038170012259,-0.0135341482213249,0.000328921897896377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39106,-0.00924726118343495,0.00257783688497651,-0.0142998214779889,-0.004194700888881,0.00033527204227054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,36765,0.0160674099218163,0.00447906496318077,0.00728844259398204,0.0248463772496507,0.00033545335465176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,36747,-0.045520970116161,0.012697464639245,-0.0704080008090813,-0.0206339394232407,0.000338266913758313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36420,0.019975949340739,0.00557256930958256,0.00905371349395715,0.0308981851875208,0.000338754455388193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,36767,0.0149218817667236,0.00416547935923939,0.00675754222261439,0.0230862213108328,0.000341871643699976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39057,-0.0134852724641773,0.00376694421807532,-0.0208684831316049,-0.00610206179674965,0.000344800928953659
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37339,0.0101894565094201,0.00284827337327342,0.00460684069780418,0.015772072321036,0.000348225100478315
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,39165,-0.033602895059525,0.00939760766339201,-0.0520222060797733,-0.0151835840392766,0.000350386856787606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39291,-0.0185531161852159,0.00519557344210806,-0.0287364401317477,-0.00836979223868413,0.000356774781244667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,38841,-0.0222159588179207,0.00624469616514634,-0.0344555633016075,-0.00997635433423386,0.000375453978256582
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,38987,-0.0267967522625313,0.00753407030596969,-0.0415635300622319,-0.0120299744628307,0.000376628569311744
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,36740,-0.0089947017527584,0.00252970853542687,-0.0139529304821951,-0.00403647302332173,0.000378429785060685
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39023,-0.0202028995747446,0.00568432988777423,-0.0313441861547821,-0.00906161299470712,0.000380371465258963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,38741,-0.0190952027696542,0.00537368758586498,-0.0296276304379496,-0.00856277510135884,0.000381370986111089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,39147,-0.0231519638723671,0.00652255283353965,-0.0359361674261049,-0.0103677603186294,0.000387085150691571
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36391,-0.0231364918084585,0.00652393913411584,-0.0359234125113255,-0.0103495711055915,0.000391959704959503
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,39099,-0.0160160429397546,0.00451676072882483,-0.0248688939682513,-0.00716319191125796,0.000392428023743688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,36729,-0.0279575343596878,0.00788970562401735,-0.0434213573827618,-0.0124937113366138,0.000396183350811496
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,36791,-0.0277794680159246,0.00784084390885859,-0.0431475220772874,-0.0124114139545618,0.000397120051141005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,38500,0.0101465187616565,0.00286415887712281,0.00453276736249575,0.0157602701608172,0.000397462341038656
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,39095,-0.0173583375783486,0.00490319668106083,-0.0269686030732278,-0.00774807208346936,0.000401003559918313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,38727,-0.0152423526768044,0.00431100833228046,-0.0236919290080741,-0.0067927763455347,0.000407961598718892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39062,-0.00933451998782321,0.00264300878565836,-0.0145148172077136,-0.00415422276793283,0.00041399851366925
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,36420,0.0138901461945108,0.00393688294705298,0.00617385561828691,0.0216064367707346,0.000419876061277122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,36792,-0.0330568973188244,0.00938098063817707,-0.0514436193696514,-0.0146701752679973,0.000426840263161251
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36391,-0.00905452504448755,0.00257638047144502,-0.0141042307685198,-0.0040048193204553,0.000442243312697853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,38741,-0.0121465480389815,0.00345806129724325,-0.0189243481815783,-0.00536874789638471,0.000445175884776658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,38942,0.0204772437686374,0.00583855665786135,0.00903367271922916,0.0319208148180457,0.000454090505109693
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,36418,-0.00848488974869683,0.00242008762413151,-0.0132282614919946,-0.00374151800539908,0.000456438263405973
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36421,-0.0199949350655693,0.00570503812457799,-0.0311768097897422,-0.00881306034139646,0.000458567384026188
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36500,-0.0279926849484638,0.00799699743864912,-0.0436667999282161,-0.0123185699687115,0.000466162496979539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39283,-0.0233292917535822,0.00666630805921924,-0.036395255549652,-0.0102633279575125,0.000467302912834704
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39071,0.0114964349793254,0.0032864102949318,0.00505507080125905,0.0179377991573917,0.000469793495988554
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,39023,-0.0290253066243727,0.00829730951436712,-0.0452880332725323,-0.0127625799762132,0.000469824384287499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,36743,-0.0198180724896156,0.00566687428428377,-0.0309251460868118,-0.00871099889241944,0.000471790938083023
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,39106,-0.0373124517405942,0.0106945662419086,-0.058273801574735,-0.0163511019064534,0.000486350572710854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39095,-0.00905484904700435,0.00259613838601198,-0.0141432802835878,-0.00396641781042086,0.000488359367003035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,36420,-0.0164992703555035,0.00473584750771325,-0.0257815314706215,-0.00721700924038553,0.000495827910076793
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,38841,-0.0168301378268427,0.00483389669147784,-0.0263045753421393,-0.00735570031154616,0.000499676863949338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39118,0.0157660562104135,0.0045296470908324,0.00688794791238198,0.024644164508445,0.000501621291573819
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,36731,-0.0136098600727687,0.00391024483875811,-0.0212739399567346,-0.00594578018880282,0.000502015770474049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,38727,-0.0235356356011648,0.00676547636407703,-0.0367959692747557,-0.0102753019275738,0.000505134917463007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",38939,-0.0129243687240489,0.00371981083428606,-0.0202151979592495,-0.00563353948884819,0.000513302755756631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39255,-0.0124320516131726,0.00358081988924209,-0.019450458596087,-0.00541364463025806,0.000518312905923332
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39062,0.00723405945628648,0.002088370590496,0.00314085309891431,0.0113272658136586,0.000533726281383907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,36747,-0.00816826834049998,0.00235838484833539,-0.0127907026432373,-0.00354583403776262,0.000534926883265583
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,36731,-0.0108776255286408,0.00314207328161125,-0.0170360891605988,-0.00471916189668272,0.00053806608205615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,36806,-0.00621432274829394,0.00179538795867794,-0.00973328314730271,-0.00269536234928517,0.000539367604827572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,39099,-0.0212209753370748,0.0061370080658763,-0.0332495111461923,-0.00919243952795727,0.000545950919761199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39076,-0.020391707243047,0.00590448190764283,-0.0319644917820269,-0.00881892270406705,0.000554666875486889
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,38990,-0.0211422830091382,0.00612218256771659,-0.0331417608418628,-0.00914280517641371,0.000555103485652976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39023,-0.0288024309663524,0.00834451973069811,-0.0451576896385207,-0.0124471722941841,0.000558671480834384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36391,-0.0114118655689878,0.0033069126775535,-0.0178934144169927,-0.00493031672098293,0.000560536746721563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",36747,-0.0313050009858366,0.00907995849770554,-0.0491017196413394,-0.0135082823303337,0.000567181005982075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,36747,-0.0122565154521673,0.00356129330174354,-0.0192366503235847,-0.00527638058074997,0.0005801385889564
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,39291,-0.00821662901433946,0.00238889217921329,-0.0128988576855975,-0.00353440034308141,0.000584299340284464
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,36747,-0.0113758551746856,0.00330980789790303,-0.0178630786545756,-0.00488863169479569,0.00059002281598313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39274,-0.0160054078739494,0.00465816053792284,-0.0251354025282781,-0.00687541321962063,0.000591942280005624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39023,-0.028216694155429,0.00821549633862031,-0.0443190669791248,-0.0121143213317332,0.000595083722041563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39241,-0.0149555100598603,0.00435903395352563,-0.0234992166087705,-0.00641180351095005,0.000603111747970135
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,38727,-0.0170317523617625,0.0049641672374249,-0.0267615201471153,-0.00730198457640974,0.000603132170576461
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,36743,-0.018546485377648,0.00541005765969589,-0.029150198390652,-0.00794277236464407,0.00060961210285165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39093,0.037803071337569,0.0110313297577025,0.0161816650124721,0.0594244776626659,0.000612165858345611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36420,-0.0308001217745365,0.00898812245127784,-0.0484168417790411,-0.013183401770032,0.000612789810133893
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",38832,-0.0296012087699458,0.00865352225021968,-0.0465621123803764,-0.0126403051595153,0.00062624133272444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36420,-0.010389409029124,0.003039848177601,-0.0163475114572219,-0.00443130660102598,0.000633438436910707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,36430,-0.015088472671316,0.00441868964316405,-0.0237491043719176,-0.00642784097071451,0.000640554623332811
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,38998,-0.00763476019765508,0.00223814292597689,-0.0120215203325698,-0.00324800006274039,0.000648458888610519
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",38951,-0.0231437120479688,0.00678942333107513,-0.036450981776876,-0.00983644231906151,0.000654225003480336
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36430,-0.0288373270836979,0.00845988710540862,-0.0454187058102988,-0.012255948357097,0.000654749853943768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,39147,-0.0199629606723876,0.00585696556474379,-0.0314426131792854,-0.00848330816548973,0.000655103534293628
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36420,-0.0179641690813511,0.00527135005854735,-0.0282960151961039,-0.00763232296659825,0.000656733037487001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,39291,-0.0192062203588663,0.0056446778140952,-0.0302697888744929,-0.00814265184323966,0.000669330506374011
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,39106,-0.0219248212406279,0.0064444524785552,-0.0345559480985961,-0.00929369438265973,0.000670362607508225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,36743,-0.0104625440071839,0.00307835217332134,-0.0164961142668937,-0.00442897374747407,0.000679000742847805
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36420,-0.0288318834210965,0.0084838099403974,-0.0454601509042754,-0.0122036159379176,0.000679770347532428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36421,-0.0194809469919884,0.0057336671497324,-0.0307189346054639,-0.00824295937851286,0.000681802927706945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39023,-0.00735244160967195,0.00216414983800652,-0.0115941752921647,-0.00311070792717917,0.000682089869856684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,39283,-0.0136277436840077,0.00401582944696172,-0.0214987694000527,-0.00575671796796277,0.000691774849576011
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36420,-0.028980278201341,0.00855089145320512,-0.045740025449623,-0.0122205309530589,0.000703244912543849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,39099,0.0186026050761127,0.00549556045418475,0.00783130658591057,0.0293739035663148,0.000713515076767895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",36767,-0.0146777870367011,0.00434606940408363,-0.023196083068705,-0.00615949100469718,0.000734292112764474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,38575,-0.0108187110755001,0.00320629793894623,-0.0171030550358347,-0.0045343671151655,0.000742199343519324
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36430,-0.017861651417859,0.00530173008658151,-0.0282530423875588,-0.00747026044815923,0.000756617836100187
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,38727,-0.0110159826068777,0.00327449874985551,-0.0174340001565945,-0.00459796505716086,0.00076967203704513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36377,-0.0124684787317004,0.00370980731064254,-0.0197397010605598,-0.00519725640284102,0.000779070770704881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,38987,0.0343274098708448,0.0102158638946273,0.0143043166373752,0.0543505031043143,0.000780768763215626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,36500,-0.0155571190852771,0.00463165750088063,-0.0246351677870032,-0.00647907038355111,0.000784941516324341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,36251,-0.013555629157877,0.0040360157234735,-0.021466219975885,-0.00564503833986892,0.000785556880773446
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,36743,-0.0131699954485189,0.00392579606773239,-0.0208645557412744,-0.00547543515576337,0.00079671057686853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36430,-0.00879143507565849,0.00262241733213915,-0.0139313730466512,-0.00365149710466575,0.000803457698621484
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36339,-0.0157793778137534,0.00471106955984377,-0.0250130741510472,-0.00654568147645959,0.000812191246532353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,36397,-0.0207181769262695,0.00619015652162903,-0.0328508837086624,-0.00858547014387661,0.000819446397215134
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,38987,0.00786663570484911,0.00235062642057603,0.00325940792052009,0.0124738634891781,0.000820047346263853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,38832,-0.0162938459094241,0.00487029078814454,-0.0258396158541874,-0.00674807596466079,0.000823186867763005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,38741,-0.0209236286764493,0.00627045263846533,-0.0332137158478413,-0.00863354150505723,0.0008493785008427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,36731,-0.0129741160255242,0.00390163573802298,-0.0206213220720493,-0.00532690997899921,0.000885698388415751
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,38727,-0.0116666990864697,0.00350949297616206,-0.0185453053197473,-0.00478809285319202,0.000888467708306122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36420,-0.013125652203867,0.00394978146157465,-0.0208672238685533,-0.00538408053918069,0.000892666340822527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,36698,-0.0148248645262746,0.00446458317986948,-0.0235754475588188,-0.00607428149373039,0.000900912791300897
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,36052,-0.03776296383853,0.0113899951714884,-0.0600873543746473,-0.0154385733024127,0.000917626981837395
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39106,-0.0248846233507756,0.00750975770176502,-0.039603748446235,-0.0101654982553161,0.000923049617796998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39106,-0.0205288810631549,0.00619603112140402,-0.0326731020611067,-0.00838466006520299,0.000924395849669608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,38863,-0.0130221022860059,0.00393528196297679,-0.0207352549334404,-0.00530894963857138,0.000938286949066508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36500,-0.0185619047794678,0.00560941482931653,-0.0295563578449282,-0.00756745171400736,0.000938706209866208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,39117,-0.00727595235386239,0.00219992861387905,-0.0115878124370653,-0.00296409227065946,0.000943980152706064
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,39099,-0.0121318615391337,0.0036732068003885,-0.0193313468678951,-0.00493237621037224,0.000959455826178212
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,39255,-0.0115664814685371,0.00350608406375066,-0.0184384062334884,-0.00469455670358577,0.000972589843851654
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,36747,-0.0257622133002368,0.00781963640291786,-0.0410887006499558,-0.0104357259505178,0.000988440059969777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,36767,-0.0349476759516114,0.0106116440036163,-0.0557464981986994,-0.0141488537045235,0.000992735178607909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,36686,-0.0186385780962428,0.00566274004132396,-0.0297375485772378,-0.00753960761524784,0.000999445639795331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,36430,-0.0137648714269332,0.00418337033588758,-0.0219642772852729,-0.00556546556859355,0.00100328182418586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,38856,-0.0226688769995234,0.00689146276574868,-0.0361761440203908,-0.00916160997865595,0.0010062748095898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,36767,-0.0113030982095698,0.00343726682197238,-0.0180401411806357,-0.00456605523850394,0.00101029159587953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,39283,0.0124888051089622,0.0037981626031048,0.00504440640687675,0.0199332038110476,0.00101085415014644
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39106,-0.0254579764707477,0.00774291763877551,-0.0406340950427477,-0.0102818578987477,0.00101164383723036
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36430,-0.0131762783163779,0.0040119457299631,-0.0210396919471056,-0.00531286468565026,0.0010252961959184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,36731,-0.0328059773704699,0.00999288831307336,-0.0523920384640937,-0.0132199162768461,0.0010300718037866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,36538,-0.020340719555664,0.0061981127877458,-0.0324890206196458,-0.00819241849168227,0.0010344017944842
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,36698,-0.0143742958710402,0.00438293039655589,-0.0229648394482897,-0.00578375229379061,0.00104228045512055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,38727,-0.0183751616778275,0.00561090609634133,-0.0293725376266566,-0.00737778572899855,0.00105940776401348
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,39145,0.0071892310224627,0.00220156043411364,0.00287417257159998,0.0115042894733254,0.00109505295270721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",36792,-0.0224248136464878,0.00686962173312445,-0.0358892722434117,-0.00896035504956386,0.00110002663400123
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,39283,0.0220990503038716,0.00677571189159751,0.00881865499634046,0.0353794456114027,0.00111061270236508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,36792,-0.00974952704104293,0.00299253789354291,-0.015614901312387,-0.00388415276969881,0.00112511223501116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,36767,-0.00958648675443622,0.00294303130228419,-0.0153548281069132,-0.0038181454019592,0.00112747635156297
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,36806,-0.00657146746547032,0.00201792807664028,-0.0105266064956853,-0.00261632843525538,0.0011306840435359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,36747,-0.0139379469613453,0.00428231285849355,-0.0223312801639927,-0.00554461375869799,0.00113776610881846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,39241,-0.00755355607458279,0.00232250284411789,-0.0121056616490539,-0.00300145050011172,0.00114707886383521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,36767,-0.0234861838164834,0.00723900557524689,-0.0376746347439673,-0.00929773288899946,0.00118000514691561
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39255,0.00959628452260245,0.00295795135987389,0.00379869985724961,0.0153938691879553,0.00118018426628826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,39162,-0.0117955576442692,0.00364499421953194,-0.0189397463145518,-0.00465136897398664,0.00121433528998759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39086,-0.0146039955239717,0.00452189634893116,-0.0234669123678768,-0.00574107868006667,0.00124218868241802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,36610,-0.00942312809331152,0.00291919674888298,-0.0151447537211222,-0.00370150246550088,0.00124980031413722
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36420,-0.0240579011056323,0.00745500808591476,-0.0386697169540252,-0.00944608525723935,0.00125381553077855
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,36747,-0.0124843199955355,0.0038765722038145,-0.0200824015150119,-0.00488623847605905,0.00128305457934608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",36792,-0.0146328444920424,0.00454670921547706,-0.0235443945543774,-0.00572129442970734,0.00129253942590093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,38960,-0.00823602665919985,0.00256201706920264,-0.013257580114837,-0.00321447320356268,0.00130871408497461
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,36743,-0.015096923400407,0.00470002647265897,-0.0243089752868186,-0.00588487151399539,0.00132095395042319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,38832,-0.0138372357304736,0.00432087417903102,-0.0223061491213744,-0.00536832233957277,0.00136565077494974
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,36767,-0.0104327764325901,0.00325919339892264,-0.0168207954944784,-0.00404475737070169,0.00137268815315031
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,38727,-0.0157259143633346,0.00491333922570939,-0.025356059245725,-0.00609576948094421,0.00137402701402211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36391,-0.029142848272917,0.00911999940766854,-0.0470180471119473,-0.0112676494338866,0.00139940604016377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39099,-0.0129707449523493,0.00406605093022787,-0.0209402047755959,-0.00500128512910267,0.00142555744563688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,36791,0.00639443132890119,0.0020056833110445,0.00246329203925397,0.0103255706185484,0.00143524258589293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,39067,-0.0196769116480279,0.00618249348256221,-0.0317945988738499,-0.00755922442220601,0.00146211310762961
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,36792,-0.0183476227046824,0.00577464161014766,-0.0296659202605718,-0.00702932514879297,0.00149015749968991
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39283,-0.00729104096659564,0.00229533783564633,-0.0117899031244624,-0.00279217880872884,0.00149379761032582
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,38832,0.0371606028935794,0.0117031931614669,0.0142223442971042,0.0600988614900545,0.00150009088539138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36421,-0.0202112638313087,0.00637035467884836,-0.0326971590018515,-0.00772536866076593,0.00151388980993023
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,38841,0.0117517027329967,0.00370566791044692,0.0044885936285207,0.0190148118374726,0.00152075799520331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,39106,-0.00770580692233789,0.00243316583395042,-0.0124748119568807,-0.00293680188779506,0.00154330245176796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39291,-0.0101051907098266,0.00319340248744649,-0.0163642595852218,-0.00384612183443152,0.00155706768434233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39291,-0.022195304561084,0.00702622842259139,-0.0359667122693631,-0.00842389685280487,0.00158659554449274
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39006,-0.0083428718888156,0.00264130679441313,-0.0135198332058653,-0.00316591057176587,0.00158832048746295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,38841,-0.0123433312000918,0.00390878504622687,-0.0200045498906965,-0.00468211250948713,0.00159256303160735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39050,-0.026220874821481,0.00830572912920457,-0.042500103914722,-0.00994164572824008,0.00159733571779326
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,38888,0.00801585816050685,0.00254598936649705,0.00302571900217263,0.0130059973188411,0.0016447367141732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,38927,-0.0167456900663128,0.00533061312304234,-0.0271936917874758,-0.00629768834514986,0.00168456667223425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,38713,-0.0104070284936619,0.00331449554626912,-0.0169034397643493,-0.00391061722297439,0.00169363970522617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39023,-0.0062541918060106,0.00199355018765807,-0.0101615501738204,-0.00234683343820077,0.00170888535702056
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,36743,-0.0283957880183926,0.0090563491035583,-0.0461462322613669,-0.0106453437754183,0.00171972675537264
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,39071,0.0201097997014733,0.00641455100971159,0.0075372797224386,0.032682319680508,0.00172164466556591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39099,-0.0279755370120077,0.00894017695748285,-0.0454982838486741,-0.0104527901753414,0.00175617958046471
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,39093,0.00555109915591684,0.00177439060890597,0.00207329356246113,0.00902890474937254,0.00176059953264999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,39222,-0.010901649532336,0.00348618248856033,-0.0177345672099143,-0.00406873185475777,0.00176868006465707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36420,-0.00906403794217964,0.00290177125240478,-0.014751509596893,-0.00337656628746627,0.00179045756990142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,39255,-0.0322970192210569,0.0103450054932499,-0.0525732299878267,-0.0120208084542872,0.00179964738628609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39147,0.00797882363468175,0.0025572069352693,0.00296669804155393,0.0129909492278096,0.00181106256402211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,39099,-0.0168722672633188,0.00541052949255135,-0.0274769050687194,-0.00626762945791815,0.00182166311751276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36420,-0.00846140795490513,0.00271426476248325,-0.0137813668893723,-0.00314144902043796,0.00182875109911461
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,36363,-0.0186233550207514,0.00598832590270317,-0.0303604737900496,-0.00688623625145316,0.00187543815679742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36500,-0.0238087322824802,0.00767318478003258,-0.038848174451344,-0.00876929011361632,0.00192090174047011
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,36743,-0.0124399826402533,0.00401201097980556,-0.0203035241606722,-0.00457644111983438,0.00193490144154661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,36743,-0.0326835642374004,0.0105476336768149,-0.0533569262439576,-0.0120102022308433,0.00194814368838852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36391,0.0074126988684354,0.00239942712259915,0.00270982170814106,0.0121155760287297,0.00201025985253034
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36500,-0.0113276579438793,0.00367114282026942,-0.0185230978716073,-0.00413221801615119,0.00203584568894088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,38987,-0.00803757781910628,0.0026057547561854,-0.0131448571412297,-0.00293029849698289,0.00204228657948928
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39023,-0.016182769247884,0.00525236854305309,-0.0264774115922681,-0.00588812690349995,0.0020664684894506
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,39255,-0.0126531323426858,0.0041166418184308,-0.0207217503068102,-0.00458451437856147,0.00211824308751158
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36420,-0.0208134046209612,0.00677425655262104,-0.0340909474640984,-0.00753586177782396,0.00212780647920085
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,39139,0.0109553610578937,0.00357086036514734,0.00395647474220488,0.0179542473735825,0.0021588153403305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,38727,-0.0242264075859321,0.00790006803553604,-0.0397105409355828,-0.00874227423628149,0.00216891712102911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,38951,-0.0216379702014057,0.00706942166625076,-0.0354940366672572,-0.00778190373555422,0.00221146339216277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36421,-0.0221112513782298,0.00722774495367823,-0.0362776314874391,-0.00794487126902044,0.00222382704324525
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,36665,-0.0267173026635089,0.00873349566896644,-0.0438349541746832,-0.00959965115233473,0.00222405152846698
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,39283,-0.00907651321684892,0.00297117324916047,-0.0149000127852034,-0.0032530136484944,0.00225551165101512
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,38841,-0.0122091386302444,0.00399762321854786,-0.0200444801385982,-0.00437379712189059,0.00226133541317208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,38727,-0.0147822812788961,0.00484014206791901,-0.0242689597320173,-0.00529560282577483,0.00226135593696277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,36767,-0.0145060498449973,0.00475054081084232,-0.0238171098342482,-0.00519498985574633,0.00226605829443736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,36796,-0.0176454280234663,0.00578616250300706,-0.0289863065293601,-0.00630454951757246,0.00229616709864918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36420,-0.0288505623222072,0.00946968510712703,-0.0474111451321762,-0.0102899795122382,0.00231907889930595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39095,-0.0145932126747437,0.00480334401690443,-0.0240077669478764,-0.00517865840161103,0.00238449538246357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,38987,0.0101097219122438,0.0033291475056156,0.00358459280123722,0.0166348510232504,0.00239566797804578
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39099,-0.0142730595813094,0.00470125349770797,-0.023487516436817,-0.0050586027258018,0.00240135036187051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,38977,-0.0134613260151773,0.00443552138531388,-0.0221549479303925,-0.0047677040999621,0.0024103129015663
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,38832,-0.0113648906040028,0.00374788134294194,-0.018710738036169,-0.00401904317183665,0.00243072318859002
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,39086,-0.00792957918957997,0.00261585200733495,-0.0130566491239565,-0.00280250925520347,0.00243866998850803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36393,-0.011205186479963,0.00369794266419205,-0.0184531541017794,-0.0039572188581466,0.00244960148161917
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,36743,-0.0182450005682603,0.00602632775556046,-0.0300566029691587,-0.00643339816736176,0.0024703348827218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,39162,-0.0100910104811563,0.00333541087005339,-0.016628415786461,-0.00355360517585169,0.0024870233636101
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39140,0.025147173824872,0.00831426135516218,0.00885122156875418,0.0414431260809899,0.00249389656822867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,38741,-0.019936802258151,0.00659323634817158,-0.0328595455005673,-0.00701405901573468,0.00250024908983133
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36391,-0.0102151249980007,0.00338061346622372,-0.0168411273917992,-0.00358912260420219,0.00251885265984474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39099,-0.0236696458974175,0.00783555653119318,-0.0390273366985561,-0.00831195509627886,0.00252526122236444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,36743,0.00921863002800254,0.00305798585560916,0.0032249777510086,0.0152122823049965,0.00257812051378556
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,36538,0.00774351945664557,0.00257156617568504,0.00270324975230289,0.0127837891609882,0.00260723511859186
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36430,0.00731248008566057,0.00242954137226917,0.002550578996013,0.0120743811753081,0.00261921787801336
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',36391,-0.0119361961949759,0.00396637229528359,-0.0197102858937317,-0.00416210649622005,0.0026232928705985
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,38727,-0.0111767529669058,0.00371875495668838,-0.018465512682015,-0.00388799325179653,0.00265578678744259
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36391,-0.0123165018752581,0.00409891124466682,-0.0203503679148051,-0.00428263583571115,0.00266261147611348
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,39241,0.00822199579502038,0.00273666542946675,0.00285813155326556,0.0135858600367752,0.0026654707381915
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,36420,-0.0197102639767195,0.00656924806829171,-0.0325859901905713,-0.00683453776286779,0.00270168954106676
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39023,-0.0202404371422831,0.00674837962081645,-0.0334672611990833,-0.00701361308548283,0.00271037043864952
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39162,-0.0072522306624683,0.00241902009023721,-0.0119935100393332,-0.00251095128560336,0.00272190984596361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,36655,-0.0277231267959314,0.00925190878029676,-0.045856868005313,-0.00958938558654972,0.00273642950841856
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,39062,0.00731772277919567,0.00244321239054961,0.00252902649371844,0.0121064190646729,0.00274775674823648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,38915,-0.0163470559134095,0.00545946330716063,-0.0270476039954444,-0.00564650783137471,0.00275557868941714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39093,0.00971158157021561,0.00324817530949076,0.00334515796361373,0.0160780051768175,0.00279553358815814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,36791,0.0137491216965253,0.00459988076516364,0.00473335539680457,0.022764887996246,0.00280402700257956
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,36420,-0.0324429700782812,0.010854329700257,-0.0537174562907849,-0.0111684838657775,0.00280486329481051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,38810,-0.0137728795796167,0.00461611279165293,-0.0228204606512564,-0.00472529850797694,0.00285289493775115
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,38949,-0.0125909394539682,0.00422195947885484,-0.0208659800325237,-0.0043158988754127,0.00286595193054398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39095,-0.00678237944141628,0.0022744277849242,-0.0112402578998677,-0.00232450098296484,0.00286810248837917
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39291,-0.00735171674861741,0.002471871618053,-0.0121965851200013,-0.00250684837723353,0.00294255940253672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,38741,-0.015448647969376,0.00520011366256885,-0.0256408707480109,-0.00525642519074102,0.00297471624091724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,38741,-0.0178265160143319,0.00600588072073462,-0.0295980422269718,-0.00605498980169206,0.0030004892072692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,36363,0.0120469648040049,0.0040668359357906,0.00407596636985529,0.0200179632381544,0.00305979173076204
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,39083,-0.010685685355805,0.00361146659954608,-0.0177641598909153,-0.00360721082069466,0.00309292991439697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,39165,-0.0124415786599514,0.00420507351204122,-0.0206835227435522,-0.00419963457635066,0.00309405826499046
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39023,-0.0105006498610552,0.00355673094643565,-0.017471842516069,-0.00352945720604129,0.00315867147534591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,36731,-0.0121700499944369,0.00413344903235379,-0.0202716100978504,-0.0040684898910235,0.00324280914620911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,39229,-0.0164661759849624,0.00559382116263493,-0.0274300654637269,-0.00550228650619795,0.00324865959710826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36363,-0.0272073615441424,0.00924983984899665,-0.0453370476481758,-0.00907767544010896,0.00327344841709915
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",36538,-0.0125727826202575,0.00427469661816866,-0.0209511879918681,-0.00419437724864696,0.00327523339710428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,39023,-0.0126257218586563,0.00429675385707609,-0.0210473594185254,-0.00420408429878717,0.00330373214779318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,39124,0.0105693739042267,0.00359723165184275,0.00351879986661485,0.0176199479418384,0.00330621419918391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,38727,-0.00931140291850423,0.00317009562029923,-0.0155247903342907,-0.00309801550271774,0.00331631693091996
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,36747,-0.0168781188880337,0.00575041151033708,-0.0281489254482944,-0.00560731232777301,0.00334012690658487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,36747,-0.0154801634808582,0.00527632086644163,-0.0258217523790838,-0.00513857458263263,0.00335329037788789
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39106,-0.0120048165090088,0.00409463356870418,-0.020030298303669,-0.0039793347143486,0.00337459399443629
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,36548,-0.0113043041430174,0.00386151623742904,-0.0188728759683783,-0.00373573231765644,0.00342387028736551
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36430,-0.0174677114751863,0.00598076814478394,-0.0291900170389628,-0.00574540591140978,0.00349926457340529
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36430,-0.0217764804361134,0.00746299097012182,-0.0364039427375522,-0.00714901813467464,0.0035298838455163
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,38948,-0.00746063110006677,0.00256745361535667,-0.0124928401861658,-0.0024284220139677,0.00366791217329091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,38741,-0.0166618343829504,0.00573401848365716,-0.0279005106109185,-0.0054231581549824,0.00366871023934044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39023,-0.0227401470193837,0.00783683003095471,-0.0381003338800549,-0.00737996015871245,0.00371675232999948
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,39092,-0.00847239918864472,0.00291985231782509,-0.0141953097315819,-0.00274948864570755,0.00371730777614636
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39075,-0.0255029496346789,0.00879037251463977,-0.0427320797633729,-0.00827381950598501,0.00372225954476308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,39255,0.00723441872640469,0.00249754095924998,0.00233923844627473,0.0121295990065347,0.00377741604214186
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,36792,-0.0078037460799767,0.00269494426965552,-0.0130858368485015,-0.00252165531145189,0.00378949250160733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",36743,-0.0274456149617482,0.00947873976406468,-0.046023944899315,-0.00886728502418146,0.0037920093758665
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39162,-0.0295447226197803,0.0102135395839069,-0.0495632602042378,-0.00952618503532292,0.00382482451272673
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",36767,-0.0126416880745901,0.00437090781004497,-0.0212086673822782,-0.00407470876690197,0.00383152020814499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36391,-0.0164904973841489,0.00570657290067996,-0.0276753802694816,-0.00530561449881618,0.00386225118514003
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,38741,-0.0103497461477363,0.00358869973629206,-0.0173835976308687,-0.00331589466460388,0.00393244070430698
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,36702,-0.0128696370572835,0.00446298979650336,-0.0216170970584301,-0.0041221770561369,0.00393766132789479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,36747,-0.00996390444674529,0.00345994480136073,-0.0167453962574123,-0.00318241263607826,0.00398599307747909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,39140,-0.0219842437673936,0.00763839462782979,-0.03695549723794,-0.00701299029684724,0.00400602968563383
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36420,-0.0162253692989753,0.00564046167058827,-0.0272806741733284,-0.00517006442462234,0.0040265761083996
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,39093,0.0126979274323438,0.00442623040499931,0.00402251583854519,0.0213733390261425,0.0041261098802586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,36747,-0.0156813595873084,0.00546810872357588,-0.0263988526855171,-0.00496386648909966,0.00414027149868983
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",36731,-0.0134215667648707,0.00468515653779325,-0.0226044735789454,-0.00423865995079587,0.00418080260027998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,38946,-0.00754352244079813,0.00264037251729201,-0.0127186525746905,-0.00236839230690579,0.00428261676844004
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36420,-0.0165564114287328,0.00579640319537411,-0.0279173616916661,-0.00519546116579957,0.00429279386566803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36430,-0.0140942120961106,0.00493713093065899,-0.0237709887202022,-0.00441743547201893,0.00431429084019453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36421,-0.0153528728715407,0.00538751884848998,-0.0259124098145811,-0.00479333592850038,0.00438301350607922
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,39195,-0.0107909747125356,0.00378784767259594,-0.0182151561508236,-0.00336679327424754,0.0043937247641477
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,36743,-0.01196731928474,0.00420359392199376,-0.0202063633718478,-0.00372827519763224,0.00442134503568308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,39255,-0.0144876827307249,0.0050924994841377,-0.0244689817196348,-0.00450638374181502,0.00444831285991227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,36782,-0.0147646245555785,0.00519949112048206,-0.0249556271517234,-0.0045736219594337,0.00452365815456612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39106,-0.0115718473496858,0.00407550516829364,-0.0195598374795413,-0.00358385721983026,0.00452631921119926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,39099,0.00892587349461415,0.0031543673932243,0.00274331340389453,0.0151084335853338,0.00466544180793378
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,36391,-0.0156190380016623,0.00552551739526142,-0.0264490520963747,-0.00478902390694989,0.00471033053981461
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39092,-0.0132486471093161,0.00468851123914387,-0.0224381291380381,-0.00405916508059414,0.00472287234138847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39241,-0.0140010268814681,0.00495953437728489,-0.0237217142609465,-0.00428033950198969,0.00476298387053383
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,36391,-0.0102099065152795,0.00364024157484451,-0.0173447800019747,-0.00307503302858421,0.00504357758511998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,38987,-0.0246398393077208,0.0087861763093395,-0.0418607448740262,-0.00741893374141536,0.00504766092384147
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,38727,-0.0134741029104261,0.00481688788212669,-0.0229152031593944,-0.00403300266145779,0.00516037795797876
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39265,-0.0144317766704233,0.00515975708486406,-0.0245449005567569,-0.00431865278408972,0.00516454671639295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,38923,0.00861152395435139,0.00308049684155855,0.00257375014489664,0.0146492977638061,0.00518853456600801
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39093,-0.00970122079332904,0.00349617435846108,-0.0165537225359128,-0.00284871905074532,0.00553012057188051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,36791,0.0101388491857828,0.00365618354698274,0.00297272943369658,0.0173049689378689,0.00556098774325461
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,39093,-0.0116481448892703,0.00420295576841944,-0.0198859381953724,-0.00341035158316823,0.00558805303837719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,36731,-0.0112023288963965,0.00404282409964084,-0.0191262641316926,-0.00327839366110047,0.0055978927028451
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,36743,0.0180562381349798,0.00651699526078831,0.0052829274238347,0.0308295488461249,0.00560266673787311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36430,-0.0230729230990575,0.00833392358772905,-0.0394074133310065,-0.0067384328671086,0.00563880083125316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,38841,0.0123065239688859,0.00444709052112111,0.00359022654748855,0.0210228213902833,0.00565885367932778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,36743,-0.0196610393634587,0.00711130990773468,-0.0335992067826186,-0.0057228719442987,0.00570463317988957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39093,-0.0199366692592568,0.0072186814461723,-0.0340852848937545,-0.00578805362475905,0.00575497410892807
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39197,0.010691818815513,0.00387213299169114,0.00310243815179832,0.0182811994792276,0.00576539849737394
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39283,0.0149708247202339,0.0054234872437263,0.00434078972253039,0.0256008597179375,0.00578043389628653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,38841,-0.021376321518285,0.00774735652002578,-0.0365611402975356,-0.00619150273903451,0.00580176331543381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39147,-0.0185735205875727,0.00674382708168789,-0.031791421667681,-0.00535561950746447,0.00589140936803343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,36618,0.0272894587334209,0.00994280005927873,0.00780157061723458,0.0467773468496072,0.00606610760079628
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,36792,-0.0226452073511858,0.00825995833370663,-0.0388347256852508,-0.00645568901712079,0.006123141940192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,36538,-0.0149411451619578,0.00546140223461143,-0.0256454935417962,-0.00423679678211937,0.00623209279945338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36430,-0.0107994165974756,0.00395914493900607,-0.0185593406779275,-0.00303949251702375,0.00638633490864761
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39093,0.00994040039975042,0.00364595742778057,0.00279432384130049,0.0170864769582003,0.00640992750264154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,36421,-0.0151001675998965,0.00554212320807942,-0.0259627290877321,-0.00423760611206079,0.00644650410692997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39099,-0.00875763332814217,0.00321548149030678,-0.0150599770491435,-0.00245528960714087,0.00646513817526667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39099,-0.0264050312789397,0.00970453340554269,-0.0454259167538034,-0.00738414580407603,0.00651790276542431
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36430,-0.00900033391554888,0.00331193606638097,-0.0154917286056556,-0.00250893922544218,0.00658583930752586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,39069,0.0199034632990186,0.00732460280108055,0.00554724180890076,0.0342596847891365,0.00658827157558169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,36731,-0.00694042154700579,0.0025556559644163,-0.0119495072372617,-0.00193133585674985,0.00662220002278283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,38841,-0.0233978464350318,0.0086215555222403,-0.0402960952586227,-0.00649959761144078,0.0066576798507619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36500,-0.0216324448154999,0.0079711470830785,-0.0372558930983338,-0.00600899653266606,0.00665977643389966
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,39136,0.0137465768685207,0.00507079672524983,0.003807815287031,0.0236853384500103,0.00671696843537797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39283,-0.00786393954107571,0.00290204993363394,-0.0135519574109982,-0.00217592167115319,0.00674006641952135
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,39211,-0.0155143733028931,0.0057294416197696,-0.0267440788776415,-0.00428466772814468,0.00677990086619185
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36391,0.00815960989725816,0.003013503383204,0.00225314326617832,0.014066076528338,0.00678467416150963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,36430,0.00654417543124645,0.00241874008571521,0.00180344486324464,0.0112849059992483,0.00682703163032886
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,36500,0.00903685758301432,0.00334020639129765,0.00249005305607093,0.0155836621099577,0.00682974500606462
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,36420,-0.00731246223348779,0.00270667588940761,-0.0126175469767267,-0.00200737749024888,0.00690911767423196
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36499,-0.0131666455894754,0.00487360631870736,-0.0227189139741419,-0.00361437720480902,0.0069094060608062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,36791,-0.0206319218051513,0.00764846108877704,-0.0356229055391543,-0.00564093807114834,0.00699474445904595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36391,0.0104222163746946,0.00386604652911262,0.00284476517763384,0.0179996675717553,0.00703065774911179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36345,-0.0245214984209511,0.00909777827577587,-0.0423531438414718,-0.00668985300043041,0.00704135029758004
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,38823,-0.00843522603741373,0.00314192282227876,-0.0145933947690801,-0.00227705730574736,0.0072667592268399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,38727,-0.0170624496715596,0.00635920408325528,-0.02952648967474,-0.00459840966837929,0.00730215082822149
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,36391,0.00833608404601883,0.00310822746164652,0.00224395822119164,0.014428209870846,0.00732922115843972
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,36796,-0.00659392617038786,0.00245991583102566,-0.0114153611991981,-0.00177249114157757,0.0073594541453278
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",36767,0.0107601379706381,0.0040179211255104,0.00288501256463772,0.0186352633766385,0.00741489758313968
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,39017,-0.00723118264410952,0.00270122180583457,-0.0125255773835453,-0.00193678790467376,0.00743636245237663
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,36420,-0.00755101439679473,0.00282507336989212,-0.0130881582017833,-0.00201387059180617,0.00753056827744162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,36767,-0.0130140546147522,0.00487051473154626,-0.0225602634885829,-0.00346784574092156,0.00754935194183528
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36500,-0.00682532866502132,0.00255443419939269,-0.011832019695831,-0.00181863763421166,0.00755078532605286
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,36767,-0.0189734094540775,0.00710531774298602,-0.0328998322303301,-0.00504698667782489,0.00758759242144089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,36538,-0.0181980634917321,0.00681536474487804,-0.0315561783916931,-0.00483994859177117,0.00759134809081192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39255,-0.00818187396534041,0.00306520906839195,-0.0141896837393886,-0.00217406419129219,0.0076095801600089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,36195,-0.0113925874212124,0.00426934404361989,-0.0197605017467074,-0.0030246730957174,0.00762987786981348
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,38727,-0.014360716919161,0.00538638387017844,-0.0249180293047108,-0.00380340453361126,0.00768165137850076
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39162,-0.032117548798764,0.0120543392565163,-0.055744053741536,-0.00849104385599204,0.00772072753390731
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,36743,-0.0219941931939855,0.00826067373155191,-0.0381851137078272,-0.0058032726801437,0.00776547430230768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,38841,-0.00974348161566687,0.00366571797312232,-0.0169282888429866,-0.00255867438834712,0.00786891429561846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39023,-0.0259685654722106,0.00977329111980023,-0.0451242160670191,-0.00681291487740216,0.00788997446804398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,36538,-0.0175002177543654,0.00659377700445094,-0.0304240206830893,-0.0045764148256416,0.00796311552957463
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,39246,0.0071961880551035,0.00271776898726854,0.00186936084005716,0.0125230152701498,0.00810930505569192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,38727,-0.0192026970850406,0.00726294886800994,-0.0334380768663401,-0.00496731730374114,0.00820366729496029
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,38807,-0.0132594990261505,0.00502829507430048,-0.0231149573717794,-0.00340404068052154,0.00837349978073034
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,39099,-0.0167607748416105,0.00635827891021297,-0.0292230015056279,-0.00429854817759306,0.0083961049209864
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,36391,0.0105241314487447,0.00399312359833901,0.00269760919600028,0.0183506537014892,0.00841011091698176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,36363,0.0115689083379219,0.00439081949144316,0.00296290213469335,0.0201749145411505,0.00842919629761563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,39093,0.00939766058544555,0.0035672006970337,0.0024059472192595,0.0163893739516316,0.00843555635838188
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39255,-0.0061553246878043,0.00233848506362575,-0.0107387554125108,-0.00157189396309783,0.00849223662867985
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,39099,-0.0137312454908829,0.00521923797562221,-0.0239609519231025,-0.00350153905866338,0.00852470691744968
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,38987,-0.0147073116372969,0.00559327286512852,-0.0256701264529488,-0.00374449682164503,0.00856060159357986
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,38987,0.00856281027381077,0.00326075106439594,0.00217173818759472,0.0149538823600268,0.00864757395376799
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39023,0.00644444887149498,0.00245484786022956,0.00163294706544504,0.0112559506775449,0.0086686820263035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,38869,-0.016813126431832,0.00643069142193172,-0.0294172816188182,-0.00420897124484582,0.00894440322962899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36363,0.0218096709101681,0.00834285310842205,0.00545767881766085,0.0381616630026753,0.00895506657188271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,38987,0.0101578797175094,0.00388658112617741,0.00254018071020168,0.0177755787248171,0.00896885554802042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,39117,0.00788456421362886,0.00301914949737266,0.00196703119877845,0.0138020972284793,0.00902293960917982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36420,-0.0149379211651311,0.00572083968020735,-0.0261507669383375,-0.00372507539192475,0.00903478330052664
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39291,-0.0110731361101414,0.00424501495259487,-0.0193933654172274,-0.00275290680305547,0.00910267502515485
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,38727,-0.00900048587852832,0.00345134580013923,-0.0157651236468012,-0.00223584811025542,0.00912121420425557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,36705,-0.00677729801360834,0.00259901873824329,-0.0118713747405652,-0.00168322128665149,0.00912749647825102
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,38960,0.00753402957603799,0.00289082531180856,0.00186801196489321,0.0132000471871828,0.00916465223343422
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,39162,-0.0117547835759791,0.004511219353705,-0.0205967735092409,-0.00291279364271729,0.00917814833626444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36363,0.0118267649256665,0.00455272184364261,0.00290343011212699,0.020750099739206,0.00939508853159564
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,38832,0.00767430537373076,0.00295714305114268,0.0018783049934911,0.0134703057539704,0.00946348369309871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,39185,0.00949415807617759,0.00366210041250525,0.00231644126766731,0.0166718748846879,0.00953593343264292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,36450,-0.0104689737560901,0.00403932891396319,-0.0183860584274579,-0.00255188908472225,0.00955964289240614
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,36743,-0.0248311034473625,0.00959038534093008,-0.0436282587155855,-0.00603394817913956,0.00963167661043054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,36718,-0.00863658488924023,0.00333983281949726,-0.0151826572154549,-0.00209051256302561,0.00972246434057058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,39024,-0.0210612237949388,0.00815646968622459,-0.037047904379939,-0.0050745432099386,0.00982799399754189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,39099,-0.0225113364908906,0.00874254356217275,-0.0396467218727492,-0.00537595110903196,0.0100357180017091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36414,-0.0142619034834952,0.00554772966610241,-0.0251354536290559,-0.00338835333793449,0.0101588616536717
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,38575,-0.00607526569126439,0.00236369048653006,-0.0107080990448633,-0.00144243233766548,0.0101723823220122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,36747,-0.00667506728343027,0.00259972267129097,-0.0117705237191606,-0.00157961084769997,0.0102514780673598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,39099,-0.0159110687523596,0.00619899007790313,-0.0280610893050497,-0.00376104819966946,0.010276023225779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,36747,-0.0114905050354484,0.00448571449751663,-0.020282505450581,-0.00269850462031585,0.0104310755492059
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,36731,-0.0148236867997363,0.00579056897067308,-0.0261732019822556,-0.0034741716172171,0.0104794150207818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36339,-0.0160399117950885,0.0062749176783356,-0.0283387504446263,-0.00374107314555071,0.010594123450091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39033,-0.00814457943810413,0.00318725941794168,-0.0143916078972698,-0.00189755097893843,0.0106176180561879
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,36391,0.00986181218228448,0.00385982335864724,0.00229655839933589,0.0174270659652331,0.0106307774397339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36391,-0.0142179771198504,0.0055666060817617,-0.0251285250401033,-0.00330742919959746,0.0106562966353925
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,36743,-0.00638320947624557,0.00249926005835085,-0.0112817591906132,-0.0014846597618779,0.0106595159236551
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,38841,0.00843563302353776,0.00330486069717938,0.00195810605706617,0.0149131599900093,0.0107053432674284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36391,-0.0112814464782583,0.00442985116447991,-0.019963954760639,-0.00259893819587772,0.0108869317192664
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,36747,-0.0127237496807429,0.00500289019208805,-0.0225294144572354,-0.00291808490425028,0.0109933085798047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,36731,-0.0255361670707455,0.0100473743420023,-0.0452290207810699,-0.00584331336042105,0.0110470178518779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,38841,-0.0114204900598448,0.00449463580832037,-0.0202299762441527,-0.00261100387553688,0.0110662611240328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,36743,-0.00690353941746832,0.00271907323624887,-0.0122329229605161,-0.00157415587442054,0.0111308359178301
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,36806,-0.00491233223215766,0.00193494859034719,-0.00870483146923815,-0.00111983299507717,0.0111368411739128
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,36747,-0.0235338985257454,0.0092794362035435,-0.0417215934846907,-0.00534620356680016,0.0112200728435892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,36767,-0.0156140216620629,0.00615731959420198,-0.0276823680666987,-0.00354567525742699,0.0112292594893965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39191,-0.00653792613661834,0.00257987696795753,-0.0115944849938151,-0.00148136727942158,0.0112802818700905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,38832,0.00759574191243452,0.00299854391814316,0.00171859583287393,0.0134728879919951,0.0113145872476758
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,39291,-0.015080553631801,0.0059580688944469,-0.0267583686649169,-0.00340273859868511,0.0113799251110574
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,36420,-0.0170493552321041,0.00673638886190762,-0.0302526774014431,-0.00384603306276522,0.0113880290800325
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,38841,-0.00718518209648704,0.00284251764262409,-0.0127565166760303,-0.00161384751694382,0.011489705632686
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,38987,-0.00683107959193226,0.00270279133414324,-0.012128550606853,-0.00153360857701151,0.0115006116351267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,36708,-0.0206632931952678,0.00818342184295801,-0.0367028000074655,-0.00462378638307012,0.0115811457393847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36363,-0.0101942704041509,0.00403747331898943,-0.0181077181093702,-0.00228082269893166,0.0115849446583881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,36731,-0.00680736990982929,0.00270090875802601,-0.0121011510755603,-0.00151358874409832,0.0117341512200863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39023,-0.0272388103258204,0.0108427496248373,-0.0484905995905015,-0.0059870210611392,0.0120094883417797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,39145,-0.0061805482110906,0.0024642333007614,-0.0110104454805829,-0.00135065094159825,0.0121484416136757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,39241,-0.00720457531366825,0.0028728609395076,-0.0128353827551031,-0.00157376787223335,0.0121585812570367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36500,-0.00959298654884121,0.00383814932534355,-0.0171157592265146,-0.00207021387116785,0.0124537283685092
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,36767,-0.0197501765703467,0.00791751136382331,-0.0352684988434404,-0.00423185429725307,0.0126261272204483
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36363,0.00783193057763982,0.00314065782708949,0.00167624123654441,0.0139876199187352,0.0126539360914164
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,38841,-0.0135801679489389,0.0054483239456047,-0.0242588828823241,-0.00290145301555367,0.0126940043364679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,38602,-0.0137722125057553,0.00552543445868071,-0.0246020640447695,-0.00294236096674107,0.0126951902832532
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36430,-0.00723250869297823,0.00290596168262928,-0.0129281935909316,-0.00153682379502483,0.0128284672956195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39147,-0.0104811548245904,0.00421491121736718,-0.01874238081063,-0.0022199288385507,0.0129045539752355
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,38727,-0.0121617458369419,0.00489529014644361,-0.0217565145239714,-0.00256697714991246,0.0129887590614236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39283,0.00945474721725902,0.00380695464608772,0.0019931161109271,0.0169163783235909,0.0130186920425041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36430,-0.0129474508375241,0.00522209578596761,-0.0231827585780206,-0.00271214309702759,0.0131748802990417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39057,-0.0252599407050415,0.0101938493835672,-0.0452398854968332,-0.0052799959132498,0.0132244141019445
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,39093,-0.0105627185292643,0.00426621528827584,-0.018924500494285,-0.00220093656424367,0.0133008996480933
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,38630,-0.0283134997122051,0.0114426549219748,-0.0507411033592757,-0.00588589606513448,0.013357836511997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,39162,0.0148135544375313,0.00599006447118967,0.00307302807399956,0.0265540808010631,0.0134084118469076
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,36258,-0.0185093247958007,0.00748833835151849,-0.0331864679647769,-0.00383218162682443,0.0134585560630043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,38741,-0.0140384248249224,0.00568357108183672,-0.0251782241453224,-0.00289862550452247,0.0135224078594138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39165,0.00689423294232831,0.00279275405429986,0.00142043499590059,0.012368030888756,0.0135745710213987
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39255,0.0128068896334419,0.00518812554881099,0.00263816355777237,0.0229756157091115,0.0135788339941629
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,36430,-0.00781452507290423,0.00317146115372372,-0.0140305889342027,-0.00159846121160573,0.0137523555974405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,39099,0.0146718522652094,0.0059617012463962,0.0029869178222729,0.026356786708146,0.0138653565256316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,38727,-0.0155200802996208,0.00630971485338989,-0.027887121412265,-0.00315303918697666,0.0139161597652713
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,35946,-0.00556913319938336,0.00226433331451468,-0.0100072264958321,-0.00113103990293459,0.0139268799866791
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39165,0.0075444172343836,0.00306786238014607,0.00153140696929729,0.0135574274994699,0.0139365694988596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39147,-0.0191058160243395,0.00777655651556865,-0.034347866794854,-0.00386376525382493,0.0140272349755107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,36500,-0.00655568703302738,0.00266860117165342,-0.0117861453294681,-0.00132522873658668,0.0140392012820487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,36500,-0.0246193888320007,0.0100906210323944,-0.0443970060554937,-0.00484177160850765,0.0147078684969316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,36538,-0.0117270925847257,0.00482069212898177,-0.02117564915753,-0.00227853601192143,0.0150022112706671
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,36767,-0.0057059457501466,0.00234599506934747,-0.0103040960860676,-0.00110779541422557,0.0150206276531261
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39106,-0.0289962399361295,0.0119227624092945,-0.0523648542583468,-0.00562762561391221,0.0150268562183487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,38832,-0.0119150374143063,0.00490267293761038,-0.0215242763720226,-0.00230579845658997,0.0150973921056723
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",36792,-0.0121656330615367,0.00500774569638819,-0.0219808146264576,-0.00235045149661588,0.01513889838719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36391,-0.015299427713055,0.00630162385089132,-0.027650610460802,-0.00294824496530797,0.0152024095161867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,36731,-0.0160384446886925,0.00661343010531336,-0.0290007676951067,-0.00307612168227832,0.0153164638058467
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36430,-0.00864923506578194,0.00357766261466392,-0.0156614537905232,-0.00163701634104064,0.0156388371318244
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,36430,-0.00879395174872881,0.00363975290526322,-0.0159278674430447,-0.00166003605441289,0.0157025651830471
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39079,0.0135959702533768,0.00562862795563451,0.00256385946033312,0.0246280810464204,0.0157251765174552
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36420,-0.0141086529148125,0.00585274460161434,-0.0255800323339766,-0.00263727349564835,0.0159403757384945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,39218,-0.0155914223989991,0.00647213108947656,-0.0282767993343731,-0.00290604546362504,0.0160075956749584
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,39023,0.00982965023354869,0.00408460510580888,0.00182382422616329,0.0178354762409341,0.0161175683696479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,39241,-0.00569193714090723,0.0023670609596053,-0.0103313766217336,-0.00105249766008085,0.0162000032376355
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,36796,-0.00572923923754205,0.00238272008470562,-0.0103993706035651,-0.00105910787151904,0.0162087796597114
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,36538,0.0074915728897223,0.00311683933064167,0.00138256780166462,0.01360057797778,0.0162496771904438
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,36430,-0.0262653846362538,0.0109282912108078,-0.0476848354094371,-0.00484593386307058,0.0162564607135895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,36796,-0.00880745691786217,0.00366467448536378,-0.0159902189091752,-0.00162469492654915,0.0162600828984896
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39093,0.00790395333786612,0.00328900837190048,0.00145749692894118,0.014350409746791,0.0162667647088386
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,36806,0.0050180954303579,0.00209048554740009,0.000920743757453719,0.00911544710326209,0.0163891811497475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,36743,-0.0111869301497233,0.00466077479527677,-0.0203220487484658,-0.00205181155098082,0.0163988851097916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,38741,-0.0235376037004894,0.00980931775189245,-0.0427638664941986,-0.00431134090678018,0.0164290304356955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,36792,-0.0219058684925813,0.00914040911066451,-0.0398210703494838,-0.0039906666356789,0.0165622657595863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39045,-0.00768044566190198,0.00320580616386894,-0.0139638257430851,-0.00139706558071885,0.0165965148888024
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,38741,-0.0186794907852959,0.00781396916125987,-0.0339948703413652,-0.00336411122922652,0.0168366477934559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,36339,-0.0160628813993144,0.00673308514954577,-0.0292597282924241,-0.00286603450620472,0.01706312744027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,39044,-0.0229188721050903,0.00962115818010409,-0.0417763421380943,-0.00406140207208631,0.0172249483737114
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36391,0.0119441520001109,0.00502007363516122,0.00210480767519496,0.0217834963250269,0.0173614590678336
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,38987,-0.00912682303932042,0.0038453027883679,-0.0166636165045215,-0.00159002957411933,0.0176328487213774
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,36806,-0.00909781101563387,0.00383421546596625,-0.0166128733289277,-0.00158274870234002,0.017668534290765
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,36430,0.00747842730215698,0.00315209176282745,0.00130032744701518,0.0136565271572988,0.0176817647398873
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36363,0.00632381961458031,0.00266746533425356,0.00109558755944334,0.0115520516697173,0.0177684379049535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,38841,-0.00790657805713389,0.00334331066754654,-0.0144594669655251,-0.00135368914874267,0.0180478637810455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36391,0.00949344120277844,0.00401438953027347,0.00162523772344243,0.0173616446821144,0.0180523776236545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,39217,-0.00517765723885483,0.00219011979157105,-0.0094702920303341,-0.000885022447375568,0.0180864168183148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",36791,-0.0135579644920354,0.00573584414002057,-0.0248002190064757,-0.00231570997759512,0.0181068845093724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,39079,0.014550440898498,0.00616086035709315,0.00247515459859545,0.0266257271984006,0.0182011939890676
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39283,0.0065998643687298,0.00280113440156636,0.00110964094165974,0.0120900877957999,0.0184784046391915
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,36538,-0.00621621760967551,0.00264023813376771,-0.0113910843518602,-0.0010413508674908,0.0185670262544022
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39086,0.00690450386815471,0.00293376659493792,0.00115432134207638,0.012654686394233,0.0186122246617618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36420,-0.00897760520542699,0.00382006372989754,-0.0164649301160262,-0.00149028029482782,0.0187827863618004
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36391,0.00800315536959437,0.00340832073430031,0.00132284673036575,0.014683464008823,0.018883763575937
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,36470,-0.00788323078109211,0.00335786646962437,-0.0144646490615559,-0.00130181250062834,0.0189055885163143
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39241,0.00969506024274349,0.00413576440054874,0.00158896201766796,0.017801158467819,0.0190805816044145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36391,-0.0110070064895396,0.00469702118464901,-0.0202131680114517,-0.00180084496762756,0.0191243551680688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36391,-0.0142230075986043,0.00607259194997656,-0.0261252878205583,-0.00232072737665021,0.019187847831095
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39093,-0.0190416369969987,0.00813184094997373,-0.0349800452589472,-0.00310322873505015,0.0192133505876974
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,38789,0.0109058231980382,0.00466164389780573,0.00176900115833892,0.0200426452377374,0.0193237109836026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,36430,-0.0113181318818811,0.00484378306478306,-0.0208119466888559,-0.00182431707490628,0.0194740233874432
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,36767,-0.00837847299521485,0.00359100986102742,-0.0154168523228286,-0.00134009366760111,0.0196539704830263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,36792,-0.0155562823225162,0.0066797003938553,-0.0286484950944726,-0.00246406955055979,0.0198802614736632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,36796,0.00545425907336384,0.00234371715139888,0.000860573456622026,0.0100479446901056,0.0199708721268712
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,36747,0.0141039477704223,0.00606261735365506,0.00222121775725836,0.0259866777835862,0.02001374849009
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,36743,-0.0190126994017565,0.00818054732060471,-0.0350465721501418,-0.00297882665337131,0.0201337108273822
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,36792,-0.00594839852575025,0.00256205679434007,-0.0109700298426568,-0.000926767208843708,0.0202630520063901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39051,-0.00851871914007213,0.00367760283033969,-0.0157268206875379,-0.00131061759260634,0.0205508653871835
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36391,-0.0259462841710102,0.0112453913966635,-0.0479872513084707,-0.00390531703354966,0.0210553475926212
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,36806,-0.00313297050050488,0.00135911241309399,-0.0057968308301691,-0.000469110170840669,0.0211733949700418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,38987,-0.00779588536148416,0.00338510860146904,-0.0144306982203635,-0.00116107250260484,0.021292672189855
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,36767,-0.00955045659571723,0.00414904006951373,-0.0176825751319641,-0.00141833805947033,0.0213596301345393
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39162,-0.00720582177840972,0.00313072732023481,-0.0133420473260699,-0.00106959623074948,0.0213685870667318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36420,-0.00588797930367165,0.00256376407601682,-0.0109129568926646,-0.000863001714678686,0.0216571146290812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,36421,-0.00930981046827625,0.00405400644616524,-0.0172556631027601,-0.00136395783379238,0.0216667231884433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36339,-0.0119886463924196,0.00522342014057131,-0.0222265498679394,-0.00175074291689985,0.0217397945932954
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,38727,-0.0215988218475424,0.00941269796909789,-0.0400477098669742,-0.0031499338281105,0.0217672134504207
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36363,0.00910361828355023,0.00396877165390162,0.00132482584190305,0.0168824107251974,0.0218177726053655
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,38987,-0.0214732669019326,0.00936619802084468,-0.0398310150227881,-0.00311551878107698,0.0218827274872736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,39023,0.00617940794995708,0.0026960601801852,0.000895129996794094,0.0114636859031201,0.0219184664861021
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36391,-0.0253799113143363,0.0110819586854412,-0.047100550337801,-0.00365927229087154,0.0220262107755673
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,38832,0.00648939341013687,0.0028457880249619,0.000911648881211547,0.0120671379390622,0.0226009158509054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,36430,-0.00627668726751066,0.00275294963650919,-0.0116724685550687,-0.000880905979952652,0.0226251773563583
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,36747,-0.00939416435630027,0.00412074029019151,-0.0174708153250756,-0.00131751338752492,0.0226401307122696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36500,-0.0265971352665805,0.0116967973579263,-0.049522858088116,-0.00367141244504496,0.0229897827338753
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,38727,-0.017636274682244,0.00776216713867068,-0.0328501222740385,-0.00242242709044945,0.0230958204969233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,36792,-0.00540672039461465,0.00238137411619254,-0.010074213662352,-0.000739227126877265,0.02319846409101
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36339,-0.00761999409152539,0.00336009186354731,-0.0142057741440781,-0.00103421403897267,0.0233588229179829
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,38832,-0.0178164670414391,0.00787850982132468,-0.0332583462912354,-0.00237458779164269,0.0237487443612491
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,38987,-0.0166760022675217,0.00737612781474027,-0.0311332127844126,-0.00221879175063074,0.0237853506281664
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,36538,-0.00924152176680751,0.00408767290368905,-0.017253360658038,-0.00122968287557698,0.0237868440733855
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,36792,-0.0139422575947889,0.00617454065624935,-0.0260443572810377,-0.00184015790854021,0.0239607956009472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,36792,-0.0149245690274216,0.00662325967693848,-0.027906157994221,-0.00194298006062218,0.0242533252559651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39162,0.0054758268420397,0.0024303917249971,0.000712259061045379,0.010239394623034,0.0242692484621963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,39108,0.00569836602448725,0.00253058043322128,0.000738428375373539,0.010658303673601,0.0243489595124683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36421,0.0131097052840807,0.00582951037687489,0.00168386494540591,0.0245355456227555,0.0245391789031443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36339,-0.00887412507769926,0.00397035665350185,-0.0166560241185629,-0.00109222603683564,0.0254287228882168
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36391,-0.00916341407912147,0.00410774252018749,-0.017214589418689,-0.00111223873955399,0.0257142343724515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,36747,-0.00781497350719585,0.00350422922608737,-0.0146832627903271,-0.000946684224064608,0.0257543229859154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,39241,0.0156928779017205,0.00703779281817646,0.00189880397809462,0.0294869518253463,0.0257750294679329
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39147,-0.00483716460393584,0.00217098600340836,-0.00909229717061624,-0.000582032037255449,0.0258886237397632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39099,0.0112171968947344,0.00504254307872427,0.00133381246043485,0.021100581329034,0.0261286151979471
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,38841,0.0161939255611068,0.00728530566509976,0.00191472645751128,0.0304731246647023,0.0262427844343439
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39165,-0.00609606133470413,0.00274675797992774,-0.0114797069753625,-0.000712415694045754,0.0264764368822882
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39023,-0.00907286735167581,0.00410950213266307,-0.0171274915316954,-0.0010182431716562,0.0272746843548535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36430,0.00649005219884812,0.00294424375855838,0.000719334432073692,0.0122607699656225,0.0275199772069723
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,38727,-0.00806106355882591,0.00365947124356257,-0.0152336271962085,-0.000888499921443283,0.0276245147831598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,36767,-0.0139389734403344,0.00633490583714441,-0.0263553888811374,-0.00152255799953131,0.0278001338149833
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39093,0.00678325773191662,0.00308426715773916,0.000738094102747874,0.0128284213610854,0.0278709017300088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36538,-0.013181774835517,0.00599453720212789,-0.0249310677516877,-0.00143248191934638,0.0278984377786606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,38727,-0.00691644660785387,0.00315301745269079,-0.0130963608151278,-0.000736532400579929,0.028279889959792
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39099,-0.00949722562729852,0.00433304784146217,-0.0179899993965644,-0.00100445185803266,0.0284081713292255
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,36791,-0.0125108018541806,0.00571010356604825,-0.0237026048436352,-0.00131899886472607,0.0284700187533929
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,38727,-0.00994879444963978,0.00456978241104433,-0.0189055679752867,-0.000992020923992891,0.0294900701179478
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,38727,-0.0155038768665487,0.00712324506607154,-0.0294654371960489,-0.00154231653704845,0.0295321733998568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,38841,-0.00679062282305708,0.00312156643015448,-0.0129088930261599,-0.000672352619954312,0.0296165230420891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,38506,-0.0124246282619515,0.00572248568771811,-0.023640700209879,-0.001208556314024,0.0299324910243303
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,39095,-0.00500471217673687,0.0023073360575828,-0.00952709084959917,-0.000482333503874581,0.0300947999636572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,36363,0.0116895225848421,0.0053921421886917,0.00112092389500639,0.0222581212746779,0.0301865463948272
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,38704,0.00881184463949446,0.00406922380944402,0.000836165972984184,0.0167875233060047,0.030366408787185
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36500,-0.0209134277976021,0.00966718803655417,-0.0398611163492482,-0.00196573924595589,0.0305336137710139
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,39241,-0.0231226914214095,0.0106931832029107,-0.0440813304991145,-0.00216405234370442,0.030604508298067
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39234,-0.00422773846470044,0.00195941591976031,-0.00806819366743064,-0.000387283261970236,0.0309703072896779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39099,-0.00486435538349578,0.00226275879940523,-0.00929936263033004,-0.000429348136661528,0.0315910481450346
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36343,-0.0110778450726443,0.00515830169293519,-0.0211881163907973,-0.000967573754491332,0.0317666452013385
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39184,0.0050799227536449,0.00236684645333139,0.000440903705115363,0.00971894180217443,0.0318660457543859
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,36731,-0.0187970195821774,0.00876777025287793,-0.0359818492778182,-0.00161218988653667,0.0320614346633019
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,36767,-0.00430410146554319,0.00200812468412683,-0.00824002584643177,-0.000368177084654615,0.0321041424896981
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,38741,-0.0069385681046621,0.00324453848380841,-0.0132978635329266,-0.000579272676397615,0.0324893554585374
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,39093,0.00468704934669419,0.00219260468154152,0.000389544170872811,0.00898455452251557,0.0325599961447472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36391,-0.00919972530258455,0.00431183294147692,-0.0176509178678793,-0.000748532737289779,0.0328949298574274
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36363,0.00752089886720277,0.00353439032652771,0.000593493827208469,0.0144483039071971,0.0333632464732176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,36747,-0.00706675745402003,0.00332343407382603,-0.0135806882387191,-0.000552826669321002,0.0334937446261891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,36538,0.0122934131038399,0.00578211917975713,0.000960459511515925,0.0236263666961639,0.033513488738357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,36714,-0.0098909158268064,0.00465368268616355,-0.019012133891687,-0.000769697761925847,0.0335726487046756
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36401,-0.0071911319197627,0.00338437355568303,-0.0138245040889015,-0.000557759750623956,0.0336224357966793
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,39147,0.00530836763251747,0.0025025469800411,0.00040337555163691,0.010213359713398,0.0339222011120905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,38705,-0.00818020182270761,0.00386938953988814,-0.0157642053208884,-0.000596198324526861,0.0345250029619173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,36731,-0.0158123322554408,0.00748189513626343,-0.0304768467225171,-0.0011478177883645,0.0345846502846507
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,38832,-0.00952753106467937,0.0045082901842917,-0.0183637798258911,-0.000691282303467643,0.0345885351517168
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36363,0.00553331995648729,0.00261904445394345,0.000399992826758119,0.0106666470862165,0.0346441040121141
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39099,-0.0121331329297764,0.00575847630815217,-0.0234197464937546,-0.000846519365798116,0.0351335266675986
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,36421,-0.00443951065806735,0.00210919209819644,-0.00857352717053237,-0.000305494145602341,0.0353250993572631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39162,-0.00485761757989543,0.00231685973374894,-0.00939866265804336,-0.0003165725017475,0.0360419534652235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36391,-0.00892194336237527,0.00425744945051206,-0.0172665442853789,-0.000577342439371622,0.0361370294890418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39283,-0.00560329859064672,0.00268759368105002,-0.0108709822055048,-0.000335614975788692,0.0370969973137409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36430,-0.00793999916800464,0.00380840780448375,-0.0154044784647928,-0.000475519871216482,0.0371020920623182
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39147,0.00764060639302064,0.0036681185466649,0.000451094041557435,0.0148301187444838,0.0372699029926521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39140,-0.014789936164917,0.00710601717847909,-0.028717729834736,-0.00086214249509799,0.0374207132216778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36391,-0.0134256108893203,0.00645338045899757,-0.0260742365889555,-0.000776985189685015,0.0375091529092591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,36743,-0.0327707056397564,0.0157574031674492,-0.0636552158479568,-0.00188619543155589,0.0375725837603874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,39145,-0.00648954678329377,0.00312128693859087,-0.0126072691829319,-0.000371824383655669,0.0376224643118199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,36430,-0.012199533728114,0.00587985612619844,-0.023724051735463,-0.000675015720765093,0.0380252419803901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,39241,-0.00640026353680039,0.00308661456756634,-0.0124500280892304,-0.000350498984370359,0.0381373086757998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,36743,-0.0185067492267358,0.00893681012486002,-0.0360228970714615,-0.000990601382010188,0.0383931439222294
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,36791,-0.00478160306436669,0.00231362388471544,-0.00931630587840895,-0.000246900250324432,0.0387807997524902
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,38963,-0.0135315736587451,0.00655423720214314,-0.0263778785749457,-0.000685268742544584,0.0389822950247413
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39291,0.0109191293682238,0.0052996072719925,0.000531899115118495,0.0213063596213291,0.0393803134639654
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,38987,-0.00943355236426218,0.00457968694772658,-0.0184097387818063,-0.000457365946718077,0.0394281933767833
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,36538,-0.0135842509188465,0.00660708806410633,-0.0265341435244949,-0.000634358313198115,0.0398018081863447
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36538,-0.00726795099189365,0.0035409695883076,-0.0142082513849765,-0.000327650598810744,0.0401385375977973
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,39147,-0.00411982059598376,0.00200872418839898,-0.00805692000524577,-0.000182721186721752,0.040287480195328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,38727,0.0262054719914055,0.0127780633439511,0.0011604678372613,0.0512504761455498,0.0403022432191433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,39006,0.0128994979370389,0.0062937930519486,0.000563663555219656,0.0252353323188582,0.0404247049598768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39023,-0.0102294109241228,0.00500541753732905,-0.0200400292972877,-0.000418792550957822,0.0410036146079243
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,39093,0.00595706870485049,0.00291629864785912,0.000241123355046623,0.0116730140546544,0.0411011749081637
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",36747,-0.0201694762671465,0.00987571451827685,-0.0395258767229691,-0.000813075811323883,0.0411390356290895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36391,0.00842137067769773,0.00412779759109636,0.000330887399148872,0.0165118539562466,0.0413552381048268
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,36791,-0.0170517629746366,0.00835826778512553,-0.0334339678334826,-0.000669558115790555,0.0413599168399171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,38741,-0.00954270088648533,0.00469333566377874,-0.0187416387874917,-0.000343762985478989,0.0420454947816577
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,36391,0.00584723402465175,0.0028827029659528,0.00019713621138426,0.0114973318379192,0.0425419863138701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,36731,-0.011108517283028,0.00547810132536363,-0.0218455958807407,-0.000371438685315273,0.0426007866088846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,36743,0.00870554783957007,0.00430620866715061,0.000265378851954887,0.0171457168271853,0.0432355305947536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36420,-0.0163377939287482,0.00809443575616967,-0.0322028880108407,-0.000472699846655593,0.0435710285521366
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39283,0.00474519809437644,0.002352212544673,0.00013486150681736,0.00935553468193553,0.0436779697243065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,36500,0.00917750037844798,0.00456451236917852,0.000231056134858075,0.0181239446220379,0.044386795941751
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,38987,-0.00620451662964399,0.00308643147381126,-0.0122539223183141,-0.000155110940973919,0.044421844638175
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,36767,-0.0236161040060516,0.0117737365406024,-0.0466926276256323,-0.000539580386471023,0.0448953094796084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,39255,-0.00380981239032996,0.00190051579252045,-0.00753482334367005,-8.48014369898742e-05,0.0450211419624938
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36391,0.00944472277625624,0.00471945212886255,0.000194596603685648,0.0186948489488268,0.0453888243250096
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,39202,-0.0111726959826445,0.00558322570506794,-0.0221158183645777,-0.000229573600711332,0.0453972088057283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36430,-0.00755129784558989,0.00377576295705342,-0.0149517932414146,-0.000150802449765187,0.0455282645941635
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,36792,-0.00527899569429438,0.00264449156691707,-0.0104621991654518,-9.57922231369351e-05,0.045930552625287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,38741,-0.0144467415286596,0.00724038272802459,-0.0286378916755878,-0.000255591381731347,0.0460282824666803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39128,-0.00416830140696989,0.00209014730961881,-0.00826499013382276,-7.16126801170291e-05,0.0461411792829787
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,39283,-0.0164383219578017,0.00825415422736908,-0.0326164642434451,-0.000260179672158311,0.0464412396790237
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36339,-0.011308080713533,0.00569741020603093,-0.0224750047173536,-0.000141156709712353,0.0471913057489418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,38987,-0.00616626824963829,0.00311113105230959,-0.0122640851121651,-6.84513871114902e-05,0.0474970749696468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36339,-0.0147175019703759,0.00742675082118477,-0.0292739335798981,-0.000161070360853789,0.0475360934375406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,36731,-0.00890566040281642,0.00449847020486819,-0.0177226620043581,-8.86588012747585e-05,0.0477575434740946
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36391,-0.00696775012691349,0.00352123832929144,-0.0138693772523247,-6.61230015022701e-05,0.0478628272605366
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39099,-0.0184576357688864,0.00933791401364314,-0.0367599472356269,-0.000155324302145817,0.0481010470884868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36391,0.00674221028456528,0.0034146244336487,4.95463946138218e-05,0.0134348741745167,0.0483456959410376
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,36421,-0.0137481216488352,0.00696961411095785,-0.0274085653063126,-8.76779913578669e-05,0.0485653258987728
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,38605,0.0155280207910191,0.00789262126841982,5.84831049162786e-05,0.030997558477122,0.0491546965522931
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,36743,-0.0143961100334283,0.00732455500464329,-0.0287522378425291,-3.99822243274013e-05,0.0493826250850623
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36363,0.0129969852938732,0.006616790265797,2.80763729111223e-05,0.0259658942148353,0.0495240130438162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,36792,-0.00600206620443105,0.00306358213947199,-0.0120066871977961,2.55478893404753e-06,0.0501147945104079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,39023,-0.00532268827673407,0.00271968829676659,-0.0106532773383966,7.90078492845288e-06,0.0503546256636109
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",38987,-0.0104536644024188,0.00534380719167498,-0.0209275264981018,2.01976932641453e-05,0.0504575770392125
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39069,-0.00315279316501551,0.0016120556238031,-0.00631242218766958,6.83585763856798e-06,0.0505117688337907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36420,-0.00960613491273218,0.00492352465300994,-0.0192562432326317,4.39734071672956e-05,0.0510710753428572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36430,0.00528126505781317,0.00270694736349058,-2.4351774628369e-05,0.0105868818902547,0.0510787595637748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36391,0.00559125580462039,0.00286843914190263,-3.08849135087644e-05,0.0112133965227495,0.0512899035405993
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",36743,0.0186518668784054,0.00957002224302031,-0.000105376717914388,0.0374091104747252,0.0513184278823434
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39106,-0.0102530728016744,0.00528179743236697,-0.0206053957691137,9.92501657648553e-05,0.0522513331137157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,38106,0.00862716475340249,0.00446030080033944,-0.000115024815262817,0.0173693543220678,0.0531069174864907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,36806,-0.00305186037791713,0.00157932241065423,-0.00614733230279942,4.36115469651614e-05,0.0533336803871748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,36731,-0.00696122580331785,0.0036046102564187,-0.0140262619058985,0.000103810299262791,0.0534801704877976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",38741,-0.00968845593001553,0.00501767378850563,-0.0195230965554866,0.000146184695455498,0.0535185933490849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,36743,-0.00873535455979504,0.00452703912244845,-0.017608351239794,0.000137642120203927,0.0536789021465936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,36363,-0.00874969427249008,0.00453897807628911,-0.0176460913020167,0.000146702757036566,0.0539176473141491
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39088,-0.0140292741903722,0.0072836108272076,-0.0283051514116991,0.000246603030954725,0.0541051443384892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,36711,-0.00722708976095484,0.00375390360643696,-0.0145847408295713,0.000130561307661601,0.0542239024594163
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,39106,-0.00625773620812189,0.00325179916775057,-0.012631262576913,0.000115790160669219,0.0543240597398192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39241,0.00379676766682883,0.0019734444902625,-7.11835340856683e-05,0.00766471886774332,0.0543818780622226
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36500,-0.0200976672330804,0.0104513738934674,-0.0405823600642765,0.000387025598115754,0.0545063934359044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39093,0.00765469601852737,0.00398145998619346,-0.000148965554411823,0.0154583575914666,0.0545507900854228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,39029,-0.0133858124734028,0.00696795134211702,-0.0270429971039522,0.000271372157146531,0.05474359009496
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39023,0.00588739028999554,0.00306663325742142,-0.000123210894550445,0.0118979914745415,0.0548991159658843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,39291,0.0079562509084978,0.00415056832104246,-0.000178863000745409,0.016091364817741,0.0552682727183113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39099,0.00712513244784364,0.00371864149884671,-0.00016340488989591,0.0144136697855832,0.0553764135690265
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39023,0.0115703823921112,0.00603926196485946,-0.0002665710590133,0.0234073358432358,0.055401660740812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,38502,-0.00521218226630325,0.00272092086157743,-0.010545187154995,0.00012082262238851,0.0554361280475338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36421,0.00863442388944815,0.00451527117512622,-0.00021550761379923,0.0174843553926955,0.0558641150921102
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,36743,-0.00979174283818537,0.00512212073029401,-0.0198310994695616,0.000247613793190887,0.0559422420766138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,38923,-0.0118689255652273,0.00621041374307036,-0.0240413365016453,0.00030348537119056,0.0560064734402397
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,38727,0.00571351580654711,0.00299764195114517,-0.000161862417697429,0.0115888940307917,0.0566690273166415
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39023,0.00424782469340498,0.00222894006766035,-0.000120897839209298,0.00861654722601925,0.0567002500373686
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,36731,0.00986939092732445,0.00518409425411068,-0.000291433810732484,0.0200302156653814,0.0569607213708707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36363,0.00574782248080051,0.00302091029148933,-0.000173161690518573,0.0116688066521196,0.0571053979256324
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39093,0.00497510579782141,0.00262422529480306,-0.000168375779992585,0.0101185873756354,0.0580003891340835
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36363,0.0133982159133952,0.00706729985602131,-0.000453691804406542,0.027250123631197,0.0580089927994248
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,39140,-0.00537579978578087,0.00283598885055861,-0.0109343379328758,0.00018273836131401,0.0580365077934721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36311,0.00922883570000397,0.00487342432167267,-0.000323075970474465,0.0187807473704824,0.0582871269253032
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,36466,-0.0179986830225361,0.00959773832060836,-0.0368102501309285,0.000812884085856259,0.0607739249102214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36339,0.00453165602371672,0.00242007553579221,-0.000211692026436006,0.00927500407386945,0.0611571384348766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,38979,0.00682893755262837,0.00364882465814311,-0.000322758777332126,0.0139806338825889,0.06128894890321
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,38741,-0.00567068144876976,0.00303064223342739,-0.0116107402262874,0.000269377328747921,0.0613486906936723
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,38841,-0.00699218325938882,0.00374107900193348,-0.0143246981031784,0.000340331584400794,0.0616383470731521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,39099,0.00797550343769994,0.00426782720370951,-0.000389437881570705,0.0163404447569706,0.061676729750276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36363,-0.0147896923783759,0.00791570480056467,-0.0303044737874826,0.000725089030730893,0.0617298900461079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,36408,0.01204865057458,0.00644917964694463,-0.000591741533431516,0.0246890426825914,0.0617511520805686
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36339,-0.00511147444905919,0.00274261172337518,-0.0104869934268745,0.000264044528756154,0.0623837796425372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36421,0.00727106478698742,0.00391285350380491,-0.000398128080470206,0.014940257654445,0.0631567253148819
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,36391,0.00824720282137466,0.00444231453269981,-0.000459733662716972,0.0169541393054663,0.0634043051647693
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,39283,0.00458317954870734,0.00247108836538872,-0.000260153647454546,0.00942651274486923,0.0636551464448724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36420,-0.00444108835862433,0.00239904874846135,-0.00914322390560859,0.000261047188359917,0.064166083939653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,38502,0.0080484572601868,0.0043548965594823,-0.000487139996398512,0.0165840545167721,0.06460228664002
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,36538,0.00562558532462136,0.0030513685241107,-0.000355096982635614,0.0116062676318783,0.0652608447931421
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,38832,-0.00400596768799984,0.00217435191939338,-0.00826769745001085,0.000255762074011177,0.0654403410185248
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39093,0.00574362250557364,0.00312487661941172,-0.000381135668473325,0.0118683806796206,0.0660771847562267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,36538,-0.00906155058058675,0.00494590150011476,-0.0187555175208117,0.000632416359638172,0.066955015877709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39106,-0.00500288965698572,0.00273910927514612,-0.0103715438362721,0.000365764522300678,0.0677996595467126
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39117,-0.00496983288846884,0.00272529901344241,-0.010311418954816,0.000371753177878282,0.0682333646412804
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,36747,0.00509453938593337,0.00279398835800439,-0.000381677795755231,0.010570756567622,0.0682670120281742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,38841,-0.00964048062458084,0.00528809806425755,-0.0200051528305256,0.000724191581363949,0.0683153531235446
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,36767,-0.00610418731692199,0.00336501638257354,-0.0126996194267661,0.000491244792922161,0.0696987576205044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,39147,0.00495528555892172,0.00273182343859092,-0.000399088380716475,0.0103096594985599,0.0697109709992426
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,36500,-0.0062190745365055,0.0034391624438749,-0.0129598329265003,0.000521683853489309,0.0705819000299701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36420,-0.00841212542681563,0.00466722323306286,-0.0175598829636188,0.000735632109987571,0.0715090778425847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39099,-0.0110673987092973,0.0061438502393073,-0.0231093451783396,0.000974547759745049,0.0716630278969026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36500,-0.019898644264921,0.0110486197591059,-0.0415539389927686,0.00175665046292652,0.0717255632079886
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,39099,0.00521048678336789,0.00289326950786916,-0.000460321452055676,0.0108812950187915,0.0717385298751149
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39162,-0.0047066274701783,0.00261712363014934,-0.00983618978527101,0.000422934844914404,0.0721338077273144
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,38832,-0.00809610113049247,0.00450228692673041,-0.0169205835068841,0.000728381245899131,0.0721623326797724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,39106,-0.0113097362456927,0.0063068829592062,-0.0236712268457369,0.00105175435435142,0.0729548399848386
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,36538,0.0073251072626483,0.00408977329895193,-0.000690848403297486,0.0153410629285941,0.0733044571699014
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36391,-0.0101880110437959,0.00569137030192126,-0.0213430968355616,0.000967074747969733,0.0734651048325134
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36363,0.0125045988537218,0.00698766842476785,-0.00119123125882323,0.0262004289662668,0.0735546945408628
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",38741,-0.00903883983106666,0.00505843274733598,-0.0189533680158452,0.000875688353711863,0.0739763542142169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,36731,-0.00600210125956377,0.00336010628648533,-0.012587909581075,0.000583707061947488,0.0740769540445113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39115,0.00814429847473367,0.00456065774902451,-0.000794590713354363,0.0170831876628217,0.0741559130018591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,36731,-0.00837569614533319,0.00469848246996729,-0.0175847217864691,0.000833329495802688,0.0746687174578234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36391,-0.0112013292782421,0.00628708770486799,-0.0235240211797834,0.00112136262329916,0.0748321075545444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,36363,0.0149250302317664,0.00840166876067302,-0.00154224053915276,0.0313923010026855,0.0756853267510172
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,38812,0.00673200023953441,0.00379263014964771,-0.000701554853775107,0.0141655553328439,0.075914668863837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,36421,0.00999588289833274,0.00563207026461587,-0.00104297482031437,0.0210347406169798,0.0759526484927911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36500,-0.00636634906415541,0.00359746511860017,-0.0134173806966118,0.000684682568300928,0.0768051713379252
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36391,0.0085121588929518,0.00481259638717663,-0.000920530025914391,0.017944847811818,0.0769641236908066
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,36743,-0.00822837059125794,0.00465452850950053,-0.017351246469879,0.000894505287363092,0.0771145941169387
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,38987,0.0235725394224116,0.0133434769884644,-0.00258067547497865,0.0497257543198018,0.0773159951901122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,36796,-0.00418096191457963,0.00236823636634128,-0.00882270519260855,0.000460781363449288,0.077514660380271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,39062,-0.0108865876234881,0.00618508989589474,-0.0230093638194418,0.00123618857246556,0.0784051805726913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36500,0.00398559438897447,0.0022647356747308,-0.000453287533497894,0.00842447631144684,0.0784574803115107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39093,-0.00467288992959506,0.00265542944873968,-0.00987753164912484,0.000531751789934722,0.0784704041799643
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,39283,0.00261601050906822,0.00148914226149355,-0.00030270832345914,0.00553472934159558,0.0789848718804414
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,38841,0.00794358996736077,0.00452511677963091,-0.000925638920715812,0.0168128188554373,0.0792037948436714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,36363,0.00861421954209222,0.00490897578075139,-0.00100737298818051,0.018235812072365,0.0793197984295118
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,36430,0.00795663810933415,0.00453461002020483,-0.000931197530267327,0.0168444737489356,0.0793441354336191
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,36724,-0.0115387272728964,0.00658898751180691,-0.024453142796038,0.0013756882502451,0.0799328840032181
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36339,-0.00641099472381198,0.00366335089247708,-0.0135911624730671,0.000769173025443101,0.0801367355224703
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39147,-0.0110064416735106,0.00629993463533346,-0.0233543135587642,0.00134143021174295,0.080644867709552
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,38832,-0.0122151932268595,0.00700660461800092,-0.0259481382781413,0.0015177518244223,0.0812873159013194
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,38841,-0.0100809274474128,0.0057924180904742,-0.0214340669047422,0.00127221200991667,0.0818153063536434
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36421,0.00591193697634667,0.00339854361087606,-0.000749208500970411,0.0125730824536638,0.0819625376047707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,38813,-0.00683923196438672,0.00393329249613465,-0.0145484852568106,0.000870021328037189,0.0820895020281286
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",38841,-0.0196021515460346,0.0112751572338241,-0.0417014597243299,0.00249715663226055,0.0821387556082776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,39099,-0.00530167713108783,0.00305043608102214,-0.0112805318498912,0.000677177587715562,0.0822299030870251
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39241,-0.00746189357842796,0.00429438984751348,-0.0158788976795544,0.000955110522698454,0.0823029048224865
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",36767,-0.00633413742977861,0.00364770815388906,-0.0134836454114012,0.000815370551843952,0.08250454455733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,36591,-0.00897031590983102,0.00517670924420823,-0.0191166660284791,0.00117603420881712,0.0831515187846071
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,39093,0.00815236103326365,0.00471223493039524,-0.00108361943031103,0.0173883414968383,0.0836431516719189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,38841,0.00459872064557087,0.00266610634025845,-0.000626847781335688,0.00982428907247742,0.0845692429873247
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39260,0.00570368343410658,0.00330727606536482,-0.000778577654008474,0.0121859445222216,0.084622095772907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39067,-0.0044128949536174,0.00255998572550043,-0.00943046697559824,0.000604677068363453,0.0847648748214734
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,35842,-0.00825328954669262,0.00480164304740174,-0.0176645099196,0.00115793082621479,0.0856680724712346
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,38841,-0.00964177002907655,0.00563749712529591,-0.0206912643946565,0.00140772433650343,0.0872324712830673
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,36743,-0.00948491957259668,0.00557078099200095,-0.0204036503169186,0.00143381117172518,0.0886634475017162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,38840,-0.00835408361740319,0.00491153939934974,-0.0179807008401287,0.00127253360532229,0.0889807526801366
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,36339,0.00946113097340589,0.00556555272334225,-0.00144735236434493,0.0203696143111567,0.0891662775993862
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,36767,-0.00809702219187219,0.00476914027324741,-0.0174445371274371,0.00125049274369274,0.0895705783900872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,39140,-0.00456928142664375,0.00269193197665809,-0.0098454681008936,0.000706905247606099,0.0896417011108036
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39106,0.00537451064209658,0.00316969369020016,-0.000838088990695736,0.0115871102748889,0.0899833899161018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39147,-0.00769565251091401,0.00454633753914745,-0.016606474087643,0.00121516906581499,0.0905301571614664
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39023,-0.00327621300761507,0.00193588507152677,-0.00707054774780754,0.0005181217325774,0.0905980420512052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,38677,-0.0107605332670572,0.00637668822216907,-0.0232588421825086,0.00173777564839417,0.0915321571980447
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36363,0.00875451771470683,0.00520568542012513,-0.00144862570873842,0.0189576611381521,0.0926476581075204
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36391,0.00972056246850496,0.00578368572561151,-0.0016154615536936,0.0210565864907035,0.0928487488556503
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,38681,0.0141406374891469,0.00842231315205592,-0.00236709628888272,0.0306483712671765,0.0931829882111847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,38841,-0.00446109821317345,0.00266048216019942,-0.00967564324716432,0.000753446820817422,0.0936023343573443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,36430,0.0090991021844412,0.00542738453209347,-0.00153857149846199,0.0197367758673444,0.0936618448919608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36391,0.00963407769717222,0.00574869926997911,-0.00163337287198683,0.0209015282663313,0.0937884342915119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,36430,-0.00733156263607515,0.00438157265195081,-0.0159194450338987,0.00125631976174843,0.094298653522865
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36421,-0.00610233429239651,0.00365205303281556,-0.013260358236715,0.00105568965192199,0.0947599127724132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36538,-0.0130082124655248,0.00778517446834734,-0.0282671544234856,0.00225072949243602,0.0947670157461684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,36421,-0.00639104700069817,0.00382659068074977,-0.0138911647349677,0.00110907073357138,0.094911163741337
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,38832,-0.00699381496616436,0.00418830557067559,-0.0152028938846885,0.00121526395235979,0.0949712294942533
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,38727,-0.0073218223318465,0.00438503094553211,-0.0159164829850894,0.00127283832139643,0.0949936397968394
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36430,0.0032935774081718,0.00197328525936278,-0.000574061700179246,0.00716121651652284,0.0951257815339384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,38832,-0.00817342842079703,0.00489847643757414,-0.0177744422384423,0.00142758539684828,0.0952244451963823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,39140,-0.0135210908015376,0.00810533658040576,-0.0294075504991329,0.00236536889605772,0.0953021929297647
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,38773,-0.00727915606185713,0.00436558915212161,-0.0158357108000155,0.00127739867630122,0.0954571328716841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36421,-0.00456203583762391,0.00274105090227257,-0.00993449560607815,0.000810423930830337,0.096069796651816
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,38741,-0.0173948785491534,0.0104637228006994,-0.0379037752385243,0.00311401814021747,0.0964539325199748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36339,0.00459972339618775,0.00277302874838801,-0.000835412950652745,0.0100348597430283,0.0971940758354092
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,36726,-0.00567858270846189,0.00342403666661588,-0.012389694575029,0.00103252915810524,0.0972516900120343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36391,0.00584660103696444,0.00352724007416768,-0.0010667895084042,0.0127599915823331,0.097431971730041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,39023,-0.0116077257451311,0.00700887488142741,-0.0253451205127288,0.00212966902246665,0.0977127842628505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,38841,-0.00726691028143539,0.00440234011473164,-0.0158954969063094,0.00136167634343862,0.0988223197627472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39023,-0.00593469348048274,0.0035991255876036,-0.0129889796321858,0.00111959267122031,0.0991834135607918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,38727,-0.00721850931828456,0.0044020336900023,-0.0158464953506891,0.00140947671411995,0.101065341199103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,36747,-0.00854360988256085,0.00521771101368151,-0.0187703234693766,0.00168310370425491,0.101566136487293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,36538,0.00770222914848519,0.00471493081926863,-0.00153903525728132,0.0169434935542517,0.102371345525472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36391,-0.0085266942742096,0.00522273014166674,-0.0187632453518764,0.00170985680345721,0.102575655366618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,38832,-0.00730109553220931,0.00447329799636371,-0.0160687596050822,0.00146656854066357,0.102668817004944
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36421,-0.00842867651931605,0.00516879830663379,-0.0185595212003183,0.00170216816168618,0.102982092983877
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36339,0.0072971127462151,0.00449551763817279,-0.00151410182460356,0.0161083273170338,0.104572462505479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36430,0.00825515246991742,0.00508916925286601,-0.00171961926569996,0.0182299242055348,0.104806553393134
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,36785,0.00288486230982779,0.00177890307421401,-0.000601787715631677,0.00637151233528725,0.104890160317235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39106,-0.00476918848682892,0.00294153890667242,-0.0105346047439069,0.000996227770249017,0.104968786703576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36363,-0.00478805091489624,0.00296677078739682,-0.010602921658194,0.00102681982840152,0.106575849921075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,38832,-0.00925013711425539,0.00573351564551662,-0.020487827779468,0.00198755355095719,0.106690713793643
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39028,-0.0067307324599228,0.0041726218833283,-0.0149090713512463,0.00144760643140067,0.106750037239744
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39099,0.0124844875634548,0.00774984618038746,-0.0027052109501046,0.0276741860770143,0.107214907299751
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,36731,-0.0119552258550612,0.00744064797551285,-0.0265388958870663,0.00262844417694402,0.108134791033734
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39234,-0.00696382752844844,0.00433760488763175,-0.0154655331082067,0.0015378780513098,0.108414345111359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39113,0.00850248922383596,0.00529789398719198,-0.00188138299106033,0.0188863614387322,0.108540705548987
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,39095,-0.00330499333302572,0.00206019967084115,-0.00734298468787437,0.000732998021822938,0.108688454593502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36421,-0.00789603699143935,0.00493095575778488,-0.0175607102766977,0.00176863629381903,0.109331256743527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,36421,-0.00467131613612673,0.00292153850202622,-0.0103975316000981,0.00105489932784466,0.109862785714203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,38832,0.00745365442413422,0.00466489564418874,-0.00168954103847571,0.0165968498867442,0.110104580940827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,38832,-0.00887255076439057,0.00556617281355309,-0.0197822494789546,0.00203714795017348,0.110954274266418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,36796,-0.00329615074943169,0.00207562407586695,-0.00736437393813091,0.000772072439267536,0.112304273038311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,36747,-0.0141298156955054,0.00891688645469491,-0.0316069131467074,0.00334728175569666,0.113078788186649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,36421,-0.00725561368748962,0.0045805881084847,-0.0162335663801196,0.0017223390051404,0.113220775379098
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36500,-0.0129365469262695,0.00817361998425265,-0.0289568420954047,0.0030837482428657,0.113510453052615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,36339,0.00723497807986776,0.00457163184086764,-0.00172542032823281,0.0161953764879683,0.113542319195802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,39234,-0.00395592513408426,0.0025012925671005,-0.00885845856560125,0.000946608297432722,0.113772370279609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36430,-0.00434502449209394,0.00274738670776503,-0.00972990243931339,0.00103985345512551,0.113786223023785
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39291,-0.00537651259523995,0.00340161414157011,-0.0120436763127174,0.00129065112223747,0.113995316127653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,38832,-0.00878813480175878,0.00556567417749322,-0.0196968561896455,0.00212058658612793,0.114359849962073
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36421,0.00461277907251588,0.00292367981921657,-0.0011176333731486,0.0103431915181804,0.114652698258245
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,39140,-0.00829868131592404,0.00526821357714281,-0.018624379927124,0.00202701729527586,0.115222611528201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36339,-0.00812863753381448,0.00516200910386595,-0.0182461753773917,0.00198890030976279,0.115350082568994
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,38727,0.00762240156581098,0.00484430419294995,-0.00187243465237092,0.0171172377839929,0.115629672806649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36391,0.0124127237145323,0.00788906921404787,-0.0030498519450015,0.0278752993740661,0.115649647975644
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39283,-0.00331644436619979,0.00210882921659412,-0.00744974963072426,0.000816860898324678,0.115821044093682
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,36792,-0.0042611856884167,0.00270962584779991,-0.00957205235010452,0.00104968097327113,0.115833530215733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36391,-0.0067644903071187,0.00430623440704471,-0.0152047097449263,0.00167572913068893,0.116240477240713
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36391,-0.00607348118500733,0.00387036972537171,-0.0136594058467359,0.00151244347672123,0.116620754568513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,38992,-0.00388762930206576,0.00248492594589293,-0.0087580841560159,0.000982825551884375,0.11772463026037
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,36796,-0.0132585281433814,0.00850701991664719,-0.0299322871800099,0.00341523089324714,0.119129830863409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36363,0.0108487692193749,0.00696188223936018,-0.00279651996977106,0.0244940584085209,0.119185140345277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,36430,-0.00785235357402348,0.00504268828348093,-0.0177360226096461,0.00203131546159913,0.119453861103243
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,39024,0.00967265534395163,0.00621402622870181,-0.00250683606430393,0.0218521467522072,0.119590094873482
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,36339,0.00432558931080666,0.00278077849657445,-0.00112473654247927,0.00977591516409259,0.119844832032561
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,36796,0.0206601371317416,0.0132873365099653,-0.00538304242779045,0.0467033166912736,0.120000488945816
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,36743,-0.0170607061593715,0.0110018363363539,-0.0386243053786251,0.00450289305988208,0.120994702949672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,36796,-0.00343295040499056,0.00221471848017275,-0.00777379862612915,0.000907897816148025,0.12115115831167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,36731,-0.00488238564349913,0.00315064764777844,-0.0110576550331449,0.00129288374614662,0.121251311691233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36391,0.0103270492241613,0.00667902888385089,-0.00276384738818643,0.023417945836509,0.122083884321043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36420,0.0137955638262093,0.00894292825346588,-0.00373257555058379,0.0313237032030024,0.122947548141219
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,36731,-0.00590904352179236,0.00383884102979337,-0.0134331719401874,0.00161508489660265,0.123761026207157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,39023,-0.00411073783356166,0.0026807759498565,-0.0093650586952804,0.00114358302815708,0.125194885884584
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,39140,-0.00730525288431446,0.00476596675828228,-0.0166465477305477,0.00203604196191881,0.125346927644128
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,38674,0.00428731703656088,0.00279792018055158,-0.00119660651732022,0.00977124059044197,0.125464137942367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36421,0.00668834447175516,0.00437178090704424,-0.00188034610605154,0.0152570350495619,0.126069107753912
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,39093,-0.0103347649187668,0.00676922106454175,-0.0236024382052687,0.00293290836773499,0.126849218467307
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,36767,-0.0037919263516823,0.0024865979422439,-0.00866565831848033,0.00108180561511573,0.127297192061311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,39099,-0.0054688632472897,0.00358830853632166,-0.0125019479784802,0.00156422148390076,0.127509898606038
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,36430,-0.00535737066461363,0.00352033065766238,-0.0122572187536319,0.00154247742440463,0.128074995431713
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,36731,-0.0107932203206527,0.00712308070423358,-0.0247544585009506,0.00316801785964509,0.129734646621772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36391,0.00670095923353635,0.00442911407820657,-0.00198010435974854,0.0153820228268212,0.130321531117673
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,39106,-0.00604873810996853,0.00399881162572864,-0.0138864088963967,0.00178893267645961,0.130393400265856
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36339,-0.0103101951845833,0.00685752984792162,-0.0237509536865097,0.00313056331734302,0.132739255637663
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,36430,0.0037304086976615,0.00248373432570837,-0.0011377105807269,0.00859852797604989,0.133138892600773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,36791,0.0046728064244529,0.00312073799184008,-0.00144384003955366,0.0107894528884595,0.134329169584508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39283,0.0032567514341418,0.00217662569840334,-0.00100943493472874,0.00752293780301234,0.134611945420216
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,39023,-0.00391279207492578,0.00262101044514942,-0.00904997254741865,0.00122438839756709,0.13549560018379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,36796,-0.0101231873741817,0.00678459773383703,-0.0234209989325023,0.00317462418413887,0.135701602307921
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39237,-0.00905553819367087,0.00608050132429303,-0.0209733207892852,0.00286224440194346,0.136435494749595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,36538,-0.0072855218222822,0.00490383506122988,-0.0168970385422928,0.00232599489772836,0.137389071568335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,39023,-0.0255274817884086,0.0172044368539331,-0.0592481780221175,0.00819321444530038,0.137889892680992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39182,0.00277769651834648,0.00187220356307635,-0.000891822465283173,0.00644721550197614,0.137922125243333
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,36731,-0.00733771590303738,0.00495063702012841,-0.0170409644624891,0.00236553265641431,0.138317924232867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,38841,-0.00801113272967166,0.00540616110521685,-0.0186072084958967,0.00258494303655336,0.13840060962776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,36731,-0.00923069792279064,0.00623806115565618,-0.0214572977878768,0.00299590194229548,0.138967578473994
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36391,0.00513494961442364,0.00348169545310599,-0.0016891734736641,0.0119590727025114,0.14028023211064
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36538,0.00989965956862923,0.00671999046826056,-0.00327152174916147,0.0230708408864199,0.140731183046732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,38811,0.00739128467372147,0.0050175521778513,-0.00244311759486708,0.01722568694231,0.140748963573448
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39121,-0.0031962079543518,0.00217100607946398,-0.0074513798701012,0.00105896396139761,0.140980932895089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36339,0.00902210931942623,0.00612928554257207,-0.00299129034401501,0.0210355089828675,0.141054862910192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,36731,0.00567432448275572,0.00385921749506812,-0.00188974180757779,0.0132383907730892,0.141496758104941
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36421,-0.00662700864075193,0.0045145804404693,-0.0154755863040718,0.0022215690225679,0.142153056437236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,36727,-0.0120007176553229,0.0081943080873633,-0.028061561506555,0.00406012619590917,0.143076701078322
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,38841,-0.00586389333296411,0.00400475840332568,-0.0137132198034824,0.00198543313755422,0.143151693851453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39093,-0.00452162429789263,0.00308886041608489,-0.010575790713419,0.00153254211763374,0.143255927804332
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,36339,0.00802838545677416,0.00549053106093714,-0.00273305542266264,0.018789826336211,0.143705060554403
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36391,-0.0061895902404357,0.00423870369181568,-0.0144974494763944,0.00211826899552304,0.144244946029547
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,38987,-0.00948072303413545,0.00650320289674175,-0.0222270007117493,0.00326555464347838,0.144901436325942
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,38727,-0.0104255878541899,0.00715471350669929,-0.0244488263273205,0.00359765061894066,0.145092355227785
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36363,0.00434174145168899,0.00298260809908256,-0.00150417042251283,0.0101876533258908,0.14550449387856
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,38832,-0.00827226377375834,0.00568466223450906,-0.0194142017533961,0.00286967420587942,0.145637627369924
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,36737,-0.00425661242624848,0.00293260824086416,-0.0100045245783422,0.00149129972584528,0.146671536794053
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,36767,-0.00373395079772277,0.00257342170683933,-0.00877785734312785,0.00130995574768232,0.146813262671743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,39252,-0.00279642174718748,0.0019318974187182,-0.00658294068787516,0.000990097193500196,0.147777269024691
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36391,0.00433691666956082,0.00299785506336026,-0.00153887925462529,0.0102127125937469,0.148013477880037
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,36792,-0.00525422834621005,0.00363230277894268,-0.0123735417929377,0.00186508510051759,0.14805334887975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,36767,-0.00367779288540558,0.00254957997247963,-0.00867496963146565,0.0013193838606545,0.149183008202077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36363,0.00754013781998011,0.00522756603520447,-0.00270589160902066,0.0177861672489809,0.149220191092367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39021,0.00357372954648075,0.00248185900177748,-0.00129071409700311,0.00843817318996461,0.14990485232326
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",38832,-0.0111962074727203,0.00778162283350781,-0.0264481882263956,0.00405577328095503,0.150227789252943
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,36779,0.00250207855098767,0.00173929867523642,-0.000906946852475722,0.00591110395445106,0.150300583946891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,38960,-0.00654200698952569,0.00454898712935065,-0.015458021763053,0.00237400778400158,0.150419634026217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,39106,-0.0036258460333333,0.00252365643897489,-0.00857221265372408,0.00132052058705749,0.150811516918727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,38832,-0.00649565492202093,0.00454336568162431,-0.0154006516580046,0.00240934181396271,0.152823689453467
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36391,0.00663686525298848,0.00464774775738169,-0.00247272035147963,0.0157464508574566,0.153324121035694
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,36667,-0.00375984833919074,0.00263513640000639,-0.00892471568320327,0.00140501900482179,0.153658020468265
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,39099,-0.00766228338840787,0.00537216192003611,-0.0181917207516786,0.0028671539748629,0.153803923310895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39271,-0.00692022629973646,0.00485210458671347,-0.0164303512896949,0.00258989869022194,0.153821673395232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,36430,-0.00423526999611878,0.00297566261665144,-0.0100675687247556,0.00159702873251804,0.154673110885455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,36538,-0.00570239269529313,0.00400692278365138,-0.0135559613512498,0.00215117596066359,0.154721583995631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,36796,0.00452381005970882,0.00318034777178719,-0.00170967157299407,0.0107572916924117,0.154926667650886
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36311,-0.0115366591044106,0.00812857922360917,-0.0274686743826846,0.00439535617386336,0.155844972758565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,39223,-0.00539279801710995,0.0038100128135373,-0.0128604231316431,0.00207482709742316,0.156963376791374
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,36767,-0.00461340282131432,0.00326252046582775,-0.0110079429343367,0.00178113729170807,0.157368124358908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36391,-0.0047725588927164,0.0033761301327255,-0.0113897739528584,0.00184465616742558,0.157498884875137
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39283,-0.00352297644721186,0.00249269467673672,-0.00840865801361583,0.00136270511919211,0.157581695276573
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,36339,0.00939179118209183,0.00665270866386059,-0.00364751779907491,0.0224311001632586,0.158056057554231
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36421,0.00502880002449874,0.00356612915633183,-0.00196081312191165,0.0120184131709091,0.158518253466888
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,38727,-0.00611765113279519,0.0043458109703013,-0.0146354406345857,0.00240013836899536,0.159237214937117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,38664,-0.0153557374822014,0.0109240066897513,-0.0367667905941139,0.00605531562971116,0.159837985725455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36363,0.00798029668293423,0.00568001333855234,-0.00315252946062835,0.0191131228264968,0.160052512413837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,38841,-0.00583249841585803,0.00415881322444959,-0.0139837723357792,0.00231877550406316,0.160803727416346
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,39099,-0.00437813375685508,0.00312924840673075,-0.0105114606340474,0.0017551931203372,0.16180312918454
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36391,0.00745224030465926,0.00533570398327724,-0.00300573950256414,0.0179102201118827,0.162536289336605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39255,-0.0038500557886398,0.00275889807936435,-0.00925749602419391,0.00155738444691432,0.16288376564199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,38841,0.00667784546846011,0.00478854680871909,-0.00270770627662931,0.0160633972135495,0.16317367690005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36430,0.00259703790791617,0.00186542750847406,-0.00105920000869298,0.00625327582452532,0.163888138132898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,36679,-0.00365973830109118,0.00262949627852813,-0.00881355100700631,0.00149407440482395,0.164006497939507
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,36743,-0.00373273939850319,0.00268871129828384,-0.00900261354313953,0.00153713474613315,0.165069546546933
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36363,0.00931017441197446,0.00671325537930789,-0.00384780613146901,0.0224681549554179,0.165516947094172
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,39099,-0.00835866526874853,0.00605358717268376,-0.0202236961272087,0.00350636558971164,0.167367211221298
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,36538,-0.0047099239930318,0.00341779578079767,-0.0114088037233952,0.00198895573733164,0.168209415174505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,36747,-0.0110693022545941,0.00804254701704374,-0.0268326944079998,0.00469408989881166,0.168739419580987
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,36796,-0.00283579161930548,0.00206044791569507,-0.00687426953406781,0.00120268629545686,0.16875302333858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,36339,-0.00909006328385705,0.00662823357087472,-0.0220814010827715,0.0039012745150574,0.170270078435107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39093,0.00662344565449462,0.00483280283672233,-0.00284884790548116,0.0160957392144704,0.170545301861251
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39162,0.00334467805010719,0.00244111002307638,-0.00143989759512252,0.0081292536953369,0.170661315165692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,39246,0.00569695081064,0.00416502412756533,-0.00246649647938806,0.0138603981006681,0.171392348681728
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,38832,-0.0048263218718114,0.00353668034404525,-0.0117582153461401,0.00210557160251728,0.172384386983494
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39052,-0.0074196565297774,0.00545056628759586,-0.0181027664534653,0.00326345339391048,0.173450646658651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,36391,0.00621951463108996,0.00457370090151566,-0.00274493913588072,0.0151839683980607,0.173904113330959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,38727,-0.006119924706575,0.00450659756061671,-0.0149528559253838,0.00271300651223375,0.174486741646062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39093,-0.00553999887918296,0.00407976605660472,-0.0135363403501282,0.00245634259176228,0.174508953428124
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,38741,-0.00878716141973147,0.00651498266066253,-0.02155652743463,0.0039822045951671,0.177433929740874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,39089,-0.0076991388686608,0.00571983012507142,-0.0189100059138008,0.00351172817647918,0.17830859726748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,38741,-0.00379663533635389,0.00282076796366962,-0.00932534054514633,0.00173206987243856,0.178336551329518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36363,-0.00719301288353422,0.00537750478832902,-0.0177329222686591,0.00334689650159066,0.181047405272397
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36421,0.00359714553105477,0.002695831200798,-0.00168668362250931,0.00888097468461884,0.182117842232077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,36731,-0.00449916241978485,0.00337340479600872,-0.0111110358199619,0.00211271098039224,0.182320698241166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39147,-0.012266297859389,0.00921754845564166,-0.0303326928324466,0.00580009711366868,0.183289517326937
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,38987,-0.00515206286257637,0.00387725061583044,-0.012751474069604,0.00244734834445128,0.183936367738843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36430,0.00590424187902889,0.00444826577149557,-0.00281435903310243,0.0146228427911602,0.184429205370152
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39099,-0.0101078041746238,0.00762212756064092,-0.02504717419348,0.00483156584423237,0.18482207080982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",38841,-0.0089150189111399,0.00673395510668215,-0.0221135709202369,0.00428353309795711,0.185559627573831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36420,-0.0104111983538659,0.00788249527745138,-0.0258608890976706,0.00503849238993884,0.186592183315874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36445,0.00413358010810532,0.00313118259307513,-0.00200353777432193,0.0102706979905326,0.186814345197678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36430,-0.00552474052702631,0.00419362641406774,-0.0137442482985991,0.00269476724454646,0.187724032390818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,36339,0.00502378347710432,0.0038247809509252,-0.00247278718670908,0.0125203541409177,0.189044506835649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,36731,-0.00586811246028399,0.00447093632421069,-0.0146311476557369,0.00289492273516896,0.189374245906187
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36391,0.00768486294061755,0.00586533777632638,-0.00381119910098216,0.0191809249822173,0.190146586071449
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,39025,-0.00501927331434621,0.00383233603341216,-0.012530651939834,0.00249210531114162,0.190311637243064
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36430,-0.00452419457689807,0.00345538692563709,-0.0112967529511468,0.00224836379735063,0.190451147706466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,38727,0.00427781212432949,0.0032687977350354,-0.00212903143633989,0.0106846556849989,0.190662801022644
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,39241,-0.00803484661678799,0.00614446890866156,-0.0200780056777646,0.00400831244418866,0.191009835509669
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36421,-0.00640089253635848,0.00490664905353267,-0.0160179246812825,0.00321613960856556,0.19207533540854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,36731,-0.00341806824079454,0.00262440696558423,-0.00856190589333963,0.00172576941175055,0.192797699836654
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,38727,-0.0145783764530864,0.0112086009910143,-0.0365472343954745,0.0073904814893016,0.193401206685108
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39023,0.0040837632286541,0.00315350083194837,-0.00209709840196471,0.0102646248592729,0.195342172759237
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39171,-0.0134893321875134,0.0104406582462481,-0.0339530223501596,0.0069743579751329,0.196376587654701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36391,-0.00463774655610147,0.00359262241924285,-0.0116792864978175,0.00240379338561452,0.196759247868891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,36731,-0.00470404151002285,0.00364658552895642,-0.0118513491467774,0.00244326612673172,0.197078958925141
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36430,-0.00771172861964998,0.00598682244780323,-0.0194459006173443,0.00402244337804436,0.197728900071778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,38961,-0.0150050937940925,0.0116684611591374,-0.0378752776660018,0.00786509007781682,0.198479147700021
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,36743,-0.00838632623011789,0.00653116694579171,-0.0211874134438696,0.00441476098363386,0.199148553776112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36421,-0.00650086088862999,0.00507560083397566,-0.0164490385232223,0.0034473167459623,0.200285402321837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,38832,-0.0133436419090826,0.0104189401766033,-0.0337647646552252,0.00707748083705989,0.200315349839807
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,38705,-0.00568033411591149,0.00443789260965339,-0.0143786036308321,0.00301793539900915,0.200578484985429
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,38727,-0.00559940677176536,0.0043813680884849,-0.0141868882251958,0.00298807468166504,0.201267902482915
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,38935,-0.00309109363287663,0.00242127148782735,-0.00783678574901824,0.00165459848326499,0.201748804917139
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,36538,-0.00853809045442125,0.00668919783318818,-0.0216489182074701,0.00457273729862759,0.201837624454961
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,36731,-0.00446491034504282,0.00350279529206364,-0.0113303891174876,0.00240056842740192,0.202448850950286
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39241,-0.00316440357495429,0.00248439400991003,-0.00803381583437794,0.00170500868446937,0.202784590344044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",38951,-0.0113995126541768,0.00895193491570481,-0.0289453050889582,0.00614627978060465,0.202891047265595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39099,-0.00713688099260042,0.00561733411077127,-0.0181468558497121,0.00387309386451128,0.203922303082992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36430,-0.00376507421987186,0.00296912702996367,-0.00958456319860066,0.00205441475885694,0.204794839711449
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,38707,-0.00901164363492076,0.00710868021016053,-0.0229446568468354,0.00492136957699389,0.204926506598171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39093,-0.00487445822476321,0.00386559342741624,-0.012451021342499,0.00270210489297263,0.207333293592113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36500,-0.00751193405072817,0.00596507884648518,-0.0192034885898391,0.00417962048838277,0.207938573454338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39283,0.00183325195942488,0.00145763297459938,-0.0010237086707899,0.00469021258963967,0.208522549256244
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,36391,0.00425619304659353,0.00338864316784721,-0.002385547562387,0.010897933655574,0.209133263858095
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39216,-0.00720750147748251,0.00576023825076983,-0.0184975684489914,0.00408256549402636,0.210862129801753
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,36421,-0.010740079053194,0.00859317158649612,-0.0275826953627264,0.00610253725633837,0.211381734086287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,36767,-0.00904492645658411,0.00723772581425022,-0.0232308690525145,0.00514101613934632,0.211434821026864
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,36767,-0.00603756140285404,0.00483647542401371,-0.0155170532339209,0.00344193042821283,0.211929542829335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,39162,-0.00482609897119341,0.00387134636271745,-0.0124139378421196,0.00276173989973278,0.21255583631622
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,36767,-0.00705730547650422,0.005672994310402,-0.0181763743248921,0.00406176337188369,0.213515631050718
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,36791,0.00293379143926397,0.00236214677449255,-0.00169601623874142,0.00756359911726937,0.214258283608631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,36538,-0.00850015120582045,0.00684541363843998,-0.0219171619371628,0.00491685952552191,0.214359398979701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39197,-0.00343074851329172,0.00276525340693361,-0.0088506451908816,0.00198914816429815,0.214749122275845
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,38987,-0.00705110648105808,0.00569474568238155,-0.0182128080185259,0.00411059505640976,0.215669434604094
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,39046,-0.003149833581243,0.002544787562266,-0.00813761720328437,0.00183795004079837,0.215824589865087
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36339,-0.00933857251816453,0.0075676565931585,-0.0241711794407552,0.00549403440442612,0.217221993463479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36363,-0.00852146369639354,0.00691809450550255,-0.0220809289271785,0.00503800153439145,0.218060207790291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36391,-0.013208170165516,0.0107455065616888,-0.0342693630264261,0.00785302269539408,0.219027112818513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,36792,-0.00608152467632449,0.00494765369757893,-0.0157789259235792,0.00361587657093021,0.21902913725641
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,39068,-0.00300167785190122,0.00244418216260862,-0.00779227489061412,0.00178891918681168,0.219431855793898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36363,-0.00540103800222078,0.00440487447008493,-0.0140345919635873,0.00323251595914569,0.220165225423228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,39106,-0.00875102906188256,0.00714694217958047,-0.0227590357338603,0.00525697761009517,0.220803773084044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39283,0.00257301978013768,0.00210244238384001,-0.00154776729218874,0.00669380685246409,0.221037264537668
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,38741,-0.00449654503559308,0.00367959667077196,-0.0117085545103061,0.00271546443911997,0.221718977159689
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,39283,-0.00302615552742,0.00247641417250436,-0.00787992730552855,0.00182761625068855,0.221729752742411
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36339,-0.00726577554347386,0.00595109126425831,-0.0189299144214202,0.00439836333447242,0.222141338570726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36421,0.00731975592614696,0.00601010991290869,-0.00446005950315408,0.019099571355448,0.223282129885294
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,39221,0.00432289381742769,0.00356601708928438,-0.0026664996775697,0.0113122873124251,0.225436457679668
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,39023,-0.00168650098677286,0.00139152576048728,-0.00441389147732793,0.00104088950378221,0.225539032897735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,36391,0.00535309423559557,0.00441691797560982,-0.00330406499659969,0.0140102534677908,0.225553462432242
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39023,-0.00345681245153303,0.00285451188007105,-0.00905165573647228,0.00213803083340622,0.225914471447427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36531,0.0111026821674412,0.0091852067730529,-0.00690032310774253,0.0291056874426248,0.226778805724176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,39147,0.0043604276307088,0.00360745917143684,-0.00271019234530742,0.011431047606725,0.226787044757881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,36791,0.0044433079973844,0.00367675457135899,-0.00276313096247922,0.011649746957248,0.22688231177518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,36792,-0.0110342564071842,0.00915044515415859,-0.028969128909335,0.00690061609496663,0.227889297659558
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36363,0.00700463271868756,0.00581826799704812,-0.00439917255552676,0.0184084379929019,0.228649702833438
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36391,0.00457417650247341,0.00380361387248448,-0.00288090668759618,0.012029259692543,0.229158912768586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,38832,-0.00441088757638593,0.00367486227191716,-0.0116136176293436,0.00279184247657171,0.230047081761308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36430,-0.00848725061581187,0.0070786064404389,-0.0223613192390721,0.00538681800744837,0.230550465521007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",38727,-0.00565427367023336,0.00471772448821081,-0.0149010136671265,0.00359246632665982,0.230734857861969
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,36747,0.00404277796260851,0.00338530484497568,-0.00259241953354382,0.0106779754587608,0.232416303569702
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,39023,0.00351721400540408,0.00294889980649659,-0.00226262961532923,0.00929705762613739,0.232997417714661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,39099,0.00468345981939582,0.00392845655254095,-0.00301631502358445,0.0123832346623761,0.233205996206731
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,36421,-0.00674842760844829,0.00566676571381949,-0.0178552884075345,0.0043584331906379,0.233723917211052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,36791,-0.00863941712191453,0.00725974866798142,-0.0228685245111581,0.00558969026732906,0.234051121065547
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,38951,0.00520330867510551,0.00437480653934004,-0.00337131214200097,0.013777929492212,0.234308765856354
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36339,0.00698936010098493,0.00588680828037421,-0.00454878412854852,0.0185275043305184,0.235135080615827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36391,0.00399542132663918,0.00338147328854245,-0.00263226631890403,0.0106231089721824,0.237401846017899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,39093,0.020732995574197,0.0175515129822868,-0.0136679698710852,0.0551339610194792,0.237515736809262
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,36791,0.00250448912307857,0.00212058421506427,-0.0016518559384474,0.00666083418460455,0.237609615001009
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,36538,-0.0180587229801569,0.0153122369261874,-0.0480707073554841,0.0119532613951704,0.238274823052573
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,38841,-0.00469321905283649,0.00399318504843641,-0.0125198617477718,0.00313342364209888,0.239890522416589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36363,0.00330040674473981,0.0028119886964532,-0.00221109110030846,0.00881190458978807,0.240541042177088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,36339,0.00509657868685716,0.00434861370067335,-0.00342670416646261,0.0136198615401769,0.241219114011707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,36430,0.0044434319627492,0.00379426871735368,-0.002993334723264,0.0118801986487624,0.241584610196373
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36421,-0.00769391083763799,0.00659431668944308,-0.0206187715489464,0.00523094987367043,0.243333994128847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36421,-0.00363756966997696,0.00311823970625432,-0.00974931949423543,0.00247418015428151,0.243415958549821
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,36731,-0.00416236625978017,0.00357017173322376,-0.0111599028568987,0.00283517033733839,0.243687464943732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,36430,0.0112505310647936,0.00968821978113558,-0.00773837970623214,0.0302394418358193,0.245558695413156
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,39106,-0.00363521713063567,0.00313246894236629,-0.0097748562576736,0.00250442199640227,0.245865163657154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39099,-0.0039798164752721,0.00342964773809105,-0.0107019260419306,0.00274229309138635,0.245897848048707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36421,-0.00736175460153605,0.00634419473328824,-0.019796376278781,0.00507286707570891,0.24591118158858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36363,0.00828166615441896,0.00716532338898114,-0.00576236768798407,0.022325699996822,0.247785893218124
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36421,-0.00692567706150032,0.0060036581501044,-0.0186928470357049,0.0048414929127043,0.248695916173071
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,36391,0.00426986417991321,0.00372511072037754,-0.00303135283202676,0.0115710811918532,0.251718496411527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36420,0.00274831279937534,0.00240772423482869,-0.00197082670088889,0.00746745229963957,0.253701710484077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39147,-0.00358911586504202,0.00314802439122691,-0.00975924367184676,0.00258101194176273,0.254255457132627
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,36430,0.00569484441472399,0.00499493552790336,-0.00409522921996661,0.0154849180494146,0.254256489502441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36430,-0.0027431106119355,0.00241391813262476,-0.00747439015188003,0.00198816892800903,0.255822289456997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,36430,-0.00516636398919414,0.00454961582709288,-0.0140836110102962,0.00375088303190791,0.256162202164646
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,36363,-0.00448622800584495,0.00395493385724713,-0.0122378983660493,0.00326544235435942,0.256674940619075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,36767,0.00841466646696761,0.00742738711888993,-0.00614301228605665,0.0229723452199919,0.25726713895281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,36421,-0.00464780761065209,0.00412288708500497,-0.0127286662972618,0.00343305107595766,0.259629302654289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,36767,-0.00304433073820812,0.00270577767858867,-0.0083476549882419,0.00225899351182567,0.2605581450993
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,36420,-0.00904012609114351,0.00806684729490103,-0.0248511467891495,0.00677089460686251,0.262457578213968
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39147,0.00282438019261464,0.00252082228087541,-0.00211643147790116,0.00776519186313045,0.262552344345167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36430,-0.00927282497266674,0.00828210987199249,-0.025505760321772,0.00696011037643853,0.262896652625848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39093,0.00375239467282189,0.00335772201863235,-0.00282874048369752,0.0103335298293413,0.263780366950059
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,39058,0.00657712958107682,0.00590038433503581,-0.00498762371559337,0.018141882877747,0.264998722670051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,38992,0.00237535099389072,0.00213486065050277,-0.00180897588109469,0.00655967786887614,0.265876796615025
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,36500,-0.00344705697075777,0.0031157209633602,-0.00955387005894375,0.00265975611742822,0.268599017960384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,36421,-0.00496788782768698,0.00449220382402137,-0.0137726073227689,0.0038368316673949,0.268794876130337
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,38727,0.00475953916994062,0.00431147404741548,-0.00369094996299372,0.013210028302875,0.269644024865927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,38832,-0.00221463734848726,0.00201491552964682,-0.00616387178659503,0.00173459708962052,0.271732666699748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,36806,0.00262864536541841,0.00239464349324954,-0.0020648558813507,0.00732214661218751,0.272347680521241
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36391,-0.00572714031026971,0.00522570500358098,-0.0159695221172884,0.00451524149674901,0.273119296996712
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,39093,-0.0034043275233803,0.00312688074575309,-0.00953301378505636,0.00272435873829577,0.276290382792769
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,38727,0.00755827835656829,0.00694412854717295,-0.0060522135958907,0.0211687703090273,0.276417850429171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36391,-0.00400294799970071,0.00368326073423574,-0.0112221390388027,0.00321624303940134,0.277148484266564
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,36430,0.00310407519559854,0.00285810837545851,-0.00249781722030015,0.00870596761149722,0.27747358195254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,38841,-0.00379708860966855,0.00349769986718256,-0.0106525803493464,0.00305840313000927,0.277675285992118
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,36538,-0.00228846452303973,0.0021084252290077,-0.00642097797189481,0.00184404892581535,0.277769415974404
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36430,0.00218840466699638,0.00202204044518529,-0.00177479460556679,0.00615160393955955,0.27915092672721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36363,0.00626806593629476,0.00579163918564122,-0.00508354686756202,0.0176196787401515,0.279157387018283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,36743,-0.00992791744127406,0.00917476115645569,-0.0279104493079272,0.0080546144253791,0.279232785435422
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,36796,0.00247906757610547,0.00229317312071795,-0.00201555174050171,0.00697368689271265,0.279688669002849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,36538,0.00422339577331974,0.0039083853047406,-0.00343703942397183,0.0118838309706113,0.279896251097094
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,38841,-0.0143893431085288,0.0133275815315381,-0.0405114029103434,0.0117327166932859,0.280308105060561
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,36538,0.00307762308094732,0.00285444801891488,-0.00251709503612584,0.00867234119802049,0.280971711113825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39099,0.00410584813834635,0.00380907383233505,-0.00335993657303034,0.011571632849723,0.281089887216926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36420,0.0257009241721324,0.0238678174954194,-0.0210799981188897,0.0724818464631544,0.281589215796818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,39198,0.0113885899890258,0.0105813882155838,-0.00935093091351844,0.03212811089157,0.281816719352243
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,39106,-0.00660344645945927,0.00613880278126164,-0.0186354999107321,0.00542860699181354,0.282083111247888
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,36391,0.00640374291237954,0.00595696076281287,-0.00527190018273369,0.0180793860074928,0.282394667736457
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,36391,0.00825540481819675,0.00768895343330867,-0.00681494391108825,0.0233257535474817,0.282990925479492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,36339,0.00528185671576767,0.00494215850360225,-0.00440477395129274,0.0149684873828281,0.285209864351588
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,36767,-0.00986682222231011,0.0092332488302213,-0.0279639899295439,0.00823034548492364,0.285261510720077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,36538,-0.0052053912514756,0.00487715759622669,-0.0147646201400799,0.00435383763712871,0.285856623149676
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,36339,0.00305775305195392,0.00287025149568099,-0.00256793987958081,0.00868344598348865,0.286749120207267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,38741,-0.00727553896237156,0.0068387754235995,-0.0206795387926266,0.00612846086788345,0.287406782044037
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39106,-0.00481781374578664,0.00454099255548384,-0.013718159154535,0.00408253166296169,0.288724657692792
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,36421,-0.00646650816863115,0.00610609911245886,-0.0184344624290505,0.00550144609178822,0.289609015275079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36339,0.00495269262698673,0.00468433217166581,-0.00422859842947825,0.0141339836834517,0.290400202780726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39283,-0.00419535637046023,0.00397535945345707,-0.0119870608992361,0.00359634815831563,0.291286324013372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,36731,-0.00437921730395814,0.00417277062028717,-0.012557847719721,0.00379941311180471,0.293979386394781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,39001,-0.00513159712627766,0.00489005293283581,-0.0147161008746358,0.00445290662208052,0.294013105274233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,36339,0.00432671945102726,0.00412993456465143,-0.00376795229568954,0.0124213911977441,0.294820907153131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39093,0.00462419099763916,0.00443065046433809,-0.0040598839124635,0.0133082659077418,0.296649012847769
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36391,-0.00320060852518058,0.00308910595708267,-0.00925525620106262,0.00285403915070146,0.300177623219757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,36767,-0.00228625475452915,0.00220971357227146,-0.0066172933561812,0.00204478384712291,0.300857147549621
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39099,-0.00885719151387658,0.00858803647224748,-0.0256897429994816,0.00797535997172848,0.302397448060318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39218,-0.00268549626358237,0.00260807542559149,-0.00779732409774168,0.00242633157057695,0.303174093381544
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,36430,-0.00382350608712763,0.00372843774305019,-0.011131244063506,0.00348423188925074,0.305147921683171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36500,-0.00907792065873399,0.00885376363386219,-0.0264312973811039,0.0082754560636359,0.305232922993945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,38727,-0.00518092989101919,0.00506299500190349,-0.01510440009475,0.00474254031271165,0.306185744677189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38294,-0.00339454341150538,0.00332373365749981,-0.00990906138020501,0.00311997455719425,0.307127415932933
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,36747,-0.0068554184880225,0.00673880468087518,-0.0200634756625379,0.00635263868649285,0.309027542021572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,36767,-0.00653972497672075,0.00644024295384587,-0.0191626011662586,0.00608315121281715,0.309911863114539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,36311,0.00332471507644804,0.00327565244508616,-0.00309556371592084,0.00974499386881692,0.310136050177173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36391,-0.00467915702783081,0.00461020380294957,-0.013715156481612,0.00435684242595034,0.310146086057821
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,36792,-0.00989141166768167,0.00975674490212695,-0.0290146316758505,0.00923180834048716,0.310696003765814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,36767,0.0044815799989147,0.00442145419041027,-0.00418447021428943,0.0131476302121188,0.310793302119274
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,38727,-0.00319372243636179,0.00315352802494729,-0.00937463736525849,0.0029871924925349,0.311198050502952
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,36430,0.00256883104847544,0.00253653338990023,-0.002402774395729,0.00754043649267989,0.311207207835979
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,36796,-0.00571044241598781,0.00564165674550392,-0.0167680896371755,0.00534720480519987,0.311464972449742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36339,-0.00623818238051366,0.00619035134932683,-0.0183712710251942,0.00589490626416692,0.313605219145479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,36391,-0.00444693811384524,0.00441559606635574,-0.0131015064039025,0.00420763017621201,0.313907112224745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,39131,-0.00349477168419131,0.00348852695842797,-0.0103322845227101,0.0033427411543275,0.316460864807831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,38987,-0.005335410708084,0.00532891256037858,-0.015780079326426,0.00510925791025803,0.316736758126962
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,36591,-0.00316933745720885,0.00316918172581501,-0.00938093363980628,0.00304225872538857,0.317305734879754
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,36339,-0.00669257718609184,0.00670924332137367,-0.0198426940959842,0.00645753972380055,0.318533480169616
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,39046,0.00429879381022588,0.00431026258248806,-0.00414932085145072,0.0127469084719025,0.318615786354887
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,36421,0.00427131954108919,0.004284934141134,-0.00412715137553346,0.0126697904577118,0.318869788670382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36500,-0.00230909985889135,0.00232353390132105,-0.00686322630548062,0.00224502658769791,0.320345165429876
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,38841,0.00482517982906569,0.00486970988647271,-0.00471945154842082,0.0143698112065522,0.32177204666615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,39035,-0.00734630514117417,0.00742657951368036,-0.0219024009879877,0.00720979070563934,0.322585504037179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,39079,0.00465108590168677,0.00470658848503655,-0.00457382752898486,0.0138759993323584,0.323066760646837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",36767,-0.00592401868261044,0.00601794971731568,-0.0177192001285492,0.00587116276332829,0.324941496895104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,36792,-0.00668256939984914,0.00678919300314445,-0.0199893876860123,0.00662424888631397,0.324988853045795
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36421,0.00614137671478823,0.00625022579350527,-0.0061090658404821,0.0183918192700586,0.32583076485317
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,36538,0.00779447941971715,0.00794952101623412,-0.00778658177210173,0.023375540611536,0.326859689104015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39095,-0.00271287257835768,0.0027698262448226,-0.00814173201820997,0.00271598686149461,0.327379250390763
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,36430,-0.00233610664380717,0.00238986584814099,-0.0070202437061635,0.00234803041854917,0.328337843953837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39283,-0.00248200357801989,0.00254079750354565,-0.00746196668496937,0.00249795952892958,0.328653763440376
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,38727,-0.00365984501721328,0.00375093831372985,-0.0110116841121238,0.00369199407769722,0.3292218248625
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36339,0.00754960040142191,0.00773972086829118,-0.00762025250042881,0.0227194533032726,0.329363067282804
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36339,0.00291989470689306,0.00299846857204127,-0.00295710369430783,0.00879689310809395,0.330177045278342
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,36339,0.00321572114680412,0.0033053278561304,-0.00326272145121147,0.0096941637448197,0.330626723263733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36500,-0.00325921013754454,0.00335760172184422,-0.00984010951235921,0.00332168923727013,0.331718321184546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,36791,0.00231916701113433,0.00238965185806664,-0.00236455063067629,0.00700288465294495,0.331813416805856
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36391,0.00284960504857077,0.00294168359422521,-0.00291609479611065,0.00861530489325218,0.332714241537083
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,38951,0.00270464455952112,0.00279764604258079,-0.00277874168393724,0.00818803080297947,0.333680898651858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36420,0.00309793261011917,0.00320700460540839,-0.00318779641648127,0.00938366163671961,0.334068059885841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,38832,-0.00511088317810733,0.00529443989784094,-0.0154879853778756,0.00526621902166091,0.334394998968259
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,36791,0.00397665071254754,0.00412011696697222,-0.00409877854271801,0.0120520799678131,0.334473171932598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,38741,-0.004807577489393,0.00498748127024338,-0.01458304077907,0.00496788580028402,0.33509722145306
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,39106,-0.00355025859250703,0.00369943546779869,-0.0108011521093925,0.00370063492437841,0.33723363872667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,36791,0.0120079741658674,0.0125459238121009,-0.0125820365058503,0.0365979848375852,0.338523796363331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,39139,-0.0026072846487314,0.0027348852314126,-0.00796765970230009,0.00275309040483728,0.340431215564139
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39100,0.00840723337800087,0.0088329722997616,-0.00890539232953186,0.0257198590855336,0.341212922669493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36363,-0.00518512841360919,0.00545519413710822,-0.0158773089223413,0.00550705209512292,0.341879755758198
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36363,-0.0102573127397788,0.0107924682495855,-0.0314105505089664,0.0108959250294088,0.341920312327818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,36792,0.00237672901847696,0.00250254671100562,-0.00252826253509405,0.00728172057204797,0.342270189257345
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,36421,0.00317493102837492,0.00334495389249839,-0.00338117860092192,0.00973104065767176,0.342552244213949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,36363,-0.00652111674253906,0.00688559085738739,-0.0200168748230183,0.00697464133794023,0.343622878071429
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39099,-0.00287951013938039,0.00304418367785201,-0.00884611014797033,0.00308708986920955,0.344211776341391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,38909,0.00333729443055801,0.00352824134398122,-0.00357805860364518,0.0102526474647612,0.34422476408316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,36363,-0.00743070020208641,0.00788199860670081,-0.02287941747122,0.00801801706704718,0.34583051134621
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,36538,-0.00307916520654084,0.00326792717986465,-0.00948430247907555,0.00332597206599386,0.34608875078975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,36538,0.00367737907290942,0.00390870294416824,-0.00398367869766033,0.0113384368434792,0.346815930845346
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36108,-0.00949472878172483,0.0100958728472885,-0.0292826395624103,0.0102931819989606,0.347002023034001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39093,-0.00263575226404942,0.00280901983694341,-0.00814143114445851,0.00286992661635967,0.348096183700778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36391,0.00415173356411756,0.0044251627734127,-0.00452158547177134,0.0128250526000065,0.348154397183911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,38960,-0.00201637406764395,0.00215136487346366,-0.00623304921963273,0.00220030108434482,0.348643211146847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,36779,-0.00126182246137756,0.001347062865503,-0.00390206567776345,0.00137842075500833,0.348919453356266
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36391,-0.00759793386490478,0.00811231236279058,-0.0234980660959743,0.00830219836616475,0.348986073895951
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,39025,-0.00630655878301865,0.00673721647240019,-0.019511503068923,0.00689838550288573,0.349248037403129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,36767,-0.00364829979160906,0.00389769786566297,-0.0112877876083085,0.00399118802509035,0.349283488999131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,36538,-0.00304461876974985,0.00325514055755281,-0.00942469426255335,0.00333545672305366,0.349637949211472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39162,-0.00765427948804932,0.00819371349335587,-0.0237139579350268,0.00840539895892818,0.350233582587916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,38727,-0.00761183647973597,0.00814832190100716,-0.02358254740571,0.00835887444623808,0.350236531476727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,36767,-0.00519422301953938,0.00556369645457907,-0.0160990680705144,0.0057106220314356,0.350531809717299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36421,0.00898905103622914,0.00963975285409707,-0.00990486455780112,0.0278829666302594,0.351097101103223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,38727,0.00401210285236365,0.00430637110913375,-0.00442838452153851,0.0124525902262658,0.351523894627001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,36421,0.00508122595838928,0.00545773604224214,-0.0056159366844053,0.0157783886011839,0.351864471484733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,39114,0.00798537269586113,0.00858941582390246,-0.0088498823189877,0.02482062771071,0.352553639134308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36311,0.00674196582624057,0.00731258389035828,-0.00759069859886167,0.0210746302513428,0.356563311139245
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,36796,-0.00193666712640465,0.00210102615407916,-0.00605467838839981,0.00218134413559051,0.356664694365665
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36421,-0.00438950841360002,0.00476558340080971,-0.013730051879187,0.004951035051987,0.357023627975264
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,38951,-0.00274035771518864,0.00297997975089499,-0.00858111802694282,0.00310040259656554,0.357802079715936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39147,-0.0030815868145222,0.00336161936991656,-0.00967036077955867,0.00350718715051426,0.359315833602287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,38841,-0.00418870064724279,0.00458770549096705,-0.0131806034095382,0.00480320211505262,0.36124284335849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,38832,-0.00231107191481164,0.00253504971391267,-0.00727976935408047,0.00265762552445719,0.361968949326306
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,38741,-0.00480583487901858,0.00527900746184872,-0.0151526895042421,0.00554101974620491,0.362643671106336
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,36731,0.00703948028509313,0.00776923765173624,-0.00818822551230989,0.0222671860824962,0.364915278601357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,38741,0.00614336855775743,0.00678396888348996,-0.00715321045388289,0.0194399475693977,0.365177385760827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36339,-0.00499589761697544,0.00551958487671101,-0.015814283975329,0.00582248874137814,0.36541824056284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,36743,-0.0122652000574814,0.0135557554446891,-0.038834480729072,0.0143040806141092,0.365590126667322
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,36466,-0.00257638263713022,0.00284803288369345,-0.0081585270891694,0.00300576181490895,0.365684929941066
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,36731,0.00432123238538267,0.00477967788530594,-0.00504693626981697,0.0136894010405823,0.365967551427798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,39023,-0.00693216931327532,0.00768136547351563,-0.0219876456413659,0.0081233070148153,0.366823838724908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39092,-0.00794558828417134,0.00880626406234171,-0.0252058658463611,0.00931468927801841,0.366930112495391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,36363,-0.00538114538011583,0.00597324389794755,-0.017088703420093,0.00632641265986138,0.367672200558491
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,36737,0.00388658746641491,0.00432558444830709,-0.00459155805226699,0.0123647329850968,0.368929705258518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,38913,0.0097811523460696,0.0109126556565655,-0.0116076527407988,0.031169957432938,0.370100087372977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,36791,-0.00490597910414983,0.0054741028812784,-0.0156352207514555,0.00582326254315582,0.370154044952492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",38741,-0.00226350357417321,0.00253084342294526,-0.00722395668314592,0.0026969495347995,0.371139872285043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,36538,-0.0048629851406177,0.00543854830798985,-0.0155225398242778,0.00579656954304241,0.371248072275785
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,39130,-0.0041573040458898,0.00465753230124026,-0.0132860673563207,0.00497145926454112,0.372086553117475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36421,-0.00651215510030524,0.0073088892985101,-0.020837578125385,0.00781326792477455,0.372951026471195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,38987,0.0084591883002766,0.00950388212146184,-0.0101684206577886,0.0270867972583418,0.37343861718959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36421,-0.00547461728854052,0.00615904451899825,-0.0175463445457771,0.00659710996869605,0.374087581542687
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",36731,-0.00300226495322095,0.00338521586695429,-0.00963728805245135,0.00363275814600946,0.375162513944159
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39291,0.00607836191913963,0.00686551851977952,-0.00737805437962822,0.0195347782179075,0.37598364186589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,39035,0.00290515637934707,0.00328827717235475,-0.00353986687846824,0.00935017963716238,0.376986173694638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,38727,-0.00664551149098085,0.00753131667585282,-0.0214068921756524,0.00811586919369068,0.377583583811507
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36391,-0.00329383993880384,0.00375855427839165,-0.0106606063244515,0.00407292644684379,0.38085212250932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,39023,-0.00152896624600948,0.00174472679946371,-0.00494863077295835,0.00189069828093939,0.380861487426829
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36339,-0.0034057878940274,0.00388710520641343,-0.0110245140985977,0.00421293831054293,0.380951282214894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,38922,0.00257529459326505,0.00296029043148766,-0.00322687465245077,0.00837746383898086,0.384343451251204
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,38962,0.00473879324408883,0.00546417058931221,-0.0059709811109631,0.0154485675991408,0.385819697290988
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36430,-0.00333196990888408,0.00385176334181804,-0.0108814260588474,0.00421748624107928,0.387027565244658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39099,-0.011931136861761,0.013801572568032,-0.0389822190951038,0.0151199453715818,0.387339723239971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,36743,0.00912938532485776,0.0105724481676379,-0.0115926130837126,0.0298513837334281,0.387874726984319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,38741,0.00299557939263063,0.00347033176421617,-0.00380627086523307,0.00979742965049433,0.388043165533911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,39023,-0.0104592085913108,0.0121573165397257,-0.0342875490091731,0.0133691318265515,0.389625093742025
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,36391,-0.00390369437786136,0.00453747587440249,-0.0127971470916902,0.00498975833596752,0.389627535378975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",36747,-0.00440053259583461,0.00512239631450446,-0.0144404293722634,0.00563936418059414,0.390314042964387
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,36421,0.00390643978965887,0.00455201673942938,-0.00501551301962271,0.0128283925989405,0.390810657585608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,39227,-0.00335616970749001,0.00391123858057038,-0.0110221973254079,0.00430985791042792,0.390859681837574
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,35989,0.00864396888464551,0.0100738295267155,-0.0111007369877169,0.0283886747570079,0.390875262348831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36363,0.00522933790586435,0.00611931069004098,-0.00676451104661597,0.0172231868583447,0.392809364658099
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39241,-0.00615450250651284,0.00721997393847854,-0.0203056514259308,0.0079966464129051,0.393990275569129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,38644,-0.0046229243796393,0.00544064096495738,-0.0152865806709558,0.00604073191167716,0.395504456696163
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,38960,-0.00259450754529533,0.0030649731294849,-0.00860185487908573,0.00341283978849508,0.397285871208932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39099,0.00279559542837219,0.00331029389119657,-0.00369258059837308,0.00928377145511747,0.398394506672609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36391,0.00525615987168604,0.00622635729587638,-0.00694750042823167,0.0174598201716037,0.398585521174341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,36430,0.0044813899745361,0.00531760406072579,-0.00594111398448645,0.0149038939335587,0.399386504915309
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36363,0.00645903293211589,0.00768882042135891,-0.00861105509374758,0.0215291209579793,0.40089354732769
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,36363,0.00748836688638843,0.00892533291680692,-0.0100052856305531,0.02498201940333,0.401484559776161
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,36731,-0.00473017926970044,0.00564489855442891,-0.0157941804363811,0.00633382189698023,0.402070711349783
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36430,0.00523167925611389,0.00624815506136193,-0.0070147046641555,0.0174780631763833,0.40243097213373
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36391,-0.00771461298756383,0.00927299884356369,-0.0258896907209487,0.010460464745821,0.405456575925469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,36792,-0.00230675977878166,0.00278350017975695,-0.00776242013110528,0.00314890057354196,0.407274600334686
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,36538,-0.0034631226591943,0.00418125017916274,-0.0116583730103533,0.00473212769196467,0.407544226223621
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,39093,-0.00938747330610984,0.0113557381401843,-0.031644720060871,0.0128697734486513,0.408435816874628
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,36391,0.00272047934175013,0.00330866760122487,-0.00376450915665061,0.00920546784015087,0.410962756383283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36339,0.00350266729295047,0.00426363211146028,-0.00485405164551167,0.0118593862314126,0.411364730821326
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39283,-0.00238550954490291,0.00290781176160267,-0.00808482059764414,0.00331380150783833,0.412012401384033
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39023,-0.00170214799746858,0.0020776939795496,-0.0057744281973858,0.00237013220244864,0.412657436644562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,38727,-0.00228923178728255,0.00283519250925096,-0.00784620910541444,0.00326774553084933,0.419429207945319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,38998,0.00269961752693796,0.00334967396455487,-0.00386574344358958,0.0092649784974655,0.420293325976695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36500,-0.00210403664435357,0.00261522861099236,-0.0072298847218986,0.00302181143319145,0.421104587789179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,38741,-0.00350204172862457,0.00437134438077173,-0.0120698767149372,0.00506579325768801,0.423065658181413
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36066,0.0036112175625858,0.00452578937330766,-0.00525932960909721,0.0124817647342688,0.424932476847014
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36500,0.00156290689451621,0.00195911078493414,-0.0022769502439547,0.00540276403298712,0.425022786702628
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,38705,-0.00255350601329241,0.00320606290132593,-0.00883738929989123,0.00373037727330641,0.425776518530466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36339,-0.00441513417025049,0.00554881296595247,-0.0152908075835173,0.00646053924301636,0.42622746112916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39162,0.00478868289460424,0.00602498843212116,-0.00702029443235324,0.0165976602215617,0.426740044977386
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39147,-0.00578442990869342,0.00729094525584182,-0.0200746826101434,0.00850582279275654,0.427573585458815
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39291,0.00190553598751577,0.00240311554972155,-0.00280457048993846,0.00661564246497,0.427822658273375
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,36391,0.00274618188024339,0.00346598690617365,-0.00404715245585697,0.00953951621634376,0.428187239217574
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36421,0.00267643581776289,0.00338777220059396,-0.00396359769540127,0.00931646933092705,0.429526171091857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,36339,0.00581360218338547,0.00736283093572064,-0.00861754645062699,0.0202447508173979,0.429783481746641
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,39080,0.00915051075792175,0.0115963299950028,-0.0135782960322837,0.0318793175481272,0.430073576363476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36421,-0.00367399142837484,0.00466055550198309,-0.0128086802122617,0.00546069735551202,0.430526647635516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39147,-0.00297930944188211,0.00379379001297209,-0.0104151378673074,0.00445651898354318,0.43228273663601
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36421,0.00275439677365874,0.00351800555771423,-0.00414089411946115,0.00964968766677864,0.433675521085545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,36538,0.00571655668216882,0.00731658319927868,-0.00862394638841739,0.020057059752755,0.434631800856225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36339,-0.0036043788220818,0.00462550539920299,-0.0126703694045197,0.00546161176035605,0.435853128951479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,36512,0.00232038353574911,0.00297892381287517,-0.00351830713748622,0.00815907420898444,0.436033460293174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36430,-0.00431581380797562,0.00554121336616075,-0.0151765920056507,0.00654496438969944,0.436078512788499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36363,0.00405826090675574,0.00523681401466101,-0.00620589456197984,0.0143224163754913,0.438384776108315
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39023,-0.00499263671717671,0.0064807075490808,-0.0176948235133751,0.00770955007902166,0.441083840956648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36421,-0.0059385591079411,0.00772310460317601,-0.0210758441301661,0.00919872591428388,0.441946842440307
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,39165,-0.00214060235151313,0.00278623488092642,-0.00760162271812891,0.00332041801510265,0.442334025822409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39162,-0.00143546870584023,0.0018716623713355,-0.0051039269536578,0.00223298954197734,0.44312394997232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36391,-0.00288205089662283,0.00376400327099654,-0.0102594973077761,0.00449539551453039,0.44387658644829
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,36792,0.00241560153851036,0.00316295373588998,-0.00378378778383401,0.00861499086085472,0.445049840578728
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,36731,-0.00370411316215189,0.00485180381100208,-0.013213648631716,0.00580542230741219,0.445208628482962
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,36791,0.00330259262194193,0.00433806992578385,-0.00520002443259442,0.0118052096764783,0.44648903235933
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",36767,0.00254704378300718,0.00335021006772851,-0.0040193679497407,0.00911345551575506,0.447110740855316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36538,0.00252468617042138,0.00332137202890774,-0.00398520300623779,0.00903457534708055,0.447188920470798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,36806,0.00107276004244368,0.00141287774371135,-0.00169648033523058,0.00384200042011793,0.447703039198874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,38727,0.00660836314822146,0.00870825811337603,-0.0104598227539956,0.0236765490504385,0.447947350604117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,36430,-0.00286658303742012,0.00377780108225983,-0.0102710731586494,0.00453790708380915,0.447988400745104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36420,-0.00227338854788714,0.00300110367965201,-0.00815555176000508,0.0036087746642308,0.448754098438427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36339,-0.00253701098404226,0.00335183124487442,-0.00910660022399613,0.0040325782559116,0.449122293035741
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,38841,-0.00196940284210535,0.00260845571019517,-0.00708197603408788,0.00314317034987718,0.450256531083928
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39044,-0.00457166703571814,0.00607729489356206,-0.0164831650270998,0.00733983095566351,0.451910219261939
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36519,-0.00380582248435347,0.00506642283206553,-0.0137360112352019,0.00612436626649497,0.45255509417627
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,36743,-0.00173673734359028,0.00231691205973116,-0.00627788498066335,0.00280441029348279,0.453514522129524
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",38832,0.00300102349939372,0.00400683808360355,-0.00485237914446923,0.0108544261432567,0.453883747427385
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,36747,-0.016537035276505,0.0221297479094138,-0.059911341178956,0.026837270625946,0.454910453044539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,36430,0.0029495482621817,0.00394935095805822,-0.00479117961561242,0.0106902761399758,0.455171824034409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,36339,-0.00231893432912864,0.00310500204742741,-0.00840473834208636,0.00376686968382909,0.455175267471357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39093,-0.00166585111345314,0.00223467738427673,-0.00604581878663553,0.00271411655972926,0.456008292637519
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,39255,0.00114219230301024,0.00153388378724936,-0.0018642199199985,0.00414860452601898,0.456500320677168
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,36363,-0.00652265411488463,0.00876570793712779,-0.0237034416716551,0.0106581334418858,0.456823694338272
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,36430,0.00700684518560759,0.00947387564056446,-0.0115619510698988,0.0255756414411139,0.459558682723091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39291,-0.00287016404048771,0.00388462274881986,-0.0104840246281746,0.00474369654719923,0.460007679255345
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,38727,0.00336721718174031,0.00455936037163883,-0.0055691291466718,0.0123035635101524,0.460205065652624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,36747,-0.003466418512814,0.00470488057480254,-0.012687984439427,0.00575514741379898,0.461275169888348
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39023,-0.00391461993312269,0.00532143804703508,-0.0143446385053115,0.00651539863906608,0.461966081914047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36420,0.00246360560684471,0.00334934872100658,-0.00410111788632818,0.0090283291000176,0.462019761408071
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39033,-0.00177476533892355,0.00241355148216056,-0.00650532624395825,0.00295579556611116,0.462147756237268
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,38939,-0.00457294432470068,0.00623424264716441,-0.0167920599131429,0.00764617126374156,0.463252477919302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36538,-0.00353402791520544,0.00482316742385332,-0.0129874360659579,0.00591938023554706,0.46374318917283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,36538,0.00271546224501595,0.00371106873560546,-0.00455823247677076,0.00998915696680266,0.464353170946254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,39291,-0.000611579557961418,0.000836204363237388,-0.0022505401099067,0.00102738099398386,0.464560804795437
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,36421,-0.00183580794842173,0.00251655272971083,-0.00676825129865495,0.00309663540181149,0.465713666045913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,36391,0.00236880312406949,0.00326129591156663,-0.00402333686260111,0.00876094311074009,0.467645160649837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36420,0.00520651844798697,0.00720227977463597,-0.00890994991029953,0.0193229868062735,0.469755603212783
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,38832,-0.00215566973829114,0.00298293039323259,-0.00800221330902701,0.00369087383244473,0.469894880107496
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,36538,0.00495603472534024,0.00685985207481898,-0.00848927534130496,0.0184013447919854,0.470019122698871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,36363,0.00320595190649499,0.00446539337276758,-0.00554621910412946,0.0119581229171194,0.47279839183695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,38976,0.00190027005879023,0.00266098030539482,-0.00331525133978362,0.00711579145736408,0.475161496188216
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36420,0.00308645105282994,0.00433629222074836,-0.00541268169983684,0.0115855838054967,0.476619241289596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,36339,0.00269072983249836,0.0037813885965664,-0.00472079181677179,0.0101022514817685,0.476743219675421
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,38931,-0.00278791843127386,0.00392474091672044,-0.0104804106280459,0.0049045737654982,0.477501473559987
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,38741,-0.00191813627986086,0.00271226155986454,-0.00723416893719536,0.00339789637747365,0.479447567514068
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36500,-0.00554909795430266,0.00786783417373534,-0.0209700529348239,0.00987185702621861,0.480643317351985
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39075,-0.00628526943248907,0.00891846948873691,-0.0237654696304134,0.0111949307654353,0.480978147871611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36375,-0.00545302621279163,0.00776736435752619,-0.0206770603535429,0.0097710079279597,0.48266520774612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,36731,-0.00290036432589464,0.00414222593411529,-0.0110191271567606,0.00521839850497132,0.483818424847151
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,36796,0.00344399271125714,0.00492722152312484,-0.00621336147406755,0.0131013468965818,0.484581737068694
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,39093,0.00256528424757134,0.00367383191967287,-0.00463542631498749,0.00976599481013017,0.485026226382899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,39218,0.00464132645843105,0.00665798882203608,-0.00840833163275968,0.0176909845496218,0.48574677601206
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36391,0.00313147601692687,0.00452518542794402,-0.00573788742184341,0.0120008394556972,0.488943530917054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,36430,-0.00376058263235115,0.00547225567397614,-0.0144862037533444,0.00696503848864209,0.491963794570373
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,36731,0.00279745208353808,0.00410022392267364,-0.00523898680490226,0.0108338909719784,0.495081702920549
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36500,-0.00200632654931946,0.00294786756872053,-0.0077841469840117,0.00377149388537278,0.49613540105808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39106,-0.00549969969977037,0.0081097572353548,-0.0213948238810658,0.010395424481525,0.497681580627789
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,38841,-0.00310314247092089,0.00458637755595214,-0.0120924424805871,0.0058861575387453,0.49867030591652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,36806,0.00138909809938261,0.00205663440461674,-0.0026419053336662,0.00542010153243142,0.499419145079609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,36421,-0.00244628571939138,0.00362361795376225,-0.00954857690876539,0.00465600546998262,0.499627949008433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,36538,-0.00253055722378516,0.00375164294556352,-0.00988377739708965,0.00482266294951933,0.499993239349051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36430,-0.00185476946483113,0.00275413509743097,-0.00725287425579584,0.00354333532613358,0.50067408039037
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36363,0.00458083985205133,0.00682032472305113,-0.00878699660512889,0.0179486763092315,0.501821865898879
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,36339,-0.00334375693295695,0.00501513978219143,-0.0131734309060522,0.00648591704013825,0.504955310370517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,38741,0.00275496567057087,0.00414872145339839,-0.00537652837808997,0.0108864597192317,0.506667489298854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,36731,0.00298145622371141,0.00452427171399724,-0.00588611633572318,0.011849028783146,0.509913069682292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39147,-0.00443192563960367,0.00674157835105792,-0.0176454192076772,0.00878156792846986,0.510932502076769
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36363,0.00293128367249188,0.00447802332016981,-0.00584564203504095,0.0117082093800247,0.512741736089822
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,38706,-0.00528155700095193,0.00807312815606041,-0.0211048881868303,0.0105417741849265,0.51298379471822
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39123,-0.00724234996187652,0.0111377017047115,-0.0290722453031111,0.0145875453793581,0.515537089637151
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39241,-0.00168680934840493,0.00259545331240274,-0.00677389784071429,0.00340027914390443,0.515760490901359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36391,-0.003131234340113,0.0048247195168062,-0.0125876845930532,0.00632521591282715,0.516351425760312
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36538,-0.00422274907015723,0.00650866152538083,-0.0169797256599036,0.00853422751958919,0.516486413930757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,36747,0.00223912621855426,0.00345684461934366,-0.00453628923535931,0.00901454167246783,0.517166597541523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,38841,-0.00233921321884512,0.00363790454268383,-0.00946950612250543,0.00479107968481518,0.520226700019427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,36538,-0.00514901363187789,0.00801706283824439,-0.0208624567948369,0.0105644295310811,0.520718030586666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39023,-0.00562571310070019,0.00877697506190014,-0.0228285842220245,0.0115771580206241,0.521556643757516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,38841,0.00352306231491252,0.00551573313490204,-0.00728777462949548,0.0143338992593205,0.523008582927245
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39093,0.00150377904213922,0.00235535392356941,-0.00311271464805681,0.00612027273233526,0.523189470214401
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36469,0.00288216070259631,0.00451618695122211,-0.00596956572179903,0.0117338871269917,0.523365148148785
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,39099,0.00378858131835406,0.00595027470206426,-0.00787395709769189,0.0154511197344,0.524325302706384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,38832,0.00315745407549187,0.00496644340538256,-0.00657677499905794,0.0128916831500417,0.524944152791675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38336,-0.00170626487941412,0.00268852800211716,-0.00697577976356376,0.00356325000473552,0.525669025001741
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,38832,0.00633893631915799,0.0100036722726901,-0.0132682613353147,0.0259461339736306,0.52631180463405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,38741,-0.00403104240155966,0.00643402645148842,-0.016641734246477,0.00857964944335764,0.530983925766493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36421,0.00296665603244902,0.00474706087347283,-0.00633758327955773,0.0122708953444558,0.532017945025408
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,36631,0.00363925064483264,0.00588943859381961,-0.0079040489990538,0.0151825502887191,0.536633636719798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39076,-0.00374716704376644,0.00606736159557171,-0.015639195771087,0.00814486168355412,0.536852142284138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39165,-0.00155852496334294,0.00253807495601053,-0.00653315187712358,0.00341610195043769,0.539186197677751
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,39093,0.00436796691580837,0.00718521885676802,-0.00971506204345695,0.0184509958750737,0.54325618153824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36430,-0.0061018506240566,0.0100999806178518,-0.0258978126350461,0.0136941113869329,0.545758289437184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,36767,-0.00873985832591014,0.0145829569823227,-0.0373224540112626,0.0198427373594424,0.548970007751173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,36339,0.00231610383551444,0.00386749426388157,-0.00526418492169345,0.00989639259272233,0.549274320757726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,38832,-0.0043583403810724,0.00728024223700987,-0.0186276151656117,0.00991093440346694,0.549413222167292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,36796,-0.00257512941081733,0.00430689537925401,-0.0110166443541552,0.00586638553252052,0.549911446341888
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36430,0.0015153746163892,0.00256360281502743,-0.00350928690106456,0.00654003613384295,0.554456471474417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,36767,-0.00210620813303249,0.00356911311214211,-0.00910166983283103,0.00488925356676605,0.555119949202536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,36391,0.00210174319703188,0.00356625215530726,-0.00488811102737035,0.0090915974214341,0.555642308469602
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36339,0.002961903603966,0.00503547228840917,-0.00690762208131596,0.012831429289248,0.556403530304914
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,36391,0.00386453426216818,0.00657430455063646,-0.00902110265707929,0.0167501711814156,0.556660998622513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36320,0.00137779842218467,0.00234847036903012,-0.00322520350111436,0.00598080034548371,0.55742989289582
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36430,0.00161144021377599,0.0027474933931327,-0.0037736468367641,0.00699652726431607,0.557541452800489
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,36339,-0.00322631400873636,0.0055403457313655,-0.0140853916422127,0.00763276362474003,0.560354398139066
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,38733,-0.0059434618574601,0.010256704216979,-0.0260466021227389,0.0141596784078187,0.562280237651556
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36430,-0.00363596919297633,0.00627944936213914,-0.015943689942769,0.00867175155681638,0.562581495131812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39095,-0.0158144581994843,0.027362087983305,-0.0694441506467621,0.0378152342477936,0.563293108159534
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36421,0.00194598912240422,0.00337749065416965,-0.00467389255976831,0.00856587080457674,0.564514539277337
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,36538,0.00346824420454122,0.00605619229968483,-0.00840189270284105,0.0153383811119235,0.566873326468146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36421,-0.00445346443100983,0.00784667835607193,-0.0198329540089108,0.0109260251468912,0.570343600848161
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36363,-0.00380663637218471,0.0067117745319755,-0.0169617144548567,0.00934844171048727,0.570617047398804
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36430,-0.00315373787933454,0.00556848858514512,-0.014067975506219,0.00776049974754988,0.571163013872007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,36737,-0.000979169574018284,0.00173069150491645,-0.00437132492365452,0.00241298577561795,0.57156147741786
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36421,-0.00193466062277296,0.00342070998881437,-0.00863925220084913,0.0047699309553032,0.571694305415348
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36363,0.00314668242952489,0.00557607448438865,-0.00778242355987687,0.0140757884189266,0.572547462243586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39093,-0.00209491513108276,0.0037124972448185,-0.00937140973092702,0.00518157946876149,0.572566915680635
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36421,-0.00401497619586307,0.00712419985796296,-0.0179784079174705,0.00994845552574432,0.573057740059057
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,38727,0.00664151117571767,0.0117999077888448,-0.0164863080904182,0.0297693304418536,0.573549379346097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,38805,0.00198038784917173,0.00353420952812806,-0.00494666282595927,0.00890743852430274,0.575250374927452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,36391,0.00267688164861554,0.00478307416277963,-0.00669794371043255,0.0120517070076636,0.575723319096285
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,36747,-0.0013912980582006,0.00248767983662796,-0.0062671505379914,0.00348455442159021,0.575983521770859
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",38741,0.00256578163172847,0.00460412569970977,-0.00645830473970267,0.0115898680031596,0.577345341687336
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,36791,-0.00117003030195855,0.00211319490238553,-0.00531189231063419,0.0029718317067171,0.579808556429018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39117,0.00169698141296357,0.00307851080319075,-0.0043368997612903,0.00773086258721745,0.581480993941657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,38841,0.00393528804021699,0.0071405263059455,-0.0100601435194362,0.0179307195998702,0.581559521463631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36339,0.00154519805741014,0.00281349232918967,-0.00396924690780162,0.0070596430226219,0.582871185365177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,36538,0.00301759540994076,0.00550070198422868,-0.00776378047914745,0.013798971299029,0.583300839081208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39283,-0.00176140335397505,0.00323840667297492,-0.00810868043300589,0.00458587372505579,0.586510933536615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,39099,-0.00268776144786749,0.00494261626334191,-0.0123752893240176,0.00699976642828266,0.586591697406731
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36430,0.00140167196174311,0.00257788476015336,-0.00365098216815748,0.00645432609164371,0.586637280017817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36391,-0.00234490835534719,0.00431728240488814,-0.0108067818689279,0.00611696515823357,0.587039950694459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,36538,-0.0029516104490028,0.00543528699350793,-0.0136047729562783,0.00770155205827274,0.587107730054959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,39255,-0.00217942296657777,0.00401917722260972,-0.0100570103228928,0.00569816438973728,0.587650010492285
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39099,-0.00279135106693763,0.00514826238974009,-0.0128819453508282,0.00729924321695295,0.587693587085161
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36391,0.00199675251686092,0.00368823090724349,-0.00523218006133632,0.00922568509505816,0.588251938185866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,36743,-0.00127951040377154,0.00236754364920052,-0.00591989595620456,0.00336087514866147,0.588904394138711
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36421,0.00205471983959607,0.00380334616080392,-0.00539983863557961,0.00950927831477176,0.589041088653507
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36421,-0.0017707802472544,0.00328129978171018,-0.00820212781940635,0.00466056732489755,0.589442356029954
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,36747,-0.00111493019739986,0.00207811372097725,-0.00518803309051527,0.00295817269571555,0.591614920491325
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36430,0.00112485444290058,0.00209668372671009,-0.0029846456614512,0.00523435454725236,0.59162792680766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,39283,-0.00211022139786991,0.00393836010892594,-0.00982940721136476,0.00560896441562494,0.592096075610799
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39117,-0.00156846213898578,0.00294929983493503,-0.00734908981545844,0.00421216553748689,0.594866514898452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36391,0.00194741453485876,0.00366448870478384,-0.00523498332651757,0.00912981239623508,0.595131144880634
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36430,-0.00228013180861721,0.0042922417019227,-0.0106929255443857,0.00613266192715129,0.595274563691762
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,36391,-0.00336363101732182,0.00633925812110662,-0.0157885769346908,0.00906131490004716,0.595703139735441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,38741,-0.00696677607725369,0.0131659220370907,-0.0327719832699515,0.0188384311154441,0.596707793539203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,38692,0.00211028095786579,0.0040351330662884,-0.00579857985205948,0.0100191417677911,0.600998213794384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,39135,0.00174078989605283,0.00333441050574473,-0.00479465469520684,0.00827623448731251,0.601630374008201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36510,0.00311197757569568,0.00597334969210298,-0.00859578782082617,0.0148197429722175,0.602391939360488
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,38741,-0.00185508944526085,0.00356628508134234,-0.00884500820469184,0.00513482931417014,0.60294991255683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,36791,-0.00205880730676933,0.00396692996279563,-0.00983399003384876,0.0057163754203101,0.603774781352034
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,38667,0.00323834025330147,0.00624350340206335,-0.0089989264147427,0.0154756069213456,0.603996140434556
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,36363,0.00225388465693144,0.00434722613826655,-0.00626667857407099,0.0107744478879339,0.604143039584528
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,39123,0.00142158690140004,0.00274527908916073,-0.00395916011335498,0.00680233391615506,0.604584636684265
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36538,-0.00343500966393444,0.00666926970264475,-0.0165067782811182,0.00963675895324927,0.606526819115351
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,38841,0.00287930175513369,0.0056001018964693,-0.00809689796194614,0.0138555014722135,0.607153536911304
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,38727,0.0018981020271551,0.00370173191366824,-0.00535729252363465,0.00915349657794485,0.608126458963343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36517,0.00249321638450206,0.00487031961954519,-0.00705261006980651,0.0120390428388106,0.608715591750132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,36363,-0.00528875926640133,0.0103448429516399,-0.0255646514516155,0.0149871329188128,0.609187860861369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39023,-0.00161128497301928,0.00315795383652469,-0.00780087449260767,0.00457830454656911,0.609897278833851
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,38739,0.0026362671708205,0.00516702901364264,-0.00749110969591908,0.0127636440375601,0.60991228180759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39283,-0.00148867948021026,0.0029178862072527,-0.00720773644642555,0.00423037748600502,0.609924910341881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,36538,-0.00325053821787015,0.00637889742581765,-0.0157531771724727,0.00925210073673244,0.610356841623072
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,39106,0.00215006900265039,0.00422568726520693,-0.00613227803715519,0.010432416042456,0.610893258990979
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,36311,0.00189958516822565,0.00376643098067983,-0.00548261955390681,0.00928178989035811,0.61402703886975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36391,-0.00236806920710595,0.00469654875632669,-0.0115733047695063,0.00683716635529436,0.614119333888901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36363,0.00491418651152734,0.0097878409398468,-0.0142699817305724,0.0240983547536271,0.615626748925
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,39283,-0.00242271879394427,0.00483178756111845,-0.0118930224137364,0.00704758482584788,0.616087984483692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36538,0.00292634138027194,0.00588836074543199,-0.00861484568077477,0.0144675284413186,0.619218496334901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39162,-0.0012874089307702,0.00260629958220063,-0.00639575611188344,0.00382093825034304,0.621341197028339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36355,0.00157434124913705,0.00319087973450821,-0.00467978303049903,0.00782846552877314,0.621747246503148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,36791,0.00149798648347569,0.00303678556281273,-0.00445411321963727,0.00745008618658864,0.621822925294225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,36421,-0.00158747756138549,0.00322077383900656,-0.00790019428583834,0.00472523916306737,0.622101047752063
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,36767,0.00135640869139309,0.00275208955920163,-0.0040376868446421,0.00675050422742829,0.622116345300247
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,36363,-0.00353029025791881,0.00717116078614439,-0.0175857653987618,0.0105251848829242,0.622523039965705
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39106,0.00127730626757649,0.00260147735189894,-0.00382158934214543,0.00637620187729842,0.623438710842612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,39151,-0.00177082597636703,0.00361191265457753,-0.00885017477933899,0.00530852282660492,0.623947231218163
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,36421,0.0031894438560963,0.00653169665018221,-0.00961268157826084,0.0159915692904534,0.625344109144494
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,36421,0.00190928821872474,0.00395420137792506,-0.00584094648200837,0.00965952291945785,0.62921028667777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36363,-0.00274500119875362,0.0056934146811873,-0.0139040939738807,0.00841409157637349,0.629717650210846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36391,0.00288787142432988,0.00599905412476611,-0.0088702746602117,0.0146460175088715,0.630249316780874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,38741,-0.00307962078744128,0.00641348774427132,-0.0156500567662131,0.0094908151913305,0.631107324926253
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36339,0.0018563224938019,0.00386717926964032,-0.00572334887469312,0.00943599386229693,0.631221750552147
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36363,0.0026065310218818,0.00543284228886953,-0.00804183986430247,0.0132549019080661,0.631397208743565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,39023,-0.00314442413167878,0.00655552597231441,-0.015993255037415,0.00970440677405747,0.631476034118715
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,39019,0.00317009150969948,0.00661632173570692,-0.00979789909228609,0.0161380821116851,0.631851632654418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,36791,0.00131609453961289,0.0027476906376918,-0.00406937911026304,0.00670156818948881,0.63195948599724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36339,0.00282084041637198,0.00589080305567418,-0.00872513357274942,0.0143668144054934,0.632050185949361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39069,0.00196777413867563,0.00411597383291635,-0.00609953457384041,0.0100350828511917,0.632598517780143
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36339,0.00174789406426809,0.00368307749275613,-0.00547093782153392,0.00896672595007009,0.635098704944653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39216,-0.00176800939475573,0.00373306884552566,-0.00908482433198603,0.00554880554247457,0.635786560667372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39059,-0.00142705774785906,0.00303432228981282,-0.00737432943589218,0.00452021394017406,0.638143684884072
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36363,0.00268801537406499,0.0057258251026097,-0.00853460182705003,0.01391063257518,0.638752860303629
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,38741,0.00213268871628419,0.00455150638962599,-0.00678826380738275,0.0110536412399511,0.639385558628591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,36767,-0.00334937734447267,0.00716180239293873,-0.0173865100346326,0.0106877553456872,0.640026774122255
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,36102,0.00301211761883034,0.00646019457732294,-0.00964986375272264,0.0156740989903833,0.641039110213069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39283,0.000926948741536186,0.00199181937267107,-0.00297701722889912,0.00483091471197149,0.641667419628875
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36391,0.00276724859764182,0.00597211096023483,-0.00893808888441846,0.0144725860797021,0.643113040949308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,39128,-0.00120201355998532,0.00259647162720433,-0.00629109794930581,0.00388707082933516,0.64341314892199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36430,-0.00142632424359724,0.0030829586437587,-0.00746892318536429,0.0046162746981698,0.643624799901989
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,36500,0.00186657939312601,0.00404591875114257,-0.00606342135911343,0.00979658014536544,0.644556382391863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",36747,-0.00107202817457668,0.0023432439851745,-0.00566478638551869,0.00352073003636533,0.647321239108105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,36538,0.0017442553635678,0.00383066446284817,-0.0057638469836146,0.00925235771075021,0.648872337162999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,39022,-0.00119854161564628,0.00263440685543117,-0.00636197905229138,0.00396489582099881,0.649146749545762
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,36339,0.00223874912960212,0.00493750416636095,-0.00743875903646534,0.0119162572956696,0.650256264352242
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36421,0.00170925574686621,0.0037840490470474,-0.00570748038534669,0.00912599187907911,0.651492766294223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,38841,-0.00197909574424813,0.00438363527947621,-0.0105710208920215,0.00661282940352525,0.65165475990675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,36806,0.00079775855866486,0.00177222112218206,-0.00267579484081197,0.00427131195814169,0.652612581741871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,36743,-0.00207650021066326,0.00461420653727826,-0.0111203450237286,0.00696734460240212,0.652701249911947
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,38645,0.00269986440696643,0.00601130977327035,-0.00908230274864346,0.0144820315625763,0.65334388147539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,38727,-0.00686357237308276,0.015289387425841,-0.0368307717277311,0.0231036269815655,0.653502489825966
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36430,0.00155803849201533,0.00347170833625004,-0.00524650984703475,0.00836258683106541,0.653597018125246
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39147,0.00099185343667204,0.00221344002293698,-0.00334648900828443,0.00533019588162851,0.654083804272018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,38841,-0.00474495225567315,0.0106107343730876,-0.0255419916269248,0.0160520871155785,0.654748567876308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,39034,-0.00133421077228332,0.00298858855663107,-0.00719184434328022,0.00452342279871358,0.655289368049546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,39283,0.000797561379608416,0.00180258085690514,-0.00273549709992566,0.00433061985914249,0.658166004152281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,38741,-0.00263534184627208,0.00595760206222412,-0.0143122418882314,0.00904155819568721,0.658242799477819
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39266,0.00108996339843821,0.00246498132035775,-0.00374139998946298,0.00592132678633939,0.658365763882523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,36767,-0.00104706831700866,0.00237111663575084,-0.0056944569230803,0.00360032028906297,0.658791206487196
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,39147,-0.00153934207754644,0.00353601781293908,-0.00846993699090704,0.00539125283581415,0.663327530542246
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,36538,-0.00273360589984815,0.00632234063740102,-0.0151253935491542,0.00965818174945786,0.66547809333881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,36430,-0.00186308086322182,0.0043243362749809,-0.0103387799621844,0.00661261823574075,0.666594820486336
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36339,0.0013356548440455,0.00311173810536546,-0.00476335184247081,0.0074346615305618,0.667762445050633
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,36363,0.0013700659643264,0.00320203684609207,-0.00490592625401405,0.00764605818266685,0.668750760956832
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39255,-0.0023658135847472,0.00553571215270737,-0.0132158094040536,0.00848418223455925,0.669113689928392
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36339,0.00160764285167279,0.00376858200334571,-0.00577877787488481,0.00899406357823038,0.669684673462807
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36391,-0.00382497810043873,0.00900458952938508,-0.0214739735780335,0.013824017377156,0.671003658756867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36363,-0.00191661092515292,0.00451806730831703,-0.0107720228494543,0.00693880099914846,0.671419709974724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36339,-0.00213159027207652,0.00502897471539655,-0.0119883807142538,0.00772520017010071,0.671673910725706
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,36391,0.00165713459130277,0.0039274701586917,-0.00604070691973296,0.0093549761023385,0.673080170726249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,38727,-0.00139008340421539,0.00331168828346056,-0.00788099243979809,0.00510082563136731,0.67467366429041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,36421,0.00234741734987257,0.00560508457855038,-0.00863854842408619,0.0133333831238313,0.675368431715009
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36363,0.00132413806137935,0.00316619311577824,-0.00488160044554599,0.00752987656830469,0.675799742748488
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,38741,0.00173001286920712,0.00414201128914565,-0.00638832925751836,0.00984835499593259,0.676191078639418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36538,-0.00263922326615085,0.00634802287104307,-0.0150813480933953,0.00980290156109357,0.677596210004295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,38713,0.00197628264723154,0.00476404859228776,-0.00736125259365247,0.0113138178881156,0.678270446825049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36421,-0.00385701144226632,0.00930973348819808,-0.0221040890791346,0.0143900661946019,0.678662364607699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,38832,-0.00103418490408532,0.00249854379178214,-0.00593133073597832,0.00386296092780768,0.678942243028557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",38741,0.00116203932996594,0.00281361347170776,-0.00435264307458127,0.00667672173451316,0.679608146378206
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,36531,-0.00375884471843183,0.00910214739259506,-0.0215990536079182,0.0140813641710545,0.679641142584709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36500,0.0020128365287171,0.00487487615734286,-0.00754192073967491,0.0115675937971091,0.679686860086541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,39023,0.00160650469880242,0.00390086616357557,-0.0060391929818057,0.00925220237941054,0.680467787716295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,36747,-0.00135437506433065,0.00330048191524581,-0.00782331961821243,0.00511456948955114,0.68155108276479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,38727,0.00213109700734497,0.00523395907450988,-0.0081274627786944,0.0123896567933843,0.683890975539842
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,38741,-0.00250650594880715,0.0062056436382175,-0.0146695674797134,0.00965655558209914,0.686286552017158
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36339,-0.00216623580132115,0.00536501658861187,-0.0126816683150004,0.00834919671235811,0.686388359189316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36421,0.00161871538526107,0.00401931000117305,-0.0062591322170381,0.00949656298756024,0.687150298280358
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,36538,0.00108752176671649,0.00270826633005886,-0.00422068024019888,0.00639572377363187,0.688017266856029
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,36743,0.00423022407737929,0.0106098846235003,-0.0165651497846813,0.0250255979394399,0.690116494601489
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,36339,-0.00168499299157243,0.00424228926325815,-0.0099998799475584,0.00662989396441353,0.691234475650643
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,36767,0.00130615096044664,0.00329373361764034,-0.00514956693012844,0.00776186885102171,0.691701207019572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,38987,0.00129966851884821,0.00328282843869091,-0.00513467522098596,0.00773401225868239,0.692185117188146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39023,-0.00317027151239331,0.00801507693018005,-0.0188798222955462,0.0125392792707596,0.692451078277469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,39255,-0.00215111777846987,0.00547394888047532,-0.0128800575842015,0.00857782202726176,0.694344370008023
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,36806,0.00067864477235532,0.00172999304816957,-0.00271214160205704,0.00406943114676768,0.694856473693209
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,36767,0.00121564403343018,0.00310088257822742,-0.00486208581989557,0.00729337388675593,0.695041320299542
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36339,-0.00206209339276749,0.00526849609253712,-0.0123883457341403,0.00826415894860527,0.69550771083122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,36731,-0.00124380387854216,0.00319312729155386,-0.00750233336998772,0.00501472561290341,0.696894040693297
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39023,0.000943246781755397,0.00242362958005139,-0.00380706719514533,0.00569356075865613,0.697142779127114
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36391,0.00123988359719576,0.00319166984683962,-0.00501578930260989,0.00749555649700141,0.697671231377858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,36723,0.00202820267810569,0.00524007773575906,-0.00824234968398208,0.0122987550401935,0.698721273970432
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,36584,0.00117868968505096,0.00304533268378926,-0.00479016237517599,0.00714754174527791,0.698727204344511
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,39098,0.000774724337660978,0.00201888142113717,-0.00318228324776788,0.00473173192308984,0.701176963857782
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,38727,0.00108330847957264,0.00283387126396824,-0.0044710791978051,0.00663769615695039,0.702265388015255
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,38741,0.00137601021638567,0.00360176695279155,-0.00568345301108576,0.00843547344385711,0.702438968989949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,38741,-0.00226915562309788,0.00601616429912779,-0.0140608376493884,0.00952252640319259,0.706047842699945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39095,-0.00327624305409208,0.00869512165033966,-0.0203186814887578,0.0137661953805736,0.706334222317071
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,36538,0.00207357383938887,0.0055107319464904,-0.00872746077573232,0.0128746084545101,0.706715633273681
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,38727,0.00307834299214082,0.00819401711388044,-0.0129819305510648,0.0191386165353465,0.707158839539605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,36806,-0.0010612691283712,0.00282915233248351,-0.00660640770003887,0.00448386944329647,0.707578024290105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36391,0.00176884403632345,0.00472001013057041,-0.00748237581959456,0.0110200638922415,0.707849555312068
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,36731,0.00380813684398278,0.0101633255006904,-0.0161119811373704,0.023728254825336,0.707894245853846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,36286,0.00118388732022586,0.00318027637058905,-0.00504945436612867,0.0074172290065804,0.709706178419329
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,36731,0.00203510413523484,0.00554577110847164,-0.00883460723736958,0.0129048155078393,0.713651125781162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39054,-0.000865310658377383,0.00236229438242749,-0.00549540764793527,0.00376478633118051,0.714145626694
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,39283,0.00057491532619454,0.0015713018777838,-0.0025048363542617,0.00365466700665078,0.714456126989488
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36339,-0.00163430393385953,0.00446947811256701,-0.0103944810344909,0.00712587316677181,0.714625902332008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,38987,-0.00130173240966424,0.00356794499478013,-0.0082949045994333,0.00569143978010483,0.715235242202018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,36796,0.00205473170351298,0.0056398516064321,-0.00899937744509394,0.0131088408521199,0.715622245887078
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39099,0.00146888374218798,0.00405542953095001,-0.00647975813847405,0.00941752562285001,0.717206281661864
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,38841,0.0010113232789884,0.00280620190049322,-0.00448883244597831,0.00651147900395512,0.718561603504173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,36791,-0.00100081319065526,0.00279412293851362,-0.00647729415014196,0.00447566776883144,0.720210647376754
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,36747,0.00130651251977985,0.00364984191564723,-0.00584717763488872,0.00846020267444843,0.720376013141476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,36538,0.00242549561837405,0.00678551906402333,-0.0108741217471117,0.0157251129838598,0.720759596310666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36339,0.000854954166738454,0.00239780763966628,-0.00384474880700745,0.00555465714048436,0.721429792479721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,36430,-0.00289442325195581,0.00812311324392843,-0.0188157252100555,0.0130268787061439,0.721607324426335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,36538,0.00138309099450648,0.00388702989534621,-0.00623548760037209,0.00900166958938504,0.721979745717024
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,36792,0.00163230173212431,0.00459039954598042,-0.00736488137799731,0.0106294848422459,0.722153179301154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,39106,0.00245933535076873,0.00694375630059108,-0.0111504269983898,0.0160690976999273,0.723209348462082
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,36363,0.00204918434338165,0.00579205290808724,-0.00930323935646935,0.0134016080432326,0.72350042933021
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,36538,-0.00175126200429489,0.00495432937888854,-0.0114617475869164,0.00795922357832664,0.723733641808872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,38741,-0.00154618228880652,0.00439541843988149,-0.0101612024309742,0.0070688378533612,0.725014725413614
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36430,0.00115190269058037,0.00327806878637089,-0.00527311213070658,0.00757691751186732,0.725296616142955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,39241,0.000977507100855031,0.00278395459557969,-0.00447904390648117,0.00643405810819123,0.725501795887386
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36420,0.00296092369671332,0.00847471075393943,-0.013649509381008,0.0195713567744346,0.726807312366327
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36420,0.000857872699325192,0.00246002771264742,-0.00396378161746375,0.00567952701611413,0.727301760903759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39062,-0.00285246173782997,0.00818757873979002,-0.0189001160678184,0.0131951925921585,0.727552944681074
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,38741,0.00169032754369292,0.00486458970710043,-0.00784426828222393,0.0112249233696098,0.728238757233947
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,36806,0.000972208903615951,0.00280203832457823,-0.00451978621255738,0.00646420401978928,0.728623339652806
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39099,-0.00106229206422545,0.0030796964947785,-0.00709849719399131,0.0049739130655404,0.730148741363167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,36391,0.00146866178319924,0.00427275056478006,-0.00690592932376969,0.00984325289016816,0.731057010115214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,36743,0.00169883551863074,0.00497017765839286,-0.00804271269181925,0.0114403837290807,0.732502624430386
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36500,0.00103716486245117,0.00303624186942843,-0.00491386920162855,0.00698819892653088,0.732661423372756
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36430,-0.00136091956551251,0.00398761586134259,-0.00917664665374398,0.00645480752271896,0.732893594624403
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,36430,-0.000906350928800182,0.0026978194399478,-0.00619407703109786,0.0043813751734975,0.736909010979743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,36391,0.00340947362102534,0.0101572594956481,-0.0164987549904449,0.0233177022324956,0.737126365844743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39283,-0.00217021457713728,0.00649157501724177,-0.0148937016109312,0.0105532724566566,0.738148315786653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,36538,0.00106351675314983,0.00318198366188452,-0.00517317122414384,0.00730020473044349,0.738210977970696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39084,0.000690001722157828,0.00206541935332297,-0.00335822021035519,0.00473822365467085,0.738328752778551
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,38841,0.00204614265070022,0.00613135936796323,-0.00997132171050772,0.0140636070119082,0.738597323645053
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36339,-0.000809219228816742,0.00242511248224784,-0.0055624396940225,0.00394400123638902,0.738624254862282
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36339,0.00162613370311346,0.00488880468100133,-0.00795592347164915,0.0112081908778761,0.739423721912227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,39106,-0.0011702508135192,0.00353691807451338,-0.00810261023956541,0.00576210861252702,0.74074921008449
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36430,-0.00119755516654554,0.00362727431262371,-0.00830701281928802,0.00591190248619694,0.741289928650058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,38713,0.00188360562772891,0.00573201340393763,-0.00935114064398885,0.0131183518994467,0.742453973463075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,36363,0.00195088191555527,0.00593691879446712,-0.00968547892160028,0.0135872427527108,0.742462227069187
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,38741,0.00241721429684533,0.00735719604054325,-0.0120028899426194,0.0168373185363101,0.742499694368054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39106,-0.00092822601878045,0.00285295715188747,-0.0065200220364799,0.004663569998919,0.744916304938199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39241,0.00213389987435001,0.00657957570824909,-0.0107620685138182,0.0150298682625182,0.745698822820595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,36339,0.00108332276822641,0.00334269299295276,-0.00546835549796101,0.00763500103441382,0.745877730701209
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,38841,0.00271820675031279,0.00839522649526733,-0.0137364371804112,0.0191728506810368,0.746109090248326
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,38841,-0.00197192349492037,0.00609045290196369,-0.0139092111827692,0.00996536419292846,0.746114507166519
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,39024,-0.00074168681029062,0.00229605745494699,-0.00524195942198672,0.00375858580140548,0.746679822516758
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,39140,0.00173827651244252,0.00542897205756524,-0.00890250872038536,0.0123790617452704,0.748832318661692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36430,0.00128509227670635,0.004024379385296,-0.00660269131847382,0.00917287587188651,0.749484002490521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36391,-0.00116968554858062,0.00367559458695219,-0.00837385093900691,0.00603447984184568,0.750315557611507
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,39162,0.00127624944325094,0.00402662028885483,-0.00661592632290453,0.0091684252094064,0.751283577574837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36339,0.00420746069685385,0.0133369781494913,-0.0219330164761491,0.0303479378698568,0.752407584988353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36339,0.00158628330888117,0.00511874077824721,-0.00844644861648336,0.0116190152342457,0.756644325520767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36420,0.00200614098980547,0.00649502174905619,-0.0107241016383447,0.0147363836179556,0.75742277455048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,39093,0.000683030993095331,0.00221550809713605,-0.00365936487729133,0.00502542686348199,0.757861768409308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,36339,-0.00327655355131689,0.0107149535670688,-0.0242778625427718,0.017724755440138,0.759767660999275
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36421,0.0010115390025418,0.00334158052912498,-0.00553795883454317,0.00756103683962677,0.762113799469191
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36363,-0.00163921561655773,0.00541940880059883,-0.0122612568657314,0.00898282563261597,0.762297841443663
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36391,-0.0014414743943803,0.0047763573056344,-0.0108031347134237,0.00792018592466313,0.762814365770219
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,36796,0.00076262347194864,0.00254801727204788,-0.0042314903812652,0.00575673732516248,0.764715393247436
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39099,-0.00337427502814754,0.0113511175168226,-0.0256224653611198,0.0188739153048248,0.76626925571632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,36731,-0.00146419398328757,0.00492827760815554,-0.0111236180952724,0.00819523012869728,0.76639453961416
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,36421,-0.0018224526077022,0.00614825483815833,-0.0138730320904925,0.0102281268750881,0.766915879997062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39098,-0.000727622236869779,0.00245534060172513,-0.00554008981625104,0.00408484534251148,0.766972426505885
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,36430,0.00173501058378539,0.00586707455517454,-0.00976445554435671,0.0132344767119275,0.767448898497323
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,36743,-0.000581230083103226,0.0019773430610471,-0.00445682248275555,0.00329436231654909,0.768804675442348
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,38727,0.000856868329337371,0.00292405231206854,-0.00487427420231696,0.00658801086099171,0.769494611353417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36363,0.00261981607509913,0.0089565173779604,-0.0149349579857032,0.0201745901359015,0.769906248155009
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,38841,0.00176613857027237,0.00604995180113342,-0.0100917669599491,0.0136240441004939,0.770347202960752
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,38841,0.0017725489226058,0.00611561206846302,-0.0102140507315817,0.0137591485767933,0.77194266631571
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36430,-0.00182877312847517,0.00632360500506256,-0.0142230389383978,0.0105654926814475,0.772434727403971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",36731,0.00117147897280848,0.00407193812862466,-0.00680951975929586,0.00915247770491282,0.773584335819901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,36712,-0.00154280153387727,0.00537153613529431,-0.0120710123590541,0.00898540929129957,0.773950082502335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36398,-0.00103233008247705,0.00360285526787013,-0.00809392640750252,0.00602926624254841,0.774476111604025
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,39099,-0.000716967812205648,0.00254068974519207,-0.0056967197127821,0.0042627840883708,0.777798467180594
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,36731,-0.00136713533582252,0.00486062603348237,-0.010893962361448,0.00815969168980293,0.778509882870955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,38974,-0.000717811092582894,0.00261202962336743,-0.00583738915438305,0.00440176696921726,0.783466197073364
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36391,-0.0019179997563905,0.00701672766552274,-0.0156707859808151,0.0118347864680341,0.784591180760764
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,38841,0.00157024967957144,0.00576253195585147,-0.00972431295389744,0.0128648123130403,0.785246720537949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36420,0.00101947948106605,0.00378320500307083,-0.00639560232495278,0.00843456128708489,0.787568541081088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36421,0.000771424869901199,0.00288610321491854,-0.00488533743133914,0.00642818717114153,0.789250716225592
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,36747,-0.000677329932414242,0.00254085756502331,-0.00565741075985993,0.00430275089503145,0.789800420831417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36339,0.000815374431050357,0.00306200703377849,-0.00518615935515548,0.0068169082172562,0.79002214009985
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,39095,-0.000865094458207665,0.00326180637657843,-0.00725823495630138,0.00552804603988605,0.790844008881288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36430,0.00111792829398467,0.00422150275364379,-0.00715621710315716,0.00939207369112651,0.791154307896694
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,36363,-0.000931679532876167,0.00353042346614427,-0.00785130952651893,0.00598795046076659,0.791861154638683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39197,0.000843014457191325,0.00319821684306528,-0.00542549055521663,0.00711151946959928,0.79210025441058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,38924,0.000937344631931801,0.00356766620030373,-0.00605528112066351,0.00792997038452712,0.792759759206991
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39162,-0.000655842312231817,0.00249741787768013,-0.00555078135248487,0.00423909672802124,0.79285614569418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,36430,0.00106168801972094,0.00405234109947187,-0.00688090053524392,0.0090042765746858,0.793330557723051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36391,-0.000816842689511941,0.00313134275436847,-0.00695427448807415,0.00532058910905026,0.794204606681055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36430,0.00175912537953429,0.00679712892927928,-0.0115632473218531,0.0150814980809217,0.795790570119555
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,36363,-0.00114495952857796,0.00443054411795814,-0.00982882599977593,0.00753890694262,0.796083846182608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,39291,-0.00186666778240763,0.00722424339554163,-0.0160261848376692,0.012292849272854,0.796109856904027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,38391,0.000671507896398648,0.00259989533606455,-0.00442428696228787,0.00576730275508517,0.7961924216851
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36420,0.0013878508458288,0.00540706655843227,-0.00920999960869845,0.0119857013003561,0.79743501327209
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,36748,0.000563019183028372,0.00220391672789553,-0.00375665760364687,0.00488269596970362,0.798369592690682
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36363,-0.00130614164492334,0.00511673602950038,-0.0113349442627441,0.00872266097289741,0.798519909155068
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36363,0.00117039797719889,0.00459175006740025,-0.00782943215490559,0.0101702281093034,0.798811108059003
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39023,-0.000742177761534221,0.0029266767348979,-0.0064784641619341,0.00499410863886566,0.799815283770988
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39226,0.000592659763813153,0.0023620361427766,-0.00403693107602898,0.00522225060365529,0.801886630280473
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,39255,-0.000669328305450903,0.0026960759657345,-0.00595363719829052,0.00461498058738872,0.803936417463842
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,36782,-0.00250430608472579,0.0101042291842914,-0.0223085952859369,0.0172999831164853,0.804256481892052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,38741,0.000728270655723407,0.00297139460674076,-0.00509566277348848,0.00655220408493529,0.806387115231012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36391,0.00111086287533609,0.00455617017745576,-0.00781923067247721,0.0100409564231494,0.807378052497574
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,39283,-0.00122674661456645,0.00504273146875953,-0.0111105002933351,0.00865700706420223,0.807799273915544
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,38713,0.00206621427565259,0.00851849326955878,-0.0146300325326826,0.0187624610839878,0.808352480869474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,36792,-0.000759686117203803,0.00316179679182997,-0.00695680782919054,0.00543743559478293,0.810124464169994
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,36456,-0.00184037608229295,0.00769355862834303,-0.0169197509938453,0.0132389988292594,0.81094664854411
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",36747,-0.00132733330633081,0.0055521049513404,-0.012209459010958,0.00955479239829637,0.811056282081293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,36806,0.000401259659356184,0.0016929881444535,-0.00291699710377267,0.00371951642248503,0.812650702504346
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39274,-0.000788109105701392,0.00333978505267586,-0.00733408780894607,0.00575786959754329,0.813454431551854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36339,0.00191312328326856,0.00812072424755562,-0.0140034962419405,0.0178297428084776,0.813758344829306
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36391,-0.00111095999231146,0.00473648511806598,-0.0103944708237208,0.00817255083909786,0.814559000430978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36538,-0.00108986252402779,0.00473618781546424,-0.0103727906423377,0.00819306559428212,0.818006997222554
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,38841,-0.000966559732659618,0.00423294300739602,-0.00926312802715581,0.00733000856183657,0.819383297394153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,36339,0.00194250776907228,0.00853006467541371,-0.0147764189947386,0.0186614345328831,0.819863876847121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36391,-0.00134132465917167,0.00589067742939913,-0.012887052420794,0.0102044031024506,0.819880889772014
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36421,0.00163851403111948,0.00728375322016407,-0.0126376422804021,0.0159146703426411,0.822018226757157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,36767,-0.000729786120592632,0.00324533796529575,-0.00709064853257231,0.00563107629138705,0.822082296586887
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36421,0.000891642425756652,0.00397190495978649,-0.00689329129542487,0.00867657614693818,0.822381758990863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,39144,-0.00314400485288992,0.014011405588814,-0.0306063598069654,0.0243183501011855,0.822457652858454
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,38841,-0.00064876392698586,0.00290233257522461,-0.00633733577442611,0.00503980792045439,0.823124603207167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36363,0.00122343886150243,0.00547580711741052,-0.00950914308862219,0.011956020811627,0.823207453035174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,36363,-0.00110424220701023,0.00494299843188624,-0.0107925191335073,0.0085840347194868,0.823231576235379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36339,-0.00052393714766685,0.002373149122286,-0.00517530942734742,0.00412743513201372,0.825269552405348
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,36538,0.00117171263702259,0.00532211151807949,-0.00925962593841321,0.0116030512124584,0.825750595115289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,36430,-0.000333983359023693,0.00154257926641661,-0.00335743872120025,0.00268947200315286,0.828593986080467
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36321,-0.00123407072333211,0.00576104973526095,-0.0125257282044436,0.0100575867577793,0.830387309438144
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,36677,0.00141410829735073,0.00668546436354945,-0.0116894018552062,0.0145176184499077,0.832485021829086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,36731,-0.000770182123468075,0.00366974671284506,-0.0079628856806444,0.00642252143370825,0.833769825892511
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,39049,-0.00115332147712392,0.00552539095082823,-0.0119830877407472,0.00967644478649941,0.834660882366153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39241,-0.000510802363725436,0.00251041698520731,-0.00543121965473176,0.00440961492728089,0.838767949026395
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,36538,0.000856965619919397,0.00424636369066758,-0.00746590721378906,0.00917983845362786,0.84006721938166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,36731,-0.000704123952619636,0.00349215585339579,-0.00754874942527538,0.0061405015200361,0.840209049511019
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,38841,-0.000764990495004988,0.00385361835617257,-0.00831808247310323,0.00678810148309325,0.842646986036128
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,38841,-0.000649765459684625,0.00330834957150569,-0.00713413061983577,0.00583459970046652,0.844298434627721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,36391,-0.000736232658607036,0.00374914593573622,-0.00808455869265002,0.00661209337543595,0.844321073154458
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39162,-0.000774685713001797,0.00396763729000628,-0.00855125480141411,0.00700188337541052,0.845198936021733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",39255,0.00132433947722818,0.00681259085471786,-0.0120283385980188,0.0146770175524752,0.84586849412492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39099,0.00216897075714569,0.0111638137568124,-0.0197121042062066,0.024050045720498,0.84595467452657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36391,0.00128335594325277,0.00661733507728606,-0.0116866208082279,0.0142533326947334,0.846227192202277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39255,0.000601034727916346,0.00310823139439922,-0.00549109880510613,0.00669316826093882,0.846672761461462
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,36500,-0.00073658214305595,0.00381749574724499,-0.00821887380765613,0.00674570952154423,0.847001977513577
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,36421,0.000627226966986153,0.00325592837892322,-0.00575439265570336,0.00700884658967566,0.847242846021525
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36430,-0.000812332916333197,0.00424223412082559,-0.00912711179315135,0.00750244596048495,0.848147114727312
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39099,0.000811787691395742,0.00427364982556441,-0.0075645659667105,0.00918814134950199,0.849349391486583
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,36421,-0.00139942738545318,0.00740824813490513,-0.0159195937298672,0.0131207389589609,0.850173260167862
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39162,0.00208780142208964,0.0111755502867419,-0.0198162771399246,0.0239918799841039,0.851805286090488
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,39241,0.000596854947321901,0.00321693257377847,-0.0057083328972839,0.0069020427919277,0.852811545129955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36339,-0.0015685259126735,0.00858015907588696,-0.0183856377014119,0.0152485858760649,0.854951257603672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,36430,-0.0012477044075044,0.00702180507728088,-0.0150104423589749,0.0125150335439661,0.858969317574227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39023,0.000756783845891673,0.00428317906236317,-0.00763824711634014,0.00915181480812349,0.859756284763831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,36548,0.000583386390724195,0.00336496463393891,-0.00601194429179607,0.00717871707324446,0.862362792722223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39180,0.000386206149048334,0.00222936649424594,-0.00398335217967371,0.00475576447777038,0.862468351878154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,39219,-0.000483814663630143,0.00280042244139165,-0.00597264264875778,0.0050050133214975,0.862838515384229
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39291,0.000460128998652808,0.00267547142793914,-0.00478379500010791,0.00570405299741353,0.863455089688678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39099,-0.00131982080721516,0.00771347081964315,-0.0164382236137157,0.0137985819992854,0.864142723604836
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36420,0.000722473995624641,0.00425856586375401,-0.00762431509733321,0.00906926308858249,0.865286598094828
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,36538,0.00138075989587512,0.00816549651282979,-0.0146236132692713,0.0173851330610215,0.865723145187955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,38727,-0.00046924383802191,0.00278083008601517,-0.00591967080661165,0.00498118313056783,0.866001591750236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36391,0.000717296014203205,0.00427855238403534,-0.00766866665850606,0.00910325868691247,0.866861944418657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,36339,0.000680302905289024,0.00408977856962025,-0.00733566309116666,0.00869626890174471,0.867890325694305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36507,0.000783410415833109,0.00471903913629876,-0.00846590629131246,0.0100327271229787,0.868151279110971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,38832,-0.000512732926357927,0.00309962176264443,-0.00658799158114101,0.00556252572842515,0.868617298053541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36430,0.000627494227076818,0.00388866987931365,-0.00699429873637794,0.00824928719053158,0.871808724765565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,36391,0.000703177902385439,0.00436871322154498,-0.00785950001184272,0.0092658558166136,0.872129334737017
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,38677,0.000678365350095974,0.00428620222972993,-0.00772259102017469,0.00907932172036663,0.8742483868785
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,38741,0.00124997953953194,0.00789947632121981,-0.0142329940500589,0.0167329531291228,0.874273183349368
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36430,-0.0013545721553251,0.00858151049653978,-0.0181743327285431,0.0154651884178929,0.874579303753799
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,36430,0.000664967309573001,0.00424111155199078,-0.00764761133232892,0.00897754595147493,0.875412235019169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,36538,-0.00120310392694968,0.00770393026037933,-0.0163028072372932,0.0138965993833938,0.875903439385132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,39071,0.00128727921766439,0.00824544897886811,-0.0148738007809171,0.0174483592162459,0.875940532186997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,36806,0.000456380332334507,0.00293135095310989,-0.00528906753576089,0.0062018282004299,0.876280263760644
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,36339,-0.000867361357959172,0.00563872696419743,-0.0119192662077861,0.0101845434918678,0.877752420457405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36363,0.000490154242859977,0.00320143192700391,-0.00578465233406768,0.00676496081978763,0.878318188085942
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",36743,0.0012415336278102,0.00812353848774432,-0.0146806018081687,0.0171636690637891,0.878533447137961
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36421,-0.000750342674931578,0.00492038094835579,-0.0103942893337089,0.00889360398384577,0.878797511299975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,36776,-0.000343389818009074,0.00227811456124196,-0.00480849435804332,0.00412171472202517,0.880187733047407
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,36391,0.000706839544603433,0.00478872419174481,-0.00867905987121639,0.0100927389604233,0.88265689845022
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39095,0.000510748014911889,0.0034664510408213,-0.00628349602509786,0.00730499205492163,0.882865356578818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,36527,-0.000306582395828603,0.00209583089620292,-0.00441441095238633,0.00380124616072913,0.883701079845665
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36363,0.000557885702437811,0.00381400385423513,-0.00691756185186305,0.00803333325673867,0.883708254873219
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39117,0.000319711649293473,0.0022066026226,-0.00400522949100252,0.00464465278958947,0.88480071092602
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,36731,0.00129568890673784,0.0090348215512596,-0.016412561333731,0.0190039391472067,0.885968180784099
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,36538,-0.00101621569913496,0.00712596132792858,-0.014983099901875,0.0129506685036051,0.886602421329433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36363,0.00120890987417155,0.00853382726742418,-0.0155173915699798,0.0179352113183229,0.88735012238642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",38741,-0.000569954006136024,0.00406746469930338,-0.00854218481677065,0.00740227680449861,0.888563024701935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36421,-0.000666491882615011,0.00479629152327658,-0.0100672232682371,0.00873423950300709,0.889484115108558
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,38832,0.0004104986066075,0.00296710907842825,-0.00540503518711186,0.00622603240032687,0.889965920598954
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,38841,0.000397104516703277,0.00288201222209794,-0.00525163943860869,0.00604584847201525,0.890410419040167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36391,-0.000504107050265911,0.0037507090564692,-0.00785549680094553,0.00684728270041371,0.893085962394033
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,36391,-0.000938447972008118,0.00699797837925169,-0.0146544855953414,0.0127775896513252,0.893323498251369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36420,0.000255993729850697,0.00193379365327003,-0.00353424183055857,0.00404622929025996,0.89468662011977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39291,-0.000446112098677505,0.00337021846011853,-0.00705174028050981,0.00615951608315481,0.894694240994371
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39023,0.00102203738431837,0.00779031093683894,-0.0142469720518859,0.0162910468205227,0.895624056828443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,38841,0.000653338137721095,0.00498342332773889,-0.00911417158464712,0.0104208478600893,0.895696161577803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36420,-0.000495484614771723,0.00382390578996547,-0.00799033996310404,0.00699937073356059,0.896904340079103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,38741,0.000580594373176372,0.00455824589492649,-0.00835356758087954,0.00951475632723229,0.898647441040389
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39106,0.000314639709648348,0.00248813382227544,-0.00456210258201151,0.00519138200130821,0.899372561436555
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36430,0.00111335048846553,0.00881471345321753,-0.0161634878798408,0.0183901888567719,0.899491790751741
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39161,0.000920550344381976,0.00747243700612982,-0.0137254261876325,0.0155665268763964,0.901956054822492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,36391,0.000597278666323942,0.0050497312085167,-0.0093001945023688,0.0104947518350167,0.905848255245353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36391,-0.000508978009398869,0.00435231556269315,-0.00903951651227744,0.0080215604934797,0.906906155526861
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,36791,-0.000854993367764386,0.00733643482620041,-0.0152344056271172,0.0135244188915884,0.907225828995881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36320,0.000511501131710888,0.00441237170636516,-0.00813674741276483,0.0091597496761866,0.907714399618595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,36767,-0.00123803694887343,0.0107079808772768,-0.022225679468336,0.0197496055705891,0.907956975670996
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,36421,-0.000723635425610008,0.00627804978253735,-0.0130286129993832,0.0115813421481632,0.908237424608999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,36731,-0.000490873117378757,0.0042669742348234,-0.00885414261763262,0.00787239638287511,0.908415137037377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,38444,-0.000222087917409505,0.00196521401322116,-0.00407390738332297,0.00362973154850396,0.910024553020276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39046,0.000345610884550781,0.00312736340303403,-0.00578402138539591,0.00647524315449747,0.912004869938915
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,36472,0.00142594700457672,0.0129462424878434,-0.0239486882715963,0.0268005822807498,0.912297166567243
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,36414,-0.000429478604394539,0.00394659699768217,-0.00816480871985159,0.00730585151106251,0.913345006022441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36363,0.00052547952015803,0.00489831410647027,-0.00907521612852369,0.0101261751688398,0.91457045335255
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,36430,-0.000288067247709386,0.00275129532311189,-0.0056806060810087,0.00510447158558993,0.916613621027511
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36430,-0.000865137360077481,0.00844760721022639,-0.0174224474921212,0.0156921727719662,0.918431197790901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36430,-0.000383970811237818,0.0038088842452548,-0.00784938393193723,0.00708144230946159,0.919703481764288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,36747,0.000357817181099036,0.0035656102130134,-0.00663077883640723,0.0073464131986053,0.920066199703546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,38832,0.000663288615299942,0.00661234151899635,-0.0122969007619329,0.0136234779925328,0.920099004997324
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",38727,-0.00074971874131637,0.0075406694335697,-0.015529430831113,0.0140299933484802,0.920803471333965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36430,0.000543118550805099,0.00559433663396005,-0.0104217812517566,0.0115080183533668,0.922661522516113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36363,-0.000474974763528307,0.00500561172037222,-0.0102859737354579,0.00933602420840125,0.924404947140702
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39106,-0.000246764521765131,0.00261705771407318,-0.00537619764134856,0.00488266859781829,0.924879379908058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,36538,0.000338970567656797,0.00363515049325053,-0.00678592439911425,0.00746386553442784,0.925708003542382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36391,-0.000508450891023057,0.00546457301889779,-0.0112190140080627,0.0102021122260166,0.925869343308878
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",36767,-0.000602638319343666,0.00650071776936552,-0.0133440451473001,0.0121387685086127,0.92614067376872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39093,0.000321499099198072,0.00348704961354417,-0.00651311814334851,0.00715611634174465,0.92654191689862
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36430,0.000266774637321026,0.0029045675984089,-0.00542617785556041,0.00595972713020246,0.926821388414218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,36731,0.000466656153537981,0.00529239383744367,-0.00990643576785161,0.0108397480749276,0.929739059875707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",38705,-0.000381323516445962,0.0043663471207881,-0.00893936387319065,0.00817671684029872,0.9304084891883
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,36420,0.000141242436564522,0.00165371636093857,-0.00310004163087507,0.00338252650400411,0.931937515116205
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36339,0.000336607884208553,0.00402139972919389,-0.00754533558501147,0.00821855135342858,0.933292992600567
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,39106,0.000594476741062271,0.00712439363024523,-0.0133693347742184,0.0145582882563429,0.933500844645978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36430,0.000453056543388458,0.00552255864626539,-0.0103711584032917,0.0112772714900686,0.934618251500755
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39291,-0.000521545250473148,0.00640602866012256,-0.0130773614243134,0.0120342709233671,0.935113171576932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36339,-0.00027657580414491,0.00343149211750433,-0.00700230035445339,0.00644914874616357,0.935761928962803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,38987,0.000417903472056868,0.00547155197833267,-0.0103063384054752,0.0111421453495889,0.939119778196086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36363,-0.000227549133400012,0.00315285957320636,-0.00640715389688448,0.00595205563008445,0.942465941850058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,36743,-0.00158388680041566,0.023509214936143,-0.047661948075256,0.0444941744744247,0.946285793059414
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,36391,-0.000344240129350925,0.00565846191893966,-0.0114348254904727,0.0107463452317708,0.951490516679823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36339,0.000515712619932012,0.00849837995282346,-0.016141112087602,0.017172537327466,0.95161213373667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36430,-0.000264628796865463,0.00460532425469362,-0.00929106433606495,0.00876180674233402,0.954178494701249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,38841,-0.000195686356403315,0.00341409573365919,-0.00688731399437532,0.00649594128156869,0.954293295712033
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,38841,0.000174581927707227,0.00306293079790283,-0.00582876243618231,0.00617792629159677,0.954547288897474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36391,-0.000278091740753464,0.00522590902155385,-0.010520873422999,0.00996468994149209,0.957562216045257
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36363,0.000218439806235608,0.00411637212133121,-0.00784964955157356,0.00828652916404477,0.957680091074089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,36500,0.000447330426190253,0.00866624449113723,-0.0165385087764387,0.0174331696288192,0.958834239915652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,38841,0.000161592050679816,0.00318336555681156,-0.00607780444067084,0.00640098854203047,0.959516336724424
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,38987,5.78559455200362e-05,0.00114254348266596,-0.00218152928050524,0.00229724117154531,0.959614770124892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39093,-0.000125100687327264,0.00254794556017504,-0.00511907398527033,0.0048688726106158,0.960841322939201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,38741,0.000210952230250851,0.00448981255913452,-0.00858908038565281,0.00901098484615451,0.962526099383196
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39139,-0.000210404539738771,0.00457410760956522,-0.00917565545448661,0.00875484637500907,0.96331161956675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,36391,-0.000240139452941603,0.00549255040756775,-0.0110055382517744,0.0105252593458912,0.965127546098962
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36339,0.000337792643157023,0.00802114467713096,-0.0153836509240197,0.0160592362103337,0.966409471748091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",36767,-0.000352232935412535,0.00845362110784008,-0.0169213303067791,0.016216864435954,0.966765191968672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,36538,0.000154380095214148,0.00406158653577198,-0.00780632951489894,0.00811508970532723,0.969680466214928
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36500,-0.000304819267092018,0.00829480726939811,-0.0165626415151123,0.0159530029809283,0.970686353899128
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,38727,0.000184460095128011,0.0053375675886892,-0.0102771723787028,0.0106460925689589,0.972431994095047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36363,-0.000120208303402769,0.003711396474428,-0.00739454539328164,0.0071541287864761,0.974162376751622
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,36731,-0.000143879994872048,0.00458419965709597,-0.00912891132278016,0.00884115133303606,0.974962139719455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,38699,0.000325917391870739,0.0110748140606117,-0.0213807181669281,0.0220325529506696,0.976523078366479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36500,7.63217946267427e-05,0.00261500683859043,-0.0050490916090105,0.00520173519826399,0.976716645101866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36363,-0.000124190481140392,0.00433136845761434,-0.0086136726580645,0.00836529169578372,0.977126372174796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,38907,-0.00026853449484481,0.00979299610199071,-0.0194628068547466,0.018925737865057,0.978124251629448
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,38841,0.000121390564146449,0.00455163193739928,-0.00879980803315615,0.00904258916144904,0.978723552153534
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,38727,0.00017817250663886,0.00687340464155849,-0.0132937005908158,0.0136500456040935,0.979319887448224
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39093,-0.00011215611658198,0.00520082475973571,-0.010305772645664,0.0100814604125,0.982795184726595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36363,-0.000138690045779394,0.0064610485740612,-0.0128023452509393,0.0125249651593805,0.982874616338822
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,36767,-0.000140022077789006,0.0070818231947895,-0.0140203955395764,0.0137403513839984,0.984225529535953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,38882,0.000282443159045911,0.0159026948923981,-0.0308868388300544,0.0314517251481462,0.985829984219325
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,36391,-9.18604109179613e-05,0.00559310362629182,-0.0110543435184499,0.010870622696614,0.986896497701959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,38741,6.57092289801422e-05,0.00438691872744441,-0.00853265147681089,0.00866406993477118,0.988049576177494
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39255,7.29474532251828e-05,0.00591120149474815,-0.0115130074764812,0.0116589023829316,0.990154078788956
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36339,8.42265448673738e-05,0.00742358100374395,-0.0144659922224708,0.0146344453122055,0.990947728388164
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,36430,-6.06472703489427e-05,0.0058318751593048,-0.0114911225825864,0.0113698280418885,0.99170289405463
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],38841,4.92484307844919e-05,0.00506499734416695,-0.00987814636378273,0.00997664322535172,0.992242189882174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36538,-5.78518692863781e-05,0.00607630126849015,-0.0119674023555271,0.0118516986169543,0.992403683809359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,38741,-4.6413078428769e-05,0.00489869318331513,-0.00964785171772642,0.00955502556086888,0.992440616077444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,36767,-2.71571881419561e-05,0.00299656025435371,-0.00590041528667523,0.00584610091039132,0.992769181005476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36339,-3.1905315177095e-05,0.00592654618701002,-0.0116479358417167,0.0115841252113626,0.995704728415614
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36363,-3.33612425406769e-05,0.00697546207372561,-0.0137052669070429,0.0136385444219615,0.996184082666847
